data_2mgp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mgp _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.823 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.2 p-10 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.045 0.45 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.66 ' HB3' ' HE1' ' A' ' 89' ' ' TYR . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.966 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.581 HG21 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.682 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.485 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.64 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.626 HD21 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.688 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.704 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.764 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.703 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.704 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.764 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.643 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.547 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.096 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 76' ' ' LYS . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.807 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.626 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.522 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.823 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 17.4 m-80 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.74 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.503 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.096 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.61 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.586 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.78 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.773 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.691 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.666 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.7 OUTLIER -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.554 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.691 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.851 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.757 HD23 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.631 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.631 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.486 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 12.0 m-80 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.643 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.807 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.406 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.787 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.6 m-80 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.934 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.522 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.819 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' HG23 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.773 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.626 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.699 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.847 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 11' ' ' THR . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.437 ' H ' HG22 ' A' ' 11' ' ' THR . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.604 HD12 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 14' ' ' ILE . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.672 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m-80 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.728 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.699 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.695 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.685 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.812 HD23 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.672 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.775 ' HZ2' ' HA ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' CG ' ' HG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.423 ' HG1' ' CG ' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.617 HG21 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.775 ' HA ' ' HZ2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 47' ' ' ASN . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.095 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.671 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.887 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.42 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.7 m-80 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.847 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.095 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.671 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.596 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 1.089 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.64 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.554 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.653 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.774 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.9 m-80 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.725 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 19' ' ' GLY . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.841 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.567 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.425 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' ILE . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.439 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.672 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.925 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.839 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.531 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 1.089 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.777 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 24.2 m-80 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.533 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.807 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.541 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.54 ' HA ' ' HG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.5 p-10 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.584 HG22 HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.663 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.579 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.715 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.759 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 19' ' ' GLY . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t30 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.4 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.855 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.46 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 22.9 m-80 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.895 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.536 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.567 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.783 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.626 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.581 HG22 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.658 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 7.9 m-80 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.593 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.69 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 14' ' ' ILE . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.771 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.734 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.575 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.811 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.687 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HZ1' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.593 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.687 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.615 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.5 m-20 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.033 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.599 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.456 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.778 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.515 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.945 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.69 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.529 ' HA ' HD23 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.033 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.617 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.603 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.586 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.54 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.773 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.76 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.506 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' N ' HG21 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.637 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.689 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.896 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.659 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.553 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.659 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.059 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.903 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.78 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.903 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.676 HD22 ' HB2' ' A' ' 3' ' ' ASP . 11.3 m-80 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.885 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.419 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' CD2' ' A' ' 34' ' ' LEU . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.059 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.53 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' HA ' HG21 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.773 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.648 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.08 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.607 HG21 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.691 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.619 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 1.08 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.648 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HD2' HG11 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 33' ' ' LEU . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.694 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 43' ' ' THR . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.594 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 m120 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.035 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.409 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.403 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.693 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.501 HD11 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.67 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 9.8 m-80 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.763 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.675 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.444 HG11 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.035 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.6 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.683 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.602 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.847 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.49 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 20' ' ' CYS . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.742 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.455 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 19' ' ' GLY . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.655 HD23 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.585 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.585 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.648 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.69 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.643 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.761 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.761 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.655 ' SG ' HD23 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.82 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.54 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.68 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.57 ' HA ' HG21 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.2 p-10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.799 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.726 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 14' ' ' ILE . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.779 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.648 ' HB3' HD12 ' A' ' 14' ' ' ILE . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 1.117 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.84 HD23 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 1.117 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.476 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.721 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 10.5 m120 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.107 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.58 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.842 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.84 ' SG ' HD23 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 16.5 m-80 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.947 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.107 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.72 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.561 ' HA ' HG23 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.829 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.481 ' O ' HG11 ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.607 HG21 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' H ' ' CD ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.791 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.627 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.67 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.728 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 19' ' ' GLY . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.72 HD23 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.791 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.599 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.599 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.502 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.6 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.419 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.489 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 54' ' ' ILE . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.092 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.591 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.579 ' HB2' HD11 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.629 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.759 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.72 ' SG ' HD23 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 62' ' ' THR . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.723 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.829 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.4 m-80 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.87 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.568 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.092 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.782 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.49 ' HA ' HG21 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.673 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.911 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.101 0.476 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.814 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.998 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.59 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.704 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.56 ' N ' HD21 ' A' ' 33' ' ' LEU . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD11 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.998 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.715 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.56 HD21 ' N ' ' A' ' 19' ' ' GLY . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.76 HD23 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.583 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.706 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.663 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.596 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.2 m-20 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.081 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.579 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.441 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.902 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.902 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.76 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 62' ' ' THR . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.434 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.814 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 28.8 m-80 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.439 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.081 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.576 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.652 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.911 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.949 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.773 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.534 ' H ' HG21 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 18' ' ' ALA . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.787 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.78 ' HB3' HD12 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HZ ' ' HE2' ' A' ' 6' ' ' HIS . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.721 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.802 HD23 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.745 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.787 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.5 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.596 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.588 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 16.0 m120 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.572 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.4 HD22 ' NH1' ' A' ' 31' ' ' ARG . 63.7 t30 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.025 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.488 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.761 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.802 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.586 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.837 HD22 ' HB2' ' A' ' 3' ' ' ASP . 5.5 m-80 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.697 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.025 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.613 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.56 ' HA ' HG21 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.949 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.741 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.671 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.68 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.687 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.739 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.739 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.446 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.445 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.639 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.413 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.142 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.755 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.646 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.646 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.746 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.8 m-80 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.909 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.142 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.764 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.565 ' HA ' HG21 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.741 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.601 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.693 ' O ' HG23 ' A' ' 7' ' ' VAL . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.565 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.531 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.72 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.726 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.5 m-80 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 24' ' ' ASP . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HD2' HG13 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.665 HD21 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.734 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.734 ' HD1' ' O ' ' A' ' 35' ' ' GLY . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.913 ' HG2' ' HG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.913 ' HG1' ' HG2' ' A' ' 40' ' ' GLU . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 49' ' ' ASN . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.552 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.3 m120 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.585 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.5 t30 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.728 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.493 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.753 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.753 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.665 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.8 m-80 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.565 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.728 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.511 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.638 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.517 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.675 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.801 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.585 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 4.5 p-80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.5 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG21 ' HD2' ' A' ' 15' ' ' PRO . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.613 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' HD11 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 1.069 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.585 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.701 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.48 ' N ' HD21 ' A' ' 33' ' ' LEU . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.69 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 48' ' ' ASN . 1.0 OUTLIER -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.043 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.851 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.726 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 96' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.801 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.0 m-80 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.757 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.043 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.676 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.542 ' HA ' HG21 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.726 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.855 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.675 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' LYS . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.816 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.601 HG21 HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' HD2' HG22 ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.762 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.0 m-80 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.669 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.816 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.702 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.724 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.577 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HE3' ' A' ' 38' ' ' LYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.411 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.693 HD21 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.707 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.476 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.536 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.062 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.701 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 74' ' ' SER . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.701 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.693 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.418 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.415 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.855 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.1 m-80 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.519 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.062 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.516 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.821 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.805 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.626 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.994 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.691 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 14' ' ' ILE . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.687 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.639 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.644 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.599 ' HB3' HD11 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.994 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.626 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.58 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.861 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.736 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.639 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.736 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.565 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' HG11 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.528 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.489 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.799 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.904 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.799 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.861 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.604 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.751 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.676 ' HB2' ' CB ' ' A' ' 4' ' ' PRO . 15.6 m-80 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.719 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.644 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 ' HA ' HD23 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.561 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.805 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.735 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 10.0 p-10 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.786 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.586 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.785 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.786 ' HZ ' ' HE2' ' A' ' 6' ' ' HIS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.691 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.659 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 19' ' ' GLY . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 1.099 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.618 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.473 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.41 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.855 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.85 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.436 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 62' ' ' THR . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.511 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 23.0 m-80 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.538 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 1.099 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.77 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CG ' ' HE3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 110.608 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.773 HG21 ' H ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' N ' HG21 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.773 ' H ' HG21 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 20' ' ' CYS . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.61 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.693 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.6 OUTLIER -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 15' ' ' PRO . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.777 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' GLY . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 24' ' ' ASP . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 93' ' ' VAL . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' ND2' ' A' ' 73' ' ' ASN . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB2' ' HZ2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.558 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.561 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.464 ' C ' HD22 ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.877 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.566 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.461 HD21 ' HB3' ' A' ' 52' ' ' CYS . 0.3 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.767 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.491 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.511 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.5 m-80 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.877 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.601 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.437 ' HA ' HG23 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' OD2' ' A' ' 24' ' ' ASP . 4.2 p -160.1 167.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.687 0.28 . . . . 0.0 110.294 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.823 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.2 p-10 -59.23 124.06 72.87 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.66 ' HB3' ' HE1' ' A' ' 89' ' ' TYR . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.579 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.966 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.581 HG21 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.493 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.626 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.682 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.703 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.565 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.682 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.966 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.67 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' OD2' HG12 ' A' ' 2' ' ' VAL . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.64 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.626 HD21 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.688 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.704 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.764 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.64 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.451 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.703 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.704 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.764 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.643 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.549 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.547 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.096 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.538 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 76' ' ' LYS . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.807 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.538 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.626 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.499 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.417 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.522 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.823 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 17.4 m-80 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.503 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.74 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.565 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.503 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.096 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.61 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.586 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.78 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 24' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG23 ' OD1' ' A' ' 3' ' ' ASP . 2.6 p -156.92 178.91 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.863 0.331 . . . . 0.0 110.848 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.773 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -47.49 129.41 10.45 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.819 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.519 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.55 HG23 HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.691 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.666 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.7 OUTLIER -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.554 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.691 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.851 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' HB3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.473 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.757 HD23 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.631 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.631 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.486 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 12.0 m-80 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.522 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.643 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.807 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.807 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.524 HD12 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.757 ' SG ' HD23 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.406 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.547 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.787 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 18.6 m-80 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.578 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.934 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.552 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.522 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.819 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.577 ' HA ' HG23 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.773 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.729 -0.148 . . . . 0.0 112.729 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 98' ' ' SER . 9.4 p 175.85 -177.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 m-20 -47.13 109.02 0.96 Allowed Pre-proline 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.626 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.699 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.847 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.468 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 12' ' ' ARG . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' N ' HG22 ' A' ' 11' ' ' THR . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.437 ' H ' HG22 ' A' ' 11' ' ' THR . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.604 HD12 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 14' ' ' ILE . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.672 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m-80 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.558 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.604 ' SG ' HD12 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.762 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.728 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.699 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.695 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.685 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.812 HD23 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.672 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.775 ' HZ2' ' HA ' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' CG ' ' HG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.423 ' HG1' ' CG ' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.617 HG21 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.488 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.775 ' HA ' ' HZ2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 47' ' ' ASN . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.095 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.671 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.887 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.887 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.812 ' SG ' HD23 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.42 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.598 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.626 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.7 m-80 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.515 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.847 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.558 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG11 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.095 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.671 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.598 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.599 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.407 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.599 HG11 ' CB ' ' A' ' 99' ' ' SER . 13.7 p -81.59 164.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.995 0.426 . . . . 0.0 109.987 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.596 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -95.48 125.43 49.65 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.878 -172.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 1.089 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.586 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.64 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.554 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.546 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.653 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.774 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.9 m-80 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.725 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.569 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.686 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 19' ' ' GLY . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.623 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.841 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.569 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.567 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.537 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.425 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.486 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 54' ' ' ILE . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.439 ' HB3' ' HB1' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.672 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.925 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.839 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.925 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.531 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.75 ' SG ' HD23 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.541 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 1.089 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.777 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 24.2 m-80 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.91 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.533 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.51 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.672 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.807 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.541 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.599 ' CB ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 HG21 ' OD1' ' A' ' 3' ' ' ASP . 5.3 p -177.46 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.5 p-10 -47.78 113.31 2.57 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.754 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.615 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.584 HG22 HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.663 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.548 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.579 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.667 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.759 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.715 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.759 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.597 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 19' ' ' GLY . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.696 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.629 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.694 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG21 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.637 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.572 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t30 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.4 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.465 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.855 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.696 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.631 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.46 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.691 ' SG ' HD23 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.584 HG23 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 22.9 m-80 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.567 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.895 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.536 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.567 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.538 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.783 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.584 ' HA ' HG23 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.789 HG13 ' HE2' ' A' ' 6' ' ' HIS . 4.7 p -179.44 -170.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -47.82 111.64 1.81 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 170.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.789 ' HE2' HG13 ' A' ' 2' ' ' VAL . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.771 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.811 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.581 HG22 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.581 ' HD2' HG22 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.658 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 7.9 m-80 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.593 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.69 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 14' ' ' ILE . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.771 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.734 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.575 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.811 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.539 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.886 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.687 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HZ1' ' HB2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.625 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.625 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.593 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.687 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.615 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.432 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.5 m-20 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.033 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.617 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.599 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.515 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.456 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.836 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.778 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.836 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.515 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.886 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.599 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.745 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.945 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.69 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.529 ' HA ' HD23 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.033 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.617 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.603 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.586 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.54 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.567 ' C ' ' HA ' ' A' ' 99' ' ' SER . 1.3 p -151.45 178.14 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.711 0.255 . . . . 0.0 110.914 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.773 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 -47.51 128.48 10.45 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.644 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.76 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.896 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.506 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.407 HG21 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' N ' HG21 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.605 HG22 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.637 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.689 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.896 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.606 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.78 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.662 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.659 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.553 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.553 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.659 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.464 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.54 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.54 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.059 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.567 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.903 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.78 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.578 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.903 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.731 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.676 HD22 ' HB2' ' A' ' 3' ' ' ASP . 11.3 m-80 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.885 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.419 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG22 ' CD2' ' A' ' 34' ' ' LEU . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.059 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.53 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' HA ' HG21 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.773 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 24' ' ' ASP . 2.0 p -169.34 -176.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -176.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -46.14 110.25 1.16 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 174.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.648 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.08 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.607 HG21 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.607 ' HD2' HG21 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.691 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.675 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 1.08 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.624 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.648 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 2' ' ' VAL . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HD2' HG11 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 33' ' ' LEU . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.694 HD23 ' SG ' ' A' ' 79' ' ' CYS . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.691 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.416 ' HG3' HG23 ' A' ' 43' ' ' THR . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.426 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.594 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 m120 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.474 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.035 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.403 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HB1' HD12 ' A' ' 78' ' ' ILE . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.693 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.501 HD11 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.694 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.603 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.67 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 9.8 m-80 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.763 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.675 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG11 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.035 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.6 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.683 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.603 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 24' ' ' ASP . 3.4 p -172.71 -171.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.7 OUTLIER -46.42 110.68 1.28 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 171.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.602 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.847 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.49 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 20' ' ' CYS . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.446 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.847 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.742 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.499 ' HB2' HG13 ' A' ' 2' ' ' VAL . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.742 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.455 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.432 HD23 ' N ' ' A' ' 19' ' ' GLY . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.655 HD23 ' SG ' ' A' ' 79' ' ' CYS . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.642 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.585 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.585 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.648 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.69 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.46 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.533 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.643 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.509 ' HB2' HD11 ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.761 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.642 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.505 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.761 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.655 ' SG ' HD23 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.643 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.57 HG21 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.417 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.82 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.696 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.54 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.475 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.68 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.57 ' HA ' HG21 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 98' ' ' SER . 2.2 p 177.09 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.2 p-10 -46.91 105.16 0.45 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.799 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.726 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.774 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.579 ' O ' HD11 ' A' ' 14' ' ' ILE . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.497 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.566 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.779 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.624 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.648 ' HB3' HD12 ' A' ' 14' ' ' ILE . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.774 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 1.117 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.779 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.84 HD23 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.633 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 1.117 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.476 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.547 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.447 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.571 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.721 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.436 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 10.5 m120 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.552 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.107 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.47 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.58 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.842 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.842 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.84 ' SG ' HD23 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.561 HG23 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.435 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 16.5 m-80 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.947 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.624 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.541 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.107 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.72 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.561 ' HA ' HG23 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.626 ' C ' ' HA ' ' A' ' 99' ' ' SER . 4.0 p -157.61 168.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 -47.76 131.91 11.24 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.829 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' O ' HG11 ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.518 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.728 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.607 HG21 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.426 ' H ' ' CD ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HD2' HG21 ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.791 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.627 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.67 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.728 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.409 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 19' ' ' GLY . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.72 HD23 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.791 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.599 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.59 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.502 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.6 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.485 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.419 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.489 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.489 ' H ' ' C ' ' A' ' 54' ' ' ILE . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.092 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.591 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.586 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.579 ' HB2' HD11 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.629 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.759 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.666 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.759 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.578 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.72 ' SG ' HD23 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.591 ' HD3' ' O ' ' A' ' 62' ' ' THR . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.723 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.829 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.4 m-80 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.87 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.524 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.568 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.092 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.782 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.49 ' HA ' HG21 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.673 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER 53.68 178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.544 1.138 . . . . 0.0 112.432 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.911 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -52.2 120.12 16.39 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.814 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.715 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.998 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.59 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.704 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.56 ' N ' HD21 ' A' ' 33' ' ' LEU . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD11 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.998 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.715 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.516 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.59 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.56 HD21 ' N ' ' A' ' 19' ' ' GLY . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.76 HD23 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.583 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.706 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.557 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.706 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.663 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.507 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.596 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.2 m-20 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.552 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.081 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.588 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.576 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.579 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.487 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.441 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.902 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.902 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.487 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.76 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 62' ' ' THR . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.434 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.814 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 28.8 m-80 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.556 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.439 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.081 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.576 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.652 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.592 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.911 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.555 ' O ' HG12 ' A' ' 2' ' ' VAL . 9.5 p -60.53 134.96 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.6 0.714 . . . . 0.0 112.148 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.949 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 -94.39 131.8 30.36 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.881 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.683 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.535 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.773 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.525 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.534 ' H ' HG21 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.633 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 18' ' ' ALA . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.787 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.633 ' HB1' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.78 ' HB3' HD12 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.773 ' HZ ' ' HE2' ' A' ' 6' ' ' HIS . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.723 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.721 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.723 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.802 HD23 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.745 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.787 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.5 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.596 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.588 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 16.0 m120 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.572 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.4 HD22 ' NH1' ' A' ' 31' ' ' ARG . 63.7 t30 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.025 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.488 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.466 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.761 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.761 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.802 ' SG ' HD23 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.586 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.837 HD22 ' HB2' ' A' ' 3' ' ' ASP . 5.5 m-80 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.697 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.453 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.025 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.613 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.56 ' HA ' HG21 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.949 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.606 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.864 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 68.89 170.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 111.991 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.741 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 -52.23 118.59 12.72 Favored Pre-proline 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.671 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.824 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.659 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.605 HG23 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.687 HD12 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.68 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.589 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.554 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.687 ' HB3' HD12 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.824 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.547 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.739 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.589 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.739 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.446 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.445 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.639 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.413 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.142 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.618 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.755 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.646 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.646 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.576 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.746 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.8 m-80 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.909 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.554 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 ' HA ' HD23 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.142 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.764 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.565 ' HA ' HG21 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.741 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.621 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER 60.83 176.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 112.343 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.601 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -47.64 110.82 1.46 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 173.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.786 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.601 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.693 ' O ' HG23 ' A' ' 7' ' ' VAL . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.565 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.531 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.663 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.72 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.726 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.5 m-80 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.663 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.447 ' CG ' ' H ' ' A' ' 24' ' ' ASP . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.565 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.523 ' HD2' HG13 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.627 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.665 HD21 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.734 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.734 ' HD1' ' O ' ' A' ' 35' ' ' GLY . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.491 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.913 ' HG2' ' HG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.913 ' HG1' ' HG2' ' A' ' 40' ' ' GLU . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 49' ' ' ASN . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.552 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.3 m120 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.585 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.5 t30 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.728 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.499 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB3' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.493 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.531 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.753 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.753 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.665 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.592 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.8 m-80 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.565 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG13 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.728 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB3' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.511 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.638 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p -169.2 175.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.675 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 -61.21 110.71 3.28 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.801 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.585 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 4.5 p-80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.069 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.66 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.5 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG21 ' HD2' ' A' ' 15' ' ' PRO . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.613 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.587 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.464 ' HB3' HD11 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 1.069 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.585 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.701 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.48 ' N ' HD21 ' A' ' 33' ' ' LEU . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.875 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.576 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.69 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.411 ' N ' HD21 ' A' ' 48' ' ' ASN . 1.0 OUTLIER -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.592 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.48 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.043 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.52 ' HA ' HD12 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.851 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.746 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.851 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.592 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.875 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.726 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 96' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.42 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.801 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.0 m-80 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.757 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.42 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.492 ' HA ' HD23 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.043 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.676 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.542 ' HA ' HG21 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.726 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 98' ' ' SER . 3.0 p -153.11 -176.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER -46.79 115.82 3.53 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 173.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.855 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.675 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' LYS . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.816 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.569 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.601 HG21 HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' HD2' HG22 ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.762 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.0 m-80 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.51 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.669 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.816 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.702 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.724 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.577 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.469 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.588 ' CZ3' ' HE3' ' A' ' 38' ' ' LYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.411 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.693 HD21 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.707 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.762 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.588 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.476 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.523 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.536 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.511 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.062 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' HB1' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.41 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' LYS . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.543 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.701 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 74' ' ' SER . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.51 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.693 ' SG ' HD21 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.418 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.537 HG23 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.415 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.855 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.1 m-80 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.89 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.519 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.519 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.494 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.062 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.516 ' SG ' ' HB1' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.821 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.537 ' HA ' HG23 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.616 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.571 ' O ' ' HB3' ' A' ' 99' ' ' SER . 6.5 p -106.4 151.22 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 120.357 0.122 . . . . 0.0 110.911 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.805 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -129.06 142.06 43.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 160.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.626 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.994 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.691 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 14' ' ' ILE . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.687 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.639 ' HB1' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.644 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.599 ' HB3' HD11 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.994 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.674 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.626 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.58 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.483 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.861 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.736 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.639 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.408 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.565 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.736 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.565 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.466 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' O ' HG11 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.528 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.489 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.675 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.904 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.799 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.904 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.609 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.861 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.604 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.618 HG23 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.751 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.676 ' HB2' ' CB ' ' A' ' 4' ' ' PRO . 15.6 m-80 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.719 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.644 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 ' HA ' HD23 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.561 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.618 ' HA ' HG23 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.805 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' O ' HG11 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG11 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 63.97 170.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.372 1.469 . . . . 0.0 112.702 176.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.735 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 10.0 p-10 -59.2 127.58 84.24 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.77 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.786 ' HE2' ' HZ ' ' A' ' 21' ' ' PHE . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.452 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.55 ' O ' HD12 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.586 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.785 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.786 ' HZ ' ' HE2' ' A' ' 6' ' ' HIS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.691 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.659 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.681 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 19' ' ' GLY . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.85 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.607 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.785 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.459 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.56 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.607 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.559 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 1.099 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.633 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.618 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.473 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.41 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.855 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.574 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.855 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.473 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.85 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.436 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 62' ' ' THR . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' H ' ' HG3' ' A' ' 83' ' ' GLU . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.584 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.511 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 23.0 m-80 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.874 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.585 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.538 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB2' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.524 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 1.099 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.77 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.584 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.632 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.547 ' HA3' ' HG ' ' A' ' 98' ' ' SER . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -172.21 -178.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CG ' ' HE3' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -51.37 107.94 0.94 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 178.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.777 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.773 HG21 ' H ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' N ' HG21 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.773 ' H ' HG21 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 20' ' ' CYS . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.61 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.693 ' N ' HD21 ' A' ' 17' ' ' ASN . 0.6 OUTLIER -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 15' ' ' PRO . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.615 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.777 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 26' ' ' GLY . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 24' ' ' ASP . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.446 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 93' ' ' VAL . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' HA3' ' ND2' ' A' ' 73' ' ' ASN . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HB2' ' HZ2' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.447 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.558 ' SG ' ' HB1' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 37' ' ' LYS . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.661 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.442 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.561 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.456 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.464 ' C ' HD22 ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.877 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.566 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.461 HD21 ' HB3' ' A' ' 52' ' ' CYS . 0.3 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.767 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.767 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.491 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.463 ' SG ' HD23 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.566 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.511 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.5 m-80 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.662 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.44 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.503 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.877 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.601 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.437 ' HA ' HG23 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.547 ' HG ' ' HA3' ' A' ' 1' ' ' GLY . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.797 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 5.2 p-10 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.045 0.45 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.668 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.668 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.987 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.6 m-20 -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.987 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.645 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.69 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.806 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.732 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.806 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.662 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 5.1 m-20 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.434 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.135 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.673 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.826 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.826 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.576 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.681 ' OD1' ' HB2' ' A' ' 3' ' ' ASP . 10.9 m120 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.73 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.135 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.611 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.797 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.646 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.867 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.537 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.673 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.9 m-20 -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.673 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.647 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.652 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.477 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 3.6 m120 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.569 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.023 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.539 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.689 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.818 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.732 ' SG ' HD22 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 83' ' ' GLU . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.4 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.722 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.5 m120 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.919 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.023 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.769 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.693 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 8' ' ' CYS . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 12' ' ' ARG . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.61 HD13 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.685 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.7 m120 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.587 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' HD13 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.724 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.702 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.685 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.702 ' HE3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG23 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.658 ' CA ' ' HD2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.102 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.675 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.896 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.896 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 82' ' ' LYS . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.578 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 m120 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.828 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.102 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.675 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.567 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HG3' ' OD1' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.7 m120 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.846 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.846 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.548 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.03 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.951 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.748 ' SG ' HD22 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.804 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 15.1 m120 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.03 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.808 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.503 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.5 p-10 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.473 ' CG2' HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.7 m-20 -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.707 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 1.3 m120 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 78' ' ' ILE . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.662 ' SG ' HD22 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 m120 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.877 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.591 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.79 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.634 ' HA ' HG22 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.541 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.71 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.827 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 13' ' ' ASP . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 11' ' ' THR . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.9 m120 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.706 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.732 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.579 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.8 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.746 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.637 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.746 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.663 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.411 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.1 m120 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.993 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.641 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.803 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.849 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.854 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.697 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.93 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.706 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.993 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.591 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.558 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.757 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.91 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.502 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.5 m120 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.91 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.623 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.787 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.711 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.568 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.711 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m120 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.933 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.69 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.4 m120 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.88 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.009 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.549 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.619 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.691 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.09 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HG23 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.1 m-20 -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.09 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.653 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HD2' HG12 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 74' ' ' SER . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.646 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.661 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.064 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.416 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.477 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.711 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 7.8 m120 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.693 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.064 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.663 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.722 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.791 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.864 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' A' ' 14' ' ' ILE . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.2 m-20 -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.763 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.763 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' SER . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.752 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.752 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.546 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.087 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.671 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.671 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.693 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.791 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.087 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.688 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.693 ' HA ' HG22 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.2 p-10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.532 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.796 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.639 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.79 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.701 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.591 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 1.073 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 1.073 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.564 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.564 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.593 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.807 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.444 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 69.3 m-20 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.615 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.86 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.46 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.744 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.0 m120 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.941 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.05 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.725 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.708 ' HA ' HG22 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.572 HG22 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.804 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.703 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.76 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.438 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD22 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.804 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 40' ' ' GLU . 44.5 m-80 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.617 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 50' ' ' PRO . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 5.3 m-20 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.656 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.073 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.608 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.738 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.744 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.751 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.8 m120 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.859 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.529 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.073 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.798 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.513 ' HA ' HG22 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.101 0.476 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.728 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.003 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.552 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.5 m-20 -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.003 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD22 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.569 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.753 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.61 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 78' ' ' ILE . 2.2 mm-40 -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.918 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.918 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 78' ' ' ILE . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.739 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.79 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.1 m120 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.737 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.674 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.613 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.941 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.675 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.582 ' N ' HG23 ' A' ' 11' ' ' THR . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.893 HD13 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.802 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' ASP . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.781 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.802 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.589 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 90.1 m-20 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.019 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HB2' HD13 ' A' ' 78' ' ' ILE . 6.0 mm-40 -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.535 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.785 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.781 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 3' ' ' ASP . 4.9 m120 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.714 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.019 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.631 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.677 ' HA ' HG22 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.941 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.756 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.845 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.693 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.729 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.778 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.778 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.557 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.433 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.078 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.805 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.645 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.894 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.819 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.8 m120 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.9 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.078 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.624 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.704 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.764 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.741 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m120 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.692 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.736 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.581 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.557 ' HD2' HG12 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD22 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.736 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.741 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.614 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.543 HD21 ' HB3' ' A' ' 50' ' ' PRO . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.575 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 89.6 m-20 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.492 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.508 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.765 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.658 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 88' ' ' ALA . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 19.0 m120 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB2' HD12 ' A' ' 34' ' ' LEU . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.729 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.509 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.719 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.581 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.767 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.669 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.511 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.667 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 11' ' ' THR . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.3 m120 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB3' HD13 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.105 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.71 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.71 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.87 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.762 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.762 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HA ' HD13 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.87 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.87 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.81 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 12.0 m120 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.044 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.692 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.643 ' HA ' HG22 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.81 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.701 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.712 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.779 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m120 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.712 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.72 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.712 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.779 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.593 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 73' ' ' ASN . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HB3' HD21 ' A' ' 47' ' ' ASN . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.034 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.9 mm-40 -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.717 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.683 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.7 m120 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.46 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.034 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.813 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 13' ' ' ASP . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 11' ' ' THR . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 4.5 m-20 -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.999 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HD2' HG12 ' A' ' 93' ' ' VAL . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.793 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 46' ' ' GLU . 6.9 m-20 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.482 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.734 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.824 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.849 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.698 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 10.1 m120 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.662 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.558 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.659 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.813 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.0 p-10 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.679 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' HD11 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.599 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.805 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.675 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.604 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.805 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 1.07 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.66 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.47 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.868 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.536 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.719 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 14.0 m120 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.602 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.452 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 1.07 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.639 ' N ' ' HG ' ' A' ' 99' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 110.608 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.787 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.718 HG23 ' N ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.631 ' N ' HG23 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 14' ' ' ILE . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.656 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 1.9 m120 -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.758 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.455 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HD2' HG12 ' A' ' 93' ' ' VAL . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.759 HD22 ' SG ' ' A' ' 79' ' ' CYS . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' A' ' 17' ' ' ASN . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.881 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 60' ' ' ASP . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' H ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 71' ' ' THR . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.783 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.8 p30 -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.633 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.759 ' SG ' HD22 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.536 ' H ' ' HG2' ' A' ' 4' ' ' PRO . 6.6 m120 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.881 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.546 ' HA ' HG22 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.427 HG12 ' OD2' ' A' ' 24' ' ' ASP . 4.2 p -160.1 167.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.687 0.28 . . . . 0.0 110.294 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.797 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 5.2 p-10 -59.23 124.06 72.87 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.668 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.668 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.987 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.6 m-20 -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.987 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' HG12 ' A' ' 2' ' ' VAL . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.645 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.69 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.806 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.732 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.806 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.662 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 5.1 m-20 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.434 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.135 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.673 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.826 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.826 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.576 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.681 ' OD1' ' HB2' ' A' ' 3' ' ' ASP . 10.9 m120 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.73 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.135 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.611 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.797 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 24' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG22 ' H ' ' A' ' 3' ' ' ASP . 2.6 p -156.92 178.91 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.863 0.331 . . . . 0.0 110.848 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -47.49 129.41 10.45 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.646 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.867 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.537 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.673 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.9 m-20 -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.673 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.647 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.52 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.652 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.477 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 3.6 m120 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.569 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.023 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.539 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.689 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.818 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.732 ' SG ' HD22 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 83' ' ' GLU . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.722 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.5 m120 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.919 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.023 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.769 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.729 -0.148 . . . . 0.0 112.729 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.692 HG22 ' H ' ' A' ' 3' ' ' ASP . 9.4 p 175.85 -177.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 2' ' ' VAL . 2.9 m-20 -47.13 109.02 0.96 Allowed Pre-proline 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.693 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 8' ' ' CYS . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 12' ' ' ARG . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.61 HD13 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.685 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.7 m120 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.587 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' HD13 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.724 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.702 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.685 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.702 ' HE3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG23 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.658 ' CA ' ' HD2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.102 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.675 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.896 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.896 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 82' ' ' LYS . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.578 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 m120 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.828 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.102 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.675 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.697 HG13 ' CB ' ' A' ' 99' ' ' SER . 13.7 p -81.59 164.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.995 0.426 . . . . 0.0 109.987 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -95.48 125.43 49.65 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.878 -172.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.567 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HG3' ' OD1' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.7 m120 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.846 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.846 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.548 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.03 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.951 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.748 ' SG ' HD22 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.804 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 15.1 m120 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.03 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.808 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.697 ' CB ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 3' ' ' ASP . 5.3 p -177.46 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.624 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.5 p-10 -47.78 113.31 2.57 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.473 ' CG2' HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.7 m-20 -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.707 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 1.3 m120 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 78' ' ' ILE . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.662 ' SG ' HD22 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.5 m120 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.877 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.591 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.79 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.634 ' HA ' HG22 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 3' ' ' ASP . 4.7 p -179.44 -170.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.702 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -47.82 111.64 1.81 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 170.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.71 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.827 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 13' ' ' ASP . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 11' ' ' THR . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.9 m120 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.706 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.732 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.579 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.8 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.746 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.637 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.746 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.663 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.411 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.1 m120 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.993 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.641 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.803 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.849 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.854 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.697 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.93 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.706 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.993 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.591 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.558 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.3 p -151.45 178.14 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.711 0.255 . . . . 0.0 110.914 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.757 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 -47.51 128.48 10.45 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' C ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.91 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.502 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.5 m120 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.91 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.623 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.787 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.711 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.568 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.711 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.5 m120 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.933 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.69 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.576 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.4 m120 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.88 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.009 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.549 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.619 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 3' ' ' ASP . 2.0 p -169.34 -176.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -176.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -46.14 110.25 1.16 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 174.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.691 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.09 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HG23 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.1 m-20 -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.09 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.653 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' HG12 ' A' ' 2' ' ' VAL . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HD2' HG12 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 74' ' ' SER . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.646 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.661 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.064 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.416 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.477 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.711 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 7.8 m120 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.693 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.064 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.663 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.722 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 3' ' ' ASP . 3.4 p -172.71 -171.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -46.42 110.68 1.28 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 171.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.791 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.864 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' A' ' 14' ' ' ILE . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.2 m-20 -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.763 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' HB2' HG12 ' A' ' 2' ' ' VAL . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.763 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' SER . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.752 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.752 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.546 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.3 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.087 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.671 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.545 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.671 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.693 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.791 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.087 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.688 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.693 ' HA ' HG22 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 98' ' ' SER . 2.2 p 177.09 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.2 p-10 -46.91 105.16 0.45 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.532 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.796 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.639 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.79 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.701 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.591 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 1.073 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 1.073 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.564 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.564 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.593 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.807 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.444 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 69.3 m-20 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.615 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.86 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.46 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.744 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.0 m120 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.941 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.05 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.725 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.708 ' HA ' HG22 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.636 ' C ' ' HA ' ' A' ' 99' ' ' SER . 4.0 p -157.61 168.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 -47.76 131.91 11.24 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.572 HG22 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' CD ' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.804 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.703 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.76 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD22 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.804 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 40' ' ' GLU . 44.5 m-80 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.617 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 50' ' ' PRO . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 5.3 m-20 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.656 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.073 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.608 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.738 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.744 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.751 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 8.8 m120 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.859 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.073 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.798 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.513 ' HA ' HG22 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER 53.68 178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.544 1.138 . . . . 0.0 112.432 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -52.2 120.12 16.39 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.728 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.003 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.552 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 2.5 m-20 -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.003 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD22 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.569 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.753 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.61 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 78' ' ' ILE . 2.2 mm-40 -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.918 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.918 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 78' ' ' ILE . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.739 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.79 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.1 m120 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.737 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.674 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.613 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 99' ' ' SER . 9.5 p -60.53 134.96 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.6 0.714 . . . . 0.0 112.148 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.941 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 -94.39 131.8 30.36 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.881 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.675 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.582 ' N ' HG23 ' A' ' 11' ' ' THR . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.893 HD13 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.802 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' ASP . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.781 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.802 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.589 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 90.1 m-20 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.019 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HB2' HD13 ' A' ' 78' ' ' ILE . 6.0 mm-40 -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.535 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.785 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.781 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.637 ' OD1' ' HB2' ' A' ' 3' ' ' ASP . 4.9 m120 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.714 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.019 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.631 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.677 ' HA ' HG22 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.941 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.864 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 68.89 170.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 111.991 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.756 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 -52.23 118.59 12.72 Favored Pre-proline 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.845 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.693 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.729 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.778 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.778 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.557 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.433 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.078 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.805 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.645 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.894 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.819 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.699 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.8 m120 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.9 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.078 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.648 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER 60.83 176.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 112.343 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -47.64 110.82 1.46 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 173.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.624 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.704 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.764 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.741 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m120 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.692 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.736 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.581 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.557 ' HD2' HG12 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD22 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.736 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.741 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.614 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.543 HD21 ' HB3' ' A' ' 50' ' ' PRO . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.575 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 89.6 m-20 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.492 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.508 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.416 ' H ' ' ND2' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.765 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.658 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 88' ' ' ALA . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 19.0 m120 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB2' HD12 ' A' ' 34' ' ' LEU . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.729 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.509 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.719 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.581 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 3' ' ' ASP . 4.1 p -169.2 175.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 -61.21 110.71 3.28 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.767 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.669 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.511 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.667 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 11' ' ' THR . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 8.3 m120 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB3' HD13 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.105 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.71 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.51 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.71 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.87 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.762 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.762 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HA ' HD13 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.87 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.87 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.81 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 12.0 m120 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.044 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.692 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.643 ' HA ' HG22 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.81 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 3' ' ' ASP . 3.0 p -153.11 -176.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER -46.79 115.82 3.53 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 173.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.701 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.712 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.779 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m120 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.712 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.72 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.712 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.779 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.593 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 73' ' ' ASN . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HB3' HD21 ' A' ' 47' ' ' ASN . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.034 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.9 mm-40 -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.717 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.683 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 13.7 m120 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.46 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.034 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 99' ' ' SER . 6.5 p -106.4 151.22 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 120.357 0.122 . . . . 0.0 110.911 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.813 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -129.06 142.06 43.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 160.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 13' ' ' ASP . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 11' ' ' THR . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 4.5 m-20 -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.999 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HD2' HG12 ' A' ' 93' ' ' VAL . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.793 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.491 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.427 ' OD1' ' HB3' ' A' ' 46' ' ' GLU . 6.9 m-20 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.482 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.734 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.824 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.849 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.698 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 10.1 m120 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.662 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.558 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.659 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.813 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 63.97 170.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.372 1.469 . . . . 0.0 112.702 176.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.0 p-10 -59.2 127.58 84.24 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.679 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' HD11 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.599 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.805 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.675 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.604 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.805 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 1.07 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.66 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.47 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.868 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.536 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.719 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 14.0 m120 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.602 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.452 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 1.07 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -172.21 -178.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.675 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -51.37 107.94 0.94 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 178.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.787 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.718 HG23 ' N ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.631 ' N ' HG23 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 14' ' ' ILE . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.656 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 1.9 m120 -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.758 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.455 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HD2' HG12 ' A' ' 93' ' ' VAL . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.759 HD22 ' SG ' ' A' ' 79' ' ' CYS . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG3' HD21 ' A' ' 17' ' ' ASN . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.881 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 60' ' ' ASP . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' H ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 71' ' ' THR . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.783 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.8 p30 -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.633 HD12 ' N ' ' A' ' 78' ' ' ILE . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.759 ' SG ' HD22 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.536 ' H ' ' HG2' ' A' ' 4' ' ' PRO . 6.6 m120 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.881 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.546 ' HA ' HG22 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.847 ' HB2' HD21 ' A' ' 87' ' ' ASN . 5.2 p-10 . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.045 0.45 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.668 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.668 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.987 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.987 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.497 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.645 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.69 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.806 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.732 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.806 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.662 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.434 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.135 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.673 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.826 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.826 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.576 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.847 HD21 ' HB2' ' A' ' 3' ' ' ASP . 17.4 m-80 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.73 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.135 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.611 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.797 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.646 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.867 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.537 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.673 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.732 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.673 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.647 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.652 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.516 ' ND2' HD22 ' A' ' 73' ' ' ASN . 12.0 m-80 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.569 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.023 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.539 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.689 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.818 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.732 ' SG ' HD22 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.4 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.725 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 18.6 m-80 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.919 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.023 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.769 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 2.9 m-20 . . . . . 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.693 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 8' ' ' CYS . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 12' ' ' ARG . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.61 HD13 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.685 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m-80 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.587 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' HD13 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.724 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.702 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.685 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.702 ' HE3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.702 HG23 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.658 ' CA ' ' HD2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.102 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.675 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.896 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.896 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 82' ' ' LYS . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.578 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.7 m-80 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.828 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.525 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.102 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.675 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.424 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.567 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.9 m-80 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.846 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.846 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.602 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.548 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.03 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.951 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.748 ' SG ' HD22 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.804 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 24.2 m-80 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.03 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.808 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.614 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.503 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 1.5 p-10 . . . . . 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.473 ' CG2' HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.707 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 1.1 m-80 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t30 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.4 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 78' ' ' ILE . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.662 ' SG ' HD22 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 22.9 m-80 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.877 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.591 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.79 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.634 ' HA ' HG22 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.541 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.71 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.827 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 13' ' ' ASP . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 11' ' ' THR . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 7.9 m-80 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.706 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.732 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.579 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.8 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.746 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.637 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.746 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.663 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.411 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.5 m-20 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.993 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.641 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.803 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.849 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.854 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.697 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.93 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.706 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.993 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.591 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.558 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.757 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.91 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.502 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.91 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.623 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.787 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.711 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.568 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.711 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.933 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.69 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 3' ' ' ASP . 11.3 m-80 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.88 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.009 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.549 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.619 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.135 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.691 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.09 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HG23 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HB2' HD22 ' A' ' 17' ' ' ASN . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.09 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.653 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HD2' HG12 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 74' ' ' SER . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.646 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 m120 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.661 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.064 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.416 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.477 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.711 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 9.8 m-80 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.693 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.064 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.663 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.722 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.791 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.864 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' A' ' 14' ' ' ILE . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.763 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.763 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' SER . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.752 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.752 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.546 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.087 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.671 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.671 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.693 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.791 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.087 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.688 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.693 ' HA ' HG22 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 1.2 p-10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.532 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.796 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.639 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.79 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.701 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.591 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 1.073 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 1.073 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.564 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.564 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.593 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.807 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.444 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 10.5 m120 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.615 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.86 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.46 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.744 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 16.5 m-80 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.941 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.05 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.725 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.708 ' HA ' HG22 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 . . . . . 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.572 HG22 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.804 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.703 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.76 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.438 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.738 HD22 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.804 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 40' ' ' GLU . 18.3 m120 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.617 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 50' ' ' PRO . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.656 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.073 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.608 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.738 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.744 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.751 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.4 m-80 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.859 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.529 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.073 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.798 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.513 ' HA ' HG22 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 121.101 0.476 . . . . 0.0 110.915 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.728 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.003 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.552 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.003 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.605 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.739 HD22 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.569 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.753 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.67 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.2 m-20 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.61 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.918 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.918 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 78' ' ' ILE . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.739 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.79 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 28.8 m-80 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.737 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.674 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.613 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.941 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.675 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.582 ' N ' HG23 ' A' ' 11' ' ' THR . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.893 HD13 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.802 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' ASP . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.73 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.781 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.802 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.589 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 16.0 m120 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.455 HD21 ' NH1' ' A' ' 31' ' ' ARG . 63.7 t30 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.019 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.535 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.785 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.781 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.882 HD21 ' HB2' ' A' ' 3' ' ' ASP . 5.5 m-80 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.714 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.019 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.631 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.677 ' HA ' HG22 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.941 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.756 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.845 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.693 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.729 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.778 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.778 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.557 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.433 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.078 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.805 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.645 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.894 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.819 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.745 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 17.8 m-80 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.9 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.566 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.078 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.624 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.704 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.764 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.741 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.5 m-80 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.692 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.736 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.581 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.557 ' HD2' HG12 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.658 HD22 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.736 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.741 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.614 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.543 HD21 ' HB3' ' A' ' 50' ' ' PRO . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.575 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.3 m120 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.5 t30 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.492 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.508 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.765 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.658 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 88' ' ' ALA . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.8 m-80 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB2' HD12 ' A' ' 34' ' ' LEU . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.729 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.509 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.719 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.581 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.767 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.669 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.621 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 4.5 p-80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.667 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 11' ' ' THR . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB3' HD13 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.105 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.71 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.587 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.71 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.87 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.762 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.762 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.512 HD21 HD22 ' A' ' 73' ' ' ASN . 1.0 OUTLIER -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HA ' HD13 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.87 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.87 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.81 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.0 m-80 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.044 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.692 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.643 ' HA ' HG22 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.81 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.701 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.712 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.779 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.0 m-80 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.712 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.72 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.712 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.779 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.593 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 73' ' ' ASN . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HB3' HD21 ' A' ' 47' ' ' ASN . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.034 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.717 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.683 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.1 m-80 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.46 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.034 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.813 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 13' ' ' ASP . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 11' ' ' THR . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.999 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HD2' HG12 ' A' ' 93' ' ' VAL . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.849 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.793 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.577 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.577 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.482 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.734 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.824 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.849 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.698 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 15.6 m-80 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.662 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.558 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.659 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.813 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.729 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 10.0 p-10 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.679 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' HD11 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.599 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.805 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.675 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.604 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.805 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 1.07 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.66 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.47 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.868 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.536 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.729 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 23.0 m-80 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.602 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.452 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.415 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 1.07 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.639 ' N ' ' HG ' ' A' ' 99' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.647 0.26 . . . . 0.0 110.608 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.787 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.718 HG23 ' N ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.631 ' N ' HG23 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 14' ' ' ILE . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.715 HD22 ' N ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.758 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.455 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HD2' HG12 ' A' ' 93' ' ' VAL . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.759 HD22 ' SG ' ' A' ' 79' ' ' CYS . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA3' ' ND2' ' A' ' 73' ' ' ASN . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.881 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 60' ' ' ASP . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' H ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.589 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.534 HD22 ' HB3' ' A' ' 52' ' ' CYS . 0.3 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 71' ' ' THR . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.783 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.759 ' SG ' HD22 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.536 ' H ' ' HG2' ' A' ' 4' ' ' PRO . 8.5 m-80 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.881 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.546 ' HA ' HG22 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 3' ' ' ASP . 4.2 p -160.1 167.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.687 0.28 . . . . 0.0 110.294 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.847 ' HB2' HD21 ' A' ' 87' ' ' ASN . 5.2 p-10 -59.23 124.06 72.87 Favored Pre-proline 0 N--CA 1.446 -0.669 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.505 173.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.668 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.6 Cg_exo -40.79 -2.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.163 1 C-N-CA 126.691 4.927 . . . . 0.0 119.189 -172.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -64.95 16.78 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 -177.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.668 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.2 m80 -51.51 -22.01 2.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -174.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 6' ' ' HIS . 18.3 m 49.81 -160.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.304 1.041 . . . . 0.0 111.459 -170.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.987 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -154.87 152.91 30.35 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -169.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.46 99.55 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 161.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -130.74 168.07 17.8 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.9 -172.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.506 HG22 HG13 ' A' ' 14' ' ' ILE . 2.1 m 30.34 110.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 158.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.569 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -7.56 -67.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 112.011 -2.359 . . . . 0.0 113.813 162.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -134.43 100.04 4.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.29 -177.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.75 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.1 mt -87.44 135.67 34.15 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -52.86 147.09 33.67 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 123.661 2.907 . . . . 0.0 112.73 -174.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -66.98 -30.42 70.53 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.546 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.694 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -96.33 27.14 3.89 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -138.71 170.71 15.51 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.838 -174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -147.36 150.59 22.86 Favored Glycine 0 C--N 1.305 -1.185 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.704 173.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.5 p -107.23 149.48 27.69 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-O 121.218 0.532 . . . . 0.0 109.666 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.987 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.4 t80 -140.98 136.09 31.82 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.173 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.701 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.0 ttt180 -107.89 110.52 22.31 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.632 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.497 ' HA ' ' HE1' ' A' ' 21' ' ' PHE . 38.3 p30 -84.14 -164.76 0.99 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 -161.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' OD2' HG12 ' A' ' 2' ' ' VAL . 4.7 t70 -67.93 -38.07 82.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.239 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.65 -16.17 59.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.509 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.78 6.9 32.26 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 6.6 m -65.62 150.37 48.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.978 -0.611 . . . . 0.0 110.649 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -126.02 113.44 17.13 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.506 0.669 . . . . 0.0 109.642 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -138.33 160.01 40.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.774 -174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.645 ' CH2' ' HE3' ' A' ' 38' ' ' LYS . 37.7 p-90 -132.79 154.12 50.58 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 109.417 170.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HD2' HG12 ' A' ' 93' ' ' VAL . 30.7 mtt180 -137.57 -179.38 5.71 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.7 m -110.88 127.32 55.4 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 mt -54.39 158.27 2.46 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.313 -1.312 . . . . 0.0 110.984 -172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.576 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.4 mt -63.08 125.74 25.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.682 -172.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.69 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 92.1 15.41 54.01 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.348 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 46' ' ' GLU . 4.9 m-30 -129.57 164.06 24.64 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.806 ' HD2' ' HB3' ' A' ' 47' ' ' ASN . 0.0 OUTLIER -137.99 178.53 7.05 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.645 ' HE3' ' CH2' ' A' ' 30' ' ' TRP . 0.3 OUTLIER -88.51 132.12 34.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.107 -176.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.97 -95.76 1.88 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.69 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -93.25 50.41 1.51 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.558 0.694 . . . . 0.0 111.485 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.96 -61.48 4.55 Favored Glycine 0 C--N 1.317 -0.522 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.728 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -115.94 47.57 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.225 0.536 . . . . 0.0 111.519 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.472 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 18.2 p -143.16 146.66 33.92 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.069 171.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 71.1 m -111.82 138.97 47.7 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.191 175.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' LYS . 8.8 m -140.21 140.26 35.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.547 -174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.732 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 22.5 mt-10 -52.66 117.22 2.75 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.678 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.806 ' HB3' ' HD2' ' A' ' 37' ' ' LYS . 30.9 p30 -80.94 -44.76 17.74 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.515 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.662 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 64.91 -8.66 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.541 0.526 . . . . 0.0 111.876 175.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.0 t30 -134.83 56.48 17.33 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 167.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.691 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 37.3 Cg_endo -71.48 140.77 37.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.613 2.876 . . . . 0.0 112.723 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.434 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 10.1 t -121.95 149.42 43.47 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.272 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.4 t -85.18 127.84 34.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 173.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 146.62 -51.56 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -161.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 73.5 mt -81.77 90.83 2.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.211 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.18 44.6 28.9 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.605 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.63 29.4 10.93 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.804 178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 86.94 1.82 84.54 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.297 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.0 11.49 10.93 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.426 -175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.3 m -104.75 -178.44 3.66 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.841 0.829 . . . . 0.0 109.855 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.135 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.55 147.09 33.13 Favored Pre-proline 0 C--N 1.3 -1.553 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.36 -18.54 31.38 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.439 1.426 . . . . 0.0 111.57 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.3 p -92.66 -4.53 53.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.72 0.772 . . . . 0.0 110.012 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.673 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -98.58 107.36 19.8 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.338 169.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.558 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 30.9 t -53.12 113.37 1.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.998 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 5.9 t -89.9 132.14 35.45 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.894 0.855 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -123.97 122.99 39.39 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 113.528 -1.669 . . . . 0.0 107.681 173.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -85.63 134.93 33.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.685 0.755 . . . . 0.0 110.262 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.51 168.25 26.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.721 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -130.46 117.43 19.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.711 0.767 . . . . 0.0 110.611 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -135.72 166.76 22.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.948 -175.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -59.61 -33.95 72.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.025 0.44 . . . . 0.0 110.003 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.444 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 3.2 mt-10 -90.65 138.74 31.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.826 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 3.6 p30 -67.28 -35.57 79.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.236 173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 11.2 t -76.09 -12.84 60.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.148 0.499 . . . . 0.0 110.36 -177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 31.0 mmmt -101.57 8.25 41.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.826 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 39.8 mttm -87.94 -53.43 4.75 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.234 0.54 . . . . 0.0 110.108 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.448 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -92.94 117.53 36.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.404 177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.2 mp -95.48 115.8 35.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.621 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.576 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.0 m -111.04 114.55 27.93 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.958 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 75.1 m -118.53 111.0 18.05 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.037 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.444 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.7 m -82.07 129.29 34.76 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.558 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.9 OUTLIER -70.62 -176.85 1.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -171.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -50.4 -46.38 84.22 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.97 8.45 3.79 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.302 1.334 . . . . 0.0 111.062 -176.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.617 HG22 ' HA ' ' A' ' 97' ' ' SER . 25.3 p -131.33 70.13 81.97 Favored Pre-proline 0 N--CA 1.435 -1.186 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.46 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 21.2 Cg_exo -65.3 -10.5 26.2 Favored 'Trans proline' 0 CA--C 1.517 -0.355 0 C-N-CA 123.348 2.699 . . . . 0.0 112.122 -172.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.847 HD21 ' HB2' ' A' ' 3' ' ' ASP . 17.4 m-80 -127.47 166.24 18.3 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.307 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -131.55 143.02 50.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.058 177.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.73 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -76.86 104.87 7.59 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 173.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.576 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.3 OUTLIER 66.58 -115.43 0.24 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.781 -171.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.2 mt-10 -95.56 5.21 52.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.485 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 109.31 7.75 27.99 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -170.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG12 ' HD2' ' A' ' 31' ' ' ARG . 39.6 t -60.65 -30.28 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.79 0.805 . . . . 0.0 109.278 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.135 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.31 162.44 38.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.781 169.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.673 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.9 m -149.33 171.21 16.9 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.611 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 8.6 t -126.91 123.2 36.67 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.284 -0.26 . . . . 0.0 111.095 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.617 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.1 p -107.04 78.41 1.23 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.532 0.682 . . . . 0.0 112.242 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.9 p -170.97 25.6 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.632 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.797 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 59.5 p . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.344 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' A' ' 24' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.89 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG22 ' H ' ' A' ' 3' ' ' ASP . 2.6 p -156.92 178.91 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 116.863 0.331 . . . . 0.0 110.848 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.769 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -47.49 129.41 10.45 Favored Pre-proline 0 N--CA 1.446 -0.661 0 CA-C-O 121.642 0.734 . . . . 0.0 110.888 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.9 Cg_endo -42.91 -17.72 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.048 1 C-N-CA 125.865 4.377 . . . . 0.0 118.395 -170.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -75.65 13.36 0.81 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.703 1.138 . . . . 0.0 112.961 -173.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.646 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 14.6 p-80 -73.75 21.73 0.09 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.332 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.5 m 45.1 -154.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.26 1.424 . . . . 0.0 113.939 169.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.867 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.3 t -154.51 155.24 34.51 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.738 0.78 . . . . 0.0 112.987 -173.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -146.58 99.5 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 160.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.603 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.1 t70 -130.45 156.16 45.23 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.79 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.537 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.5 m 55.39 157.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 116.278 1.955 . . . . 0.0 116.278 162.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -77.38 -47.06 20.84 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 113.036 -1.893 . . . . 0.0 109.96 -176.411 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -143.12 104.71 4.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.842 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.672 HD13 ' HB3' ' A' ' 20' ' ' CYS . 5.8 mt -84.53 140.39 38.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 76.7 Cg_exo -54.52 150.85 33.02 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.985 2.457 . . . . 0.0 112.416 -178.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -66.43 -37.46 85.24 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.992 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.673 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -94.87 28.78 2.58 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -131.79 162.7 29.9 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.03 -175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.607 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.8 152.04 21.96 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.717 175.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.672 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.4 p -107.68 150.02 27.42 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.055 0.455 . . . . 0.0 110.307 -173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.867 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -129.82 138.67 51.14 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.377 170.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.718 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -137.92 111.27 7.97 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.674 175.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.54 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.5 OUTLIER -81.23 -173.09 4.13 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 120.155 -0.618 . . . . 0.0 112.106 -167.478 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' HB3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 t70 -63.46 -34.68 78.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.821 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -72.18 -28.26 63.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.699 -177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.18 11.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.355 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 27.4 m -75.46 119.77 19.99 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.369 -0.415 . . . . 0.0 110.0 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 29.1 mt-10 -114.49 120.17 39.36 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.895 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -147.72 127.32 13.3 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.9 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 30.4 p-90 -99.67 153.67 18.9 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.607 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.1 mtt180 -135.77 -178.62 5.21 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.015 -178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.9 m -109.32 126.68 53.64 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.2 mt -58.02 165.19 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.133 -168.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.732 HD22 ' SG ' ' A' ' 79' ' ' CYS . 68.6 mt -62.37 128.68 37.17 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.986 -171.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.0 2.26 81.16 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 114.859 -1.064 . . . . 0.0 112.006 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.673 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.7 m-30 -104.77 -174.74 2.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.1 ptmt -151.53 175.37 12.38 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.825 -176.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.412 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -97.79 128.67 44.59 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.32 -89.0 1.23 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.647 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.4 pt-20 -85.44 175.34 8.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -47.3 -42.55 18.06 Favored Glycine 0 CA--C 1.519 0.322 0 O-C-N 123.472 0.482 . . . . 0.0 113.526 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -116.79 48.46 1.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.647 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 17.8 p -144.96 140.87 28.52 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 121.409 0.623 . . . . 0.0 111.956 174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.7 m -112.43 139.1 48.28 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.95 174.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 37' ' ' LYS . 18.9 m -139.85 151.02 21.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.655 -174.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 32.1 mt-10 -66.94 121.62 15.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.372 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.652 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 20.8 t30 -89.54 -49.95 6.37 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.982 -177.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.516 ' ND2' HD22 ' A' ' 73' ' ' ASN . 12.0 m-80 63.26 -4.47 0.29 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 47' ' ' ASN . 3.1 m-20 -120.38 45.81 0.85 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 122.586 0.354 . . . . 0.0 111.131 166.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.569 ' HB2' ' CG1' ' A' ' 77' ' ' ILE . 36.8 Cg_endo -68.56 130.53 21.04 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 121.886 1.724 . . . . 0.0 112.557 -178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 t -120.2 150.26 40.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.608 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.8 t -83.63 127.87 34.09 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 177.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.6 t70 148.29 -58.49 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -160.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 41.5 mt -77.94 91.09 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.639 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.8 t30 55.36 43.73 28.42 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.9 OUTLIER 65.95 28.89 10.47 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.823 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 0.37 81.64 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.997 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 116.25 10.93 10.21 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.672 -175.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 6.3 m -104.39 -178.3 3.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.889 0.852 . . . . 0.0 109.966 -175.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.023 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.9 t70 -100.06 145.08 29.6 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -56.48 -16.79 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.098 1.865 . . . . 0.0 112.104 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.474 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 32.2 p -89.98 -20.64 23.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.523 0.678 . . . . 0.0 109.879 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -81.11 117.13 21.41 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.497 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.539 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 44.7 t -59.85 117.05 4.55 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -92.0 132.9 36.19 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.858 0.837 . . . . 0.0 111.513 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.524 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.1 mm100 -128.08 122.15 31.39 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.008 -1.451 . . . . 0.0 107.792 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -88.92 130.07 35.5 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.96 0.886 . . . . 0.0 110.789 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -148.89 170.95 17.14 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.461 -175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -127.42 112.13 14.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.377 0.608 . . . . 0.0 111.01 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.689 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 23.7 t -123.74 161.98 24.08 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.994 -1.003 . . . . 0.0 108.927 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.9 t -63.03 -16.99 61.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.208 0.528 . . . . 0.0 110.245 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 35.0 mt-10 -104.56 131.43 51.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.818 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.7 p30 -64.49 -30.09 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.234 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 28.7 t -78.72 -24.21 45.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.0 110.169 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.499 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 16.4 mmmt -86.62 5.21 36.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.09 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.818 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 56.4 mttm -86.22 -55.94 3.68 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-O 121.308 0.575 . . . . 0.0 110.572 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -92.04 116.79 33.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.258 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -93.05 110.59 23.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.371 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.732 ' SG ' HD22 ' A' ' 34' ' ' LEU . 26.0 m -107.65 113.57 26.95 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.654 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.4 m -121.88 118.01 27.89 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.072 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.433 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.0 m -83.15 147.16 28.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.539 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.1 mmtt -81.23 -177.36 6.43 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -169.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 83' ' ' GLU . 22.8 mm-40 -49.48 -50.3 66.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 87.5 Cg_endo -80.23 4.2 7.0 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.858 1.705 . . . . 0.0 111.316 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.616 HG22 ' HA ' ' A' ' 97' ' ' SER . 19.1 p -127.74 69.31 76.03 Favored Pre-proline 0 N--CA 1.437 -1.111 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.22 179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 15.2 Cg_exo -68.13 -0.99 6.32 Favored 'Trans proline' 0 CA--C 1.52 -0.203 0 C-N-CA 123.513 2.808 . . . . 0.0 112.558 -168.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.725 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 18.6 m-80 -142.18 177.91 7.91 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.34 -173.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.584 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -139.14 145.29 39.22 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.01 0.434 . . . . 0.0 111.336 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.919 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -75.14 104.56 5.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 170.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.607 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.36 -131.51 0.1 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.199 0.599 . . . . 0.0 110.835 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -83.05 1.16 41.47 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 116.25 6.33 15.88 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -172.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 22.0 t -59.42 -30.2 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.844 0.831 . . . . 0.0 109.838 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.023 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.26 156.03 41.49 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.887 173.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -144.3 163.23 34.32 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.37 0.532 . . . . 0.0 109.768 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.787 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 9.3 t -113.79 122.36 46.84 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.616 ' HA ' HG22 ' A' ' 85' ' ' THR . 18.4 m -98.78 63.35 1.4 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.321 0.581 . . . . 0.0 110.012 174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.7 m -155.94 41.06 0.39 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.015 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.769 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.9 p . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.139 -177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 112.729 -0.148 . . . . 0.0 112.729 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.692 HG22 ' H ' ' A' ' 3' ' ' ASP . 9.4 p 175.85 -177.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.692 ' H ' HG22 ' A' ' 2' ' ' VAL . 2.9 m-20 -47.13 109.02 0.96 Allowed Pre-proline 0 CA--C 1.518 -0.26 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 169.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.684 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.3 Cg_endo -51.28 -1.45 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 124.519 3.48 . . . . 0.0 116.058 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.27 14.42 0.74 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.693 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -70.56 -11.91 61.23 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -173.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.8 m 53.09 158.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 125.318 1.447 . . . . 0.0 114.307 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.828 ' HB3' ' HE2' ' A' ' 89' ' ' TYR . 29.2 p -115.35 153.32 31.2 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.25 -0.887 . . . . 0.0 111.796 -167.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 8' ' ' CYS . 2.1 m -158.29 100.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 170.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 28.0 t70 -131.38 167.93 18.44 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.575 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.84 168.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 160.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 12' ' ' ARG . 8.9 mmt-85 -73.79 -42.7 60.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -157.66 97.89 1.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.996 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.61 HD13 ' SG ' ' A' ' 20' ' ' CYS . 4.0 mt -63.0 135.21 96.11 Favored Pre-proline 0 CA--C 1.512 -0.485 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 74.3 Cg_exo -54.45 149.53 38.06 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.019 2.48 . . . . 0.0 113.457 -169.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -64.21 151.75 42.67 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 165.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.685 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.8 m-80 66.48 7.96 5.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.587 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.75 156.77 38.9 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.4 0.619 . . . . 0.0 111.241 177.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -137.52 162.67 25.47 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.68 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.61 ' SG ' HD13 ' A' ' 14' ' ' ILE . 7.7 p -114.27 155.38 26.29 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 122.793 0.437 . . . . 0.0 110.823 -172.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.75 ' HD2' ' HB2' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -132.29 123.76 27.52 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.989 172.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.724 ' N ' ' HD1' ' A' ' 21' ' ' PHE . 1.9 ttt180 -118.51 105.84 12.06 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.397 177.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.693 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 5.9 t70 -83.86 -178.67 7.07 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.279 -174.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.8 t70 -55.06 -34.47 63.61 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -174.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -76.63 0.26 20.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.57 78.54 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.3 m -54.72 135.89 46.59 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.354 0.662 . . . . 0.0 111.308 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.702 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.4 mm-40 -134.65 139.17 45.08 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -151.7 128.83 11.13 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.431 -175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 20.9 p-90 -107.1 151.7 25.02 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 118.588 -1.245 . . . . 0.0 109.692 173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.678 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 31.1 mtt-85 -135.61 -179.0 5.38 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.457 -173.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -111.89 129.21 56.24 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HG ' ' C ' ' A' ' 17' ' ' ASN . 17.3 mt -56.79 169.21 0.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.885 -169.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD22 ' SG ' ' A' ' 79' ' ' CYS . 37.4 mt -65.14 127.42 31.58 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.88 -171.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 85.36 8.08 81.66 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.845 -178.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.685 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.6 m-30 -114.71 -174.34 2.47 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.289 0.566 . . . . 0.0 110.451 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.702 ' HE3' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -161.8 172.85 15.46 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.102 -173.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.49 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -88.78 132.21 34.73 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.684 -174.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.79 -109.9 2.97 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.824 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.425 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.6 pt-20 -81.66 56.28 2.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.247 0.546 . . . . 0.0 111.739 -176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -81.62 1.53 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.956 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -104.9 42.21 1.24 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.263 0.554 . . . . 0.0 111.19 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 7.3 p -135.74 145.11 46.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.574 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -113.41 133.99 54.88 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.232 0.539 . . . . 0.0 109.793 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.702 HG23 ' HE3' ' A' ' 37' ' ' LYS . 1.6 m -133.83 163.68 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.298 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.57 -173.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.501 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 31.5 mt-10 -76.54 116.88 17.63 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.872 0.368 . . . . 0.0 111.301 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.658 ' CA ' ' HD2' ' A' ' 37' ' ' LYS . 40.6 t-20 -75.37 -47.62 26.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.507 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.27 -18.95 0.3 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.444 0.465 . . . . 0.0 112.141 173.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 11.4 t30 -129.82 54.73 15.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 17.9 Cg_endo -70.74 134.76 26.6 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.876 2.384 . . . . 0.0 112.588 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -118.18 150.97 38.5 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.981 178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.7 t -84.9 129.19 34.85 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.9 t70 146.32 -48.17 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.645 1.216 . . . . 0.0 107.82 -165.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.5 mt -82.02 91.73 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.471 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.6 t30 54.52 44.6 28.51 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 123.714 0.634 . . . . 0.0 109.44 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.7 OUTLIER 65.13 30.26 11.6 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.66 85.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.748 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.52 14.46 7.5 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.888 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.3 m -106.78 -177.85 3.48 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.77 0.795 . . . . 0.0 109.765 -176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.102 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.8 t70 -99.55 142.89 25.42 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 174.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -55.76 -18.07 20.11 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.036 1.824 . . . . 0.0 112.419 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.6 p -87.71 -20.93 25.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.877 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.675 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.18 106.55 16.7 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.675 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 t -57.73 119.84 7.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.273 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.6 t -92.39 135.75 33.78 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.865 0.841 . . . . 0.0 111.854 -178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.1 mm-40 -125.1 139.85 53.41 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.721 -1.581 . . . . 0.0 106.778 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -101.87 138.64 38.58 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.842 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -152.24 172.57 16.19 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.055 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -138.55 79.66 1.75 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.76 1.267 . . . . 0.0 109.922 169.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 174.47 11.12 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.604 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -55.88 -38.15 69.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.275 0.56 . . . . 0.0 110.371 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 18.7 mt-10 -94.78 136.37 35.18 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.896 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 16.4 m-80 -67.98 -27.97 67.04 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.57 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 35.9 t -79.32 -21.69 45.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.267 0.556 . . . . 0.0 109.924 175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.8 mmmt -88.82 4.79 46.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.939 177.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.896 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 55.8 mttm -82.83 -51.44 7.65 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.164 0.506 . . . . 0.0 110.454 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.8 mm -95.71 117.22 39.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.387 0.613 . . . . 0.0 109.605 178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.0 mp -89.51 110.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.062 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.795 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.3 m -106.94 116.93 32.78 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.807 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.3 m -120.41 111.1 17.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.728 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 7.4 m -83.72 138.98 33.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 176.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' CB ' ' HD2' ' A' ' 84' ' ' PRO . 0.5 OUTLIER -76.86 -176.68 4.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.71 -175.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 26.4 mt-10 -69.88 -25.1 0.87 Allowed Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -177.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 82' ' ' LYS . 82.3 Cg_endo -82.72 5.26 6.51 Favored 'Trans proline' 0 C--N 1.364 1.356 0 CA-C-N 121.732 1.654 . . . . 0.0 109.598 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.646 HG22 ' HA ' ' A' ' 97' ' ' SER . 28.6 p -132.04 65.58 75.64 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-N 113.612 -1.631 . . . . 0.0 108.387 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 8.6 Cg_exo -73.39 9.02 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.002 2.468 . . . . 0.0 112.282 -166.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.578 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.7 m-80 -139.05 161.98 36.04 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -136.18 134.61 38.39 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.817 0.341 . . . . 0.0 110.309 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.828 ' HE2' ' HB3' ' A' ' 8' ' ' CYS . 1.7 m-85 -78.1 112.72 15.34 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.431 0.634 . . . . 0.0 109.617 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.575 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 68.82 -118.88 0.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.989 -171.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.468 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -96.44 -0.37 49.26 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.973 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.525 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 122.57 10.2 6.08 Favored Glycine 0 CA--C 1.509 -0.342 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -171.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' HD2' ' A' ' 31' ' ' ARG . 11.1 t -64.35 -31.4 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-O 121.272 0.558 . . . . 0.0 110.205 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.102 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -143.7 164.82 29.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.383 165.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.675 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -145.68 166.4 25.93 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 173.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 4' ' ' PRO . 6.3 t -122.18 126.8 49.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.155 0.434 . . . . 0.0 110.081 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.646 ' HA ' HG22 ' A' ' 85' ' ' THR . 5.1 p -108.65 95.74 5.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -174.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.591 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 2.8 m 166.95 47.44 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.279 175.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 85.0 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.329 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.697 HG13 ' CB ' ' A' ' 99' ' ' SER . 13.7 p -81.59 164.07 3.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.995 0.426 . . . . 0.0 109.987 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.616 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -95.48 125.43 49.65 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.878 -172.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 7.4 Cg_exo -36.82 -1.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.867 1 C-N-CA 127.542 5.495 . . . . 0.0 118.614 176.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.616 ' HG3' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -69.25 13.33 0.12 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -169.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.562 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.3 p-80 -77.99 12.02 1.98 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.093 0.406 . . . . 0.0 111.749 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.2 m 44.94 -152.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.345 1.058 . . . . 0.0 112.726 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 7.3 t -153.61 153.02 31.55 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-O 121.806 0.813 . . . . 0.0 112.43 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.408 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.83 101.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 162.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 8.3 t70 -129.61 157.46 42.03 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.249 -176.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.567 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.9 m 56.62 164.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 163.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.542 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.7 mpt_? -90.3 -43.95 10.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.19 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -139.05 92.12 2.57 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.885 174.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.699 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -71.46 137.28 83.59 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.7 Cg_exo -56.45 150.18 52.55 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.244 2.629 . . . . 0.0 113.385 -175.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.664 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 28.1 tptp -66.71 144.57 56.28 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 167.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.786 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.9 m-80 69.39 14.87 8.46 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 122.009 0.909 . . . . 0.0 108.84 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -125.86 154.03 43.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.575 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.78 157.08 22.44 Favored Glycine 0 C--N 1.313 -0.705 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.955 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.699 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.18 150.31 28.83 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 117.256 0.528 . . . . 0.0 110.359 -174.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 52.6 t80 -131.75 140.38 49.22 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.159 172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.74 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -131.97 118.94 20.41 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.796 174.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 1.4 p-10 -83.99 -173.93 4.99 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.543 -0.463 . . . . 0.0 112.164 -168.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -66.49 -29.46 69.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.843 0.354 . . . . 0.0 111.496 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.71 -27.82 60.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.0 111.109 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.81 4.02 15.33 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.646 -178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 4.6 m -69.77 135.16 49.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.249 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.8 mt-10 -121.51 123.56 42.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.148 0.499 . . . . 0.0 110.998 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -146.38 124.91 12.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.078 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.7 p-90 -100.2 153.52 19.19 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 172.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -136.5 -179.92 5.98 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.134 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.579 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 71.6 m -110.65 127.84 55.44 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.3 mt -60.25 167.5 2.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.884 -167.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.848 ' O ' ' HA ' ' A' ' 74' ' ' SER . 51.6 mt -64.0 133.2 52.7 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.774 -169.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.635 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 86.0 0.9 87.1 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.007 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.846 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 3.3 m-30 -105.6 -173.91 2.41 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 61.3 pttt -152.46 170.2 20.71 Favored 'General case' 0 N--CA 1.436 -1.141 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.963 -177.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.579 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.3 OUTLIER -88.64 128.59 35.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.445 177.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.32 -110.96 2.47 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.982 -175.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.0 pt-20 -81.59 60.83 4.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.327 0.584 . . . . 0.0 111.582 -176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.92 -89.36 1.6 Allowed Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.717 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -104.57 55.81 0.71 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.556 0.693 . . . . 0.0 110.721 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.448 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 5.4 p -143.59 155.05 44.17 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.967 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.771 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 62.9 m -124.57 140.44 52.94 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.421 0.629 . . . . 0.0 110.129 176.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.14 144.42 23.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.254 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.569 ' HB3' ' CE1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -74.45 111.29 9.49 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.392 -175.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.846 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 17.1 t30 -63.29 -40.38 97.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.049 -1.432 . . . . 0.0 111.221 -173.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.602 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 16.7 m-80 66.68 -10.89 0.27 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 176.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.0 t30 -126.27 53.78 9.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 164.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.548 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 36.9 Cg_endo -72.01 133.16 21.0 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.919 2.413 . . . . 0.0 113.036 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 5.7 t -121.54 151.46 40.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.169 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 10.2 m -82.35 129.14 34.81 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 29.3 t70 149.49 -52.07 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -161.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.403 ' C ' ' H ' ' A' ' 56' ' ' ASN . 64.1 mt -74.76 89.85 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 CA-C-N 113.893 -1.503 . . . . 0.0 108.974 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.6 t30 70.58 -54.63 0.64 Allowed 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.348 1.03 . . . . 0.0 110.093 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 35.4 p-10 162.83 45.17 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 113.562 -1.654 . . . . 0.0 108.244 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 82.51 -6.52 68.57 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.001 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.17 22.6 7.1 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 27.7 m -107.48 -175.04 2.68 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.842 0.829 . . . . 0.0 109.672 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.03 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.0 t70 -99.95 144.52 28.53 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 172.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -53.98 -17.5 11.09 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 122.593 2.196 . . . . 0.0 112.307 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 53.3 p -90.56 -25.78 20.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.164 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.6 106.51 11.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.83 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.17 109.61 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.335 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.11 155.17 28.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.832 0.825 . . . . 0.0 112.119 -175.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.542 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 12.1 mm-40 -142.03 140.97 32.78 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.533 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.85 129.59 45.96 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.546 0.689 . . . . 0.0 110.204 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -149.08 155.08 40.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.203 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -111.11 106.8 15.95 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.62 0.724 . . . . 0.0 110.119 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 t -127.83 160.96 30.16 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.303 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -65.33 -23.39 66.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.944 0.878 . . . . 0.0 108.644 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 4.5 mm-40 -92.31 111.57 23.19 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.418 176.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.951 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.52 -40.27 74.75 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.848 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 4.5 p -69.87 -15.16 63.04 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.124 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.3 tppt? -113.86 19.65 16.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.328 0.585 . . . . 0.0 110.235 -177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.951 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 53.3 mttm -86.75 -48.92 7.84 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.295 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 66' ' ' GLN . 48.0 mm -93.59 117.1 36.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 3.9 mp -93.3 104.82 16.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.584 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.748 ' SG ' HD22 ' A' ' 34' ' ' LEU . 28.1 m -99.76 113.24 25.6 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.36 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 86.5 m -107.93 110.92 22.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.928 -177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.4 m -81.52 150.15 28.36 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 62' ' ' THR . 56.7 mmtt -88.24 -176.97 5.57 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 -165.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -51.9 -44.45 91.42 Favored Pre-proline 0 CA--C 1.547 0.855 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 85.2 Cg_endo -75.93 -3.02 13.3 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 121.773 1.648 . . . . 0.0 112.1 -176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 97' ' ' SER . 11.0 p -110.64 86.12 5.38 Favored Pre-proline 0 N--CA 1.441 -0.889 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.235 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 1.131 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.2 Cg_exo -74.64 0.97 8.05 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.595 2.197 . . . . 0.0 111.848 -176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.804 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 24.2 m-80 -142.28 177.13 8.46 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.798 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -131.43 141.83 49.9 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.479 -0.782 . . . . 0.0 108.948 171.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.901 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.3 m-30 -69.67 102.95 1.99 Allowed 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 170.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.605 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.93 -118.52 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.318 -171.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.1 mt-10 -95.94 -2.03 47.97 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -173.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.56 3.57 16.37 Favored Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -170.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.4 t -55.45 -31.29 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.043 0.925 . . . . 0.0 109.175 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.03 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.42 157.1 42.66 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.127 171.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 4.3 m -144.08 159.38 42.72 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 118.506 0.593 . . . . 0.0 110.39 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.808 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.1 t -118.6 120.84 38.68 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.574 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.6 p -78.57 -19.84 51.91 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.05 0.928 . . . . 0.0 109.662 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.2 t -156.14 103.21 2.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 168.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.697 ' CB ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.95 0 O-C-N 124.245 0.965 . . . . 0.0 113.015 -173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 112.3 -0.32 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG22 ' H ' ' A' ' 3' ' ' ASP . 5.3 p -177.46 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.624 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.5 p-10 -47.78 113.31 2.57 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 121.797 0.808 . . . . 0.0 110.538 171.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 2.3 Cg_endo -46.45 -15.3 0.17 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.152 3.901 . . . . 0.0 117.835 -171.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE3' ' OD2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -76.21 13.6 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.723 1.147 . . . . 0.0 113.801 -173.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.645 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 10.0 p-80 -72.46 18.52 0.09 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 5' ' ' LYS . 14.7 m 47.95 -156.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.103 1.361 . . . . 0.0 113.587 170.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 8.2 t -159.0 159.85 35.27 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -172.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -150.32 102.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 164.004 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.661 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 15.5 t70 -129.5 168.07 16.91 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.538 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.473 ' CG2' HG13 ' A' ' 14' ' ' ILE . 4.3 m 30.57 114.68 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 159.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.638 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -39.46 -34.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 113.687 -1.597 . . . . 0.0 113.8 172.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -142.08 79.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.203 0.525 . . . . 0.0 111.122 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.767 HD13 ' HB3' ' A' ' 20' ' ' CYS . 8.0 mt -84.24 136.94 40.05 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.284 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.547 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 77.1 Cg_exo -55.77 147.84 58.87 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.143 2.562 . . . . 0.0 112.861 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.68 -37.69 87.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.771 -175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.707 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -95.78 29.11 2.78 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -133.67 156.8 47.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.647 -174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -132.72 155.14 21.44 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.722 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.767 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.25 150.43 27.29 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.127 0.489 . . . . 0.0 110.224 -173.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' CE2' ' HB2' ' A' ' 23' ' ' ASP . 30.1 t80 -130.9 139.95 50.15 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.753 173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.707 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 1.2 ttm180 -133.54 119.64 19.77 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.767 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 18.0 t70 -92.38 179.81 5.43 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.174 -0.611 . . . . 0.0 112.2 -169.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 6.3 t70 -56.0 -31.22 62.86 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 124.714 1.206 . . . . 0.0 110.926 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -64.77 -27.81 69.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.281 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.61 -22.85 29.56 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.6 m -59.11 142.35 51.73 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 122.963 0.505 . . . . 0.0 111.337 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.528 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 1.3 mt-10 -123.96 140.62 52.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.712 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -149.29 128.77 13.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.371 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.0 p-90 -100.44 156.04 17.49 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.063 171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 76.5 mtt180 -139.96 -179.03 5.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.229 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -109.51 126.67 53.79 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.5 mt -57.91 161.7 3.75 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.93 -168.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.701 ' O ' ' HA ' ' A' ' 74' ' ' SER . 60.1 mt -59.0 132.3 53.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.72 -171.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.628 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 93.4 -19.42 52.61 Favored Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.585 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.707 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.9 m-30 -91.2 179.42 5.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 0.0 110.897 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HG2' ' HB2' ' A' ' 47' ' ' ASN . 13.3 ptmt -143.28 168.1 20.59 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.713 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -90.42 128.81 36.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.377 176.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -105.13 -113.97 3.9 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.738 -173.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -76.7 63.02 2.07 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.54 -119.02 5.15 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.225 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -79.95 57.21 2.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.513 0.673 . . . . 0.0 110.925 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 p -141.99 143.13 33.05 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.666 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.725 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.7 m -116.52 138.26 51.54 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.416 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.592 HG23 ' HG3' ' A' ' 37' ' ' LYS . 16.5 m -140.08 151.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.961 -175.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -65.32 124.83 23.25 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.81 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.646 ' HB2' ' HG2' ' A' ' 37' ' ' LYS . 28.9 t30 -111.81 118.0 34.37 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.536 171.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 1.1 m-80 -95.12 15.89 17.84 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.519 0.676 . . . . 0.0 110.511 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 62.3 t30 -135.22 46.23 1.71 Allowed Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.143 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 47' ' ' ASN . 20.0 Cg_endo -66.03 136.18 43.62 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.053 1.835 . . . . 0.0 112.178 174.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -120.98 151.37 39.82 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.345 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 9.7 t -84.97 128.93 34.84 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.3 t70 144.97 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -165.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 62.9 mt -82.14 94.42 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.897 -177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.4 t30 55.18 44.07 28.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.558 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.4 OUTLIER 61.49 34.49 18.01 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.349 -178.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.72 -0.59 89.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.536 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.7 11.93 10.92 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.557 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.7 m -103.84 -177.32 3.34 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 124.01 0.924 . . . . 0.0 109.781 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.077 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.4 t70 -99.2 146.59 31.98 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.16 -12.69 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 121.909 1.739 . . . . 0.0 112.21 -177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 81' ' ' CYS . 31.0 p -99.45 -2.99 34.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.656 0.741 . . . . 0.0 109.976 175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -100.72 108.66 20.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.462 169.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.4 t -56.32 124.93 19.71 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 6.5 t -97.49 135.25 39.61 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.014 0.911 . . . . 0.0 111.676 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' A' ' 66' ' ' GLN . 0.1 OUTLIER -131.89 134.12 45.35 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.482 173.471 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -100.76 141.41 33.68 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.064 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.34 159.77 42.55 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 113.635 -1.621 . . . . 0.0 109.84 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -111.86 81.34 1.44 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 122.389 1.09 . . . . 0.0 110.225 170.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.6 t -92.94 163.16 13.78 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.71 -1.586 . . . . 0.0 108.663 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 90.2 m -61.64 -34.39 75.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.606 0.717 . . . . 0.0 109.895 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 1.5 mp0 -91.0 128.34 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.759 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.874 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -58.77 -37.28 75.91 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.701 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 38.9 m -76.27 -17.34 59.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.623 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 19.9 mmmt -99.7 4.0 45.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.853 177.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 57.2 mttm -77.47 -50.89 11.7 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.318 0.58 . . . . 0.0 110.071 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 48.4 mm -94.43 117.13 37.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.515 0.674 . . . . 0.0 109.885 178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 78' ' ' ILE . 4.1 mp -91.02 120.63 40.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.027 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.662 ' SG ' HD22 ' A' ' 34' ' ' LEU . 17.2 m -115.87 122.9 46.73 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.816 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 64.7 m -127.19 113.16 15.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.675 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 62' ' ' THR . 4.0 m -82.19 139.82 34.07 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' HD2' ' N ' ' A' ' 82' ' ' LYS . 0.9 OUTLIER -76.96 -175.58 3.59 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -170.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -47.53 -50.54 49.65 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 115.348 1.611 . . . . 0.0 115.348 -174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.27 9.2 4.09 Favored 'Trans proline' 0 C--N 1.357 1.01 0 CA-C-N 120.683 1.28 . . . . 0.0 111.009 -176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.634 HG22 ' HA ' ' A' ' 97' ' ' SER . 22.5 p -131.92 69.32 80.91 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.314 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.4 Cg_exo -65.21 -17.94 59.82 Favored 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 123.241 2.627 . . . . 0.0 111.537 -172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.71 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 22.9 m-80 -123.51 -176.31 3.42 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.509 -173.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.582 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -143.93 148.26 35.13 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.503 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.877 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.9 m-30 -74.45 103.74 4.92 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 170.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.591 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.55 -128.34 0.21 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 123.247 0.619 . . . . 0.0 110.903 -170.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 3.4 mt-10 -85.68 0.92 51.36 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 115.53 6.05 17.97 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -171.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.542 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -58.05 -31.44 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 122.065 0.936 . . . . 0.0 109.638 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.077 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.61 156.75 42.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.301 -1.318 . . . . 0.0 108.31 173.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.3 m -141.99 164.18 30.87 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 118.758 0.708 . . . . 0.0 110.479 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.79 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 t -120.22 131.98 55.17 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 120.359 0.124 . . . . 0.0 111.32 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.634 ' HA ' HG22 ' A' ' 85' ' ' THR . 4.1 p -92.32 169.83 10.27 Favored 'General case' 0 C--N 1.315 -0.932 0 O-C-N 123.584 0.552 . . . . 0.0 110.451 174.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 t 73.23 58.07 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.726 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 47.2 p . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.816 176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.16 -0.376 . . . . 0.0 112.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 3' ' ' ASP . 4.7 p -179.44 -170.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.702 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -47.82 111.64 1.81 Allowed Pre-proline 0 C--N 1.32 -0.711 0 CA-C-O 121.75 0.786 . . . . 0.0 111.337 170.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.71 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.2 Cg_endo -51.8 -4.62 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.704 3.603 . . . . 0.0 116.417 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.541 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -73.34 16.54 0.18 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.71 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.8 m80 -49.63 -27.72 4.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.179 0.591 . . . . 0.0 112.301 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 6' ' ' HIS . 10.1 m 50.37 -160.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.981 0.912 . . . . 0.0 109.98 -167.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.827 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 2.0 t -158.97 155.76 28.18 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.6 m -142.66 99.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 163.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.8 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.9 t70 -130.11 159.47 36.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.581 -176.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 13' ' ' ASP . 2.9 m 58.31 167.37 0.05 OUTLIER 'General case' 0 N--CA 1.44 -0.962 0 O-C-N 124.187 0.929 . . . . 0.0 112.839 165.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -84.9 -37.94 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 121.054 -1.029 . . . . 0.0 109.765 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.443 ' N ' HG22 ' A' ' 11' ' ' THR . 38.5 t70 -152.24 95.2 2.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.903 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -64.51 140.3 97.96 Favored Pre-proline 0 N--CA 1.465 0.289 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 176.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 14' ' ' ILE . 82.2 Cg_exo -53.35 152.66 19.42 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.196 2.597 . . . . 0.0 113.256 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -63.01 149.33 45.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 168.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.671 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 7.9 m-80 66.4 8.72 5.91 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.25 0.547 . . . . 0.0 110.342 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -118.42 169.93 9.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.153 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.706 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -150.28 151.09 23.19 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.338 175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 p -108.68 151.41 26.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.142 0.496 . . . . 0.0 111.004 -174.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.827 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 24.9 t80 -138.75 134.89 34.09 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.816 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.732 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 0.8 OUTLIER -126.46 120.45 29.75 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.172 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.579 ' OD1' ' HB ' ' A' ' 27' ' ' THR . 3.0 p-10 -96.0 -164.43 1.16 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -163.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.09 -36.32 83.21 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.947 -1.024 . . . . 0.0 111.17 -178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.38 -29.39 68.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.126 0.489 . . . . 0.0 110.768 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.71 -4.87 32.58 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.9 m -60.53 130.23 45.51 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.722 -0.739 . . . . 0.0 110.563 176.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.8 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.5 mt-10 -112.26 130.23 56.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.235 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -139.61 167.12 22.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.562 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 38.3 p-90 -139.58 154.68 47.67 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.312 0.577 . . . . 0.0 109.947 167.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 81.2 mtt180 -139.4 -179.17 5.73 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.493 -177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.5 m -111.1 127.1 55.45 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 33' ' ' LEU . 3.3 mt -54.18 163.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.768 -1.105 . . . . 0.0 111.687 -172.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD22 ' SG ' ' A' ' 79' ' ' CYS . 54.6 mt -64.49 128.41 35.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.971 -1.013 . . . . 0.0 112.273 -169.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.541 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 97.61 -14.05 63.51 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.647 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.746 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -96.53 -177.09 3.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.96 0.409 . . . . 0.0 110.636 -173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -144.09 174.08 11.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.123 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -91.35 130.58 37.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.149 176.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.28 -87.83 1.59 Allowed Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.096 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.637 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.2 pt-20 -106.48 56.09 0.66 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.481 0.658 . . . . 0.0 111.61 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.46 -63.55 3.9 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.731 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -123.27 42.83 3.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.241 0.543 . . . . 0.0 111.424 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.637 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 24.8 p -137.29 149.1 46.84 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.988 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -113.38 137.57 51.33 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.603 176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.74 147.71 21.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.954 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 11.9 mt-10 -62.38 111.76 2.15 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.683 -178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.746 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 33.5 t30 -90.99 127.18 36.32 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.52 1.76 49.35 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.139 0.495 . . . . 0.0 110.377 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.409 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 6.1 t30 -132.71 53.09 10.09 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.681 174.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.663 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.2 Cg_endo -62.09 130.31 30.28 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.951 1.767 . . . . 0.0 112.397 176.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.411 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.6 t -121.87 150.38 42.04 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.225 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 6.4 t -84.93 128.3 34.56 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 7.7 t70 149.25 -57.16 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -160.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.87 89.03 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.507 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 59.9 t30 54.85 45.58 26.27 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.5 m-20 69.44 20.19 7.33 Favored 'General case' 0 C--O 1.217 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.72 176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 94.85 5.84 60.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.215 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.3 13.86 11.44 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.57 -175.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 3.7 m -106.14 -178.46 3.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.919 0.866 . . . . 0.0 109.779 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.993 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 10.3 t70 -101.6 144.95 29.59 Favored Pre-proline 0 C--N 1.304 -1.401 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -57.91 -15.36 21.66 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.847 1.698 . . . . 0.0 111.545 -176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.8 p -87.83 -15.03 37.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.06 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.614 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.61 119.97 31.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.219 172.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.641 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 20.9 t -66.84 109.88 3.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.265 -177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 4.6 t -78.57 137.11 37.72 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 121.933 0.873 . . . . 0.0 111.656 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 3.2 mm-40 -128.07 117.94 22.55 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.098 -1.41 . . . . 0.0 107.623 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 3.5 p-10 -86.65 128.62 35.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.087 0.946 . . . . 0.0 110.736 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.04 171.24 14.76 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 113.475 -1.693 . . . . 0.0 110.13 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -131.24 119.69 22.17 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.505 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.9 t -145.31 164.26 31.98 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -176.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 72' ' ' GLU . 3.4 t -58.14 -30.93 66.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.382 0.61 . . . . 0.0 110.086 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.849 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 7.8 mm-40 -87.86 123.47 32.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.944 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.803 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 2.0 p30 -59.36 -32.79 70.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.94 0.4 . . . . 0.0 110.405 173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t -77.64 -17.79 57.38 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.519 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.849 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 22.7 mmmt -94.84 1.92 55.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.693 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.803 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 37.4 mttt -86.54 -35.62 19.42 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-O 121.503 0.668 . . . . 0.0 110.073 178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' A' ' 50' ' ' PRO . 51.2 mm -111.89 115.58 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.916 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.123 174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' CG ' ' A' ' 66' ' ' GLN . 3.9 mp -99.36 105.11 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.801 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.854 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.6 m -99.5 112.84 24.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.595 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.1 m -117.76 112.27 20.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.79 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.43 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 4.3 m -83.1 139.24 33.32 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.641 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 0.3 OUTLIER -83.35 -174.92 5.57 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -51.09 -43.61 85.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.19 3.13 7.35 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 121.418 1.412 . . . . 0.0 110.533 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.665 HG22 ' HA ' ' A' ' 97' ' ' SER . 17.9 p -123.89 74.02 55.81 Favored Pre-proline 0 N--CA 1.429 -1.489 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.597 177.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 99' ' ' SER . 16.9 Cg_exo -70.02 2.18 3.92 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.239 2.626 . . . . 0.0 111.824 -173.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.697 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.4 m-80 -142.65 173.51 11.47 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.812 -1.086 . . . . 0.0 108.477 -173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.23 145.44 35.6 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.658 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.93 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.1 m-30 -76.79 103.05 6.54 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 171.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.706 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 67.08 -123.19 0.23 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.388 0.675 . . . . 0.0 110.652 -170.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.492 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 2.7 mt-10 -90.34 -11.0 41.98 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -171.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.8 2.07 5.32 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -167.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.516 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.7 t -56.91 -32.08 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 114.347 -0.927 . . . . 0.0 109.415 175.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.993 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.84 157.72 43.47 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.63 170.034 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -148.02 160.63 42.64 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.014 0.37 . . . . 0.0 110.019 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.591 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 5.2 t -112.68 125.71 54.6 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.665 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 m -107.9 82.52 1.66 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.122 0.487 . . . . 0.0 111.293 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 t -172.35 29.62 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.558 ' HB3' ' CD ' ' A' ' 86' ' ' PRO . 6.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.704 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.3 p -151.45 178.14 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.711 0.255 . . . . 0.0 110.914 -176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.757 ' HA ' ' CB ' ' A' ' 99' ' ' SER . 10.6 p-10 -47.51 128.48 10.45 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-O 121.776 0.798 . . . . 0.0 111.057 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.8 Cg_endo -44.41 -12.53 0.05 OUTLIER 'Trans proline' 0 CA--C 1.549 1.243 0 C-N-CA 125.252 3.968 . . . . 0.0 118.033 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -75.79 11.66 1.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.859 1.209 . . . . 0.0 112.827 -174.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.677 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 16.7 p-80 -74.76 17.19 0.23 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 32.1 m 44.92 -145.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 124.843 1.257 . . . . 0.0 113.748 169.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.91 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 7.6 t -159.14 153.82 24.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -170.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' H ' ' HB3' ' A' ' 22' ' ' ARG . 0.8 OUTLIER -144.67 98.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.568 159.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 9.3 t70 -130.71 157.13 43.62 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.655 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 4.9 m 57.95 162.56 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 165.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -80.63 -38.76 28.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.933 178.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 11.5 t70 -156.66 92.72 1.32 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.129 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.502 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -67.41 139.22 94.37 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.715 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 14' ' ' ILE . 81.8 Cg_exo -53.38 151.42 23.28 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 123.388 2.726 . . . . 0.0 113.763 -173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -55.15 142.12 32.22 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.954 168.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.655 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 68.15 1.29 2.75 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.428 0.691 . . . . 0.0 111.55 -178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -103.26 167.17 9.99 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.417 0.627 . . . . 0.0 111.47 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -144.18 153.23 24.91 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 1.8 p -109.61 150.32 28.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.104 0.452 . . . . 0.0 110.949 -171.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.91 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 46.7 t80 -130.32 140.05 50.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.654 170.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -140.85 111.73 7.07 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 174.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.623 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.4 OUTLIER -80.51 -175.69 5.32 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.714 -169.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.0 -39.79 87.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.702 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -65.53 -28.58 69.28 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.812 -177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.99 9.56 18.1 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 26.5 m -73.57 118.97 17.16 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.599 -0.301 . . . . 0.0 110.196 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 19.0 mt-10 -113.91 121.79 45.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.176 0.512 . . . . 0.0 111.165 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -147.64 129.58 15.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.888 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 44.2 p-90 -100.78 155.61 17.82 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.355 172.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.0 mtt180 -140.77 -179.21 5.92 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.59 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.3 m -110.55 126.14 54.09 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.423 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -50.37 158.18 0.62 Allowed 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 124.17 0.919 . . . . 0.0 111.631 -175.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.787 ' O ' ' HA ' ' A' ' 74' ' ' SER . 62.9 mt -60.43 141.28 56.58 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.604 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 79.2 -0.67 78.87 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.281 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.711 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 6.7 m-30 -102.24 -174.45 2.58 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -150.22 170.75 18.24 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.821 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HE2' ' CZ3' ' A' ' 30' ' ' TRP . 1.8 tppp? -88.93 128.7 35.69 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.109 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.63 -90.98 1.21 Allowed Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.842 -0.695 . . . . 0.0 112.614 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -101.37 53.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.361 0.6 . . . . 0.0 111.748 -176.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.05 -63.56 3.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.773 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -121.39 46.35 2.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.371 0.605 . . . . 0.0 111.206 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.568 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.3 p -140.1 146.18 38.56 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.352 174.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 70.2 m -111.85 133.45 54.04 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.897 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.91 147.07 28.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.124 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -62.71 105.98 0.73 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.911 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.711 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 32.8 t30 -72.6 -49.61 30.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.507 -177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 66.94 -10.53 0.3 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' ASN . 62.2 t30 -122.86 49.78 2.53 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.975 168.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' HG3' ' HA2' ' A' ' 35' ' ' GLY . 29.2 Cg_endo -67.88 136.13 37.46 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.723 2.282 . . . . 0.0 113.399 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.55 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.9 t -120.48 149.93 41.63 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.974 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.7 t -86.27 129.55 34.81 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 171.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 25.6 t70 151.95 -52.97 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.187 0.929 . . . . 0.0 109.233 -165.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.59 -90.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.342 -171.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -112.4 54.21 0.72 Allowed 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.8 OUTLIER 64.97 29.92 12.07 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 90.65 -5.39 82.34 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.155 -178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 14.57 5.47 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.59 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 9.1 m -105.48 -177.48 3.37 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.392 1.077 . . . . 0.0 110.396 -175.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.009 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 16.2 t70 -100.43 145.18 29.84 Favored Pre-proline 0 C--N 1.303 -1.432 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -58.25 -15.24 22.87 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.024 1.816 . . . . 0.0 112.125 -176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.7 p -88.98 -16.73 31.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 121.629 0.728 . . . . 0.0 109.78 175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.06 100.61 13.4 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.723 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 10.8 t -54.05 118.52 4.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.842 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.0 t -90.4 137.52 32.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.902 0.858 . . . . 0.0 112.506 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.05 120.39 17.97 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 113.832 -1.531 . . . . 0.0 107.715 172.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -88.81 133.17 34.34 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.938 0.875 . . . . 0.0 111.375 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.86 171.13 14.86 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.816 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -124.79 93.07 3.79 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.849 0.833 . . . . 0.0 110.414 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.486 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 9.3 t -104.14 168.63 8.99 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.01 -178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 t -61.28 -33.78 74.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.425 0.631 . . . . 0.0 109.746 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 10.0 mm-40 -89.9 126.56 35.76 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.723 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.933 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.89 -35.0 68.45 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 172.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 2.4 t -74.67 -26.33 59.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.792 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HE2' ' C ' ' A' ' 74' ' ' SER . 8.9 mmpt? -94.23 8.38 41.94 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.679 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.933 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 61.1 mttm -75.87 -50.29 15.49 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.384 0.612 . . . . 0.0 110.398 177.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 46.8 mm -92.76 117.79 36.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.262 177.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -91.48 108.45 19.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.278 -0.873 . . . . 0.0 109.894 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.69 ' SG ' HD22 ' A' ' 34' ' ' LEU . 13.8 m -103.13 112.49 25.36 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.597 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 64.7 m -111.93 111.08 21.76 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 7.5 m -80.52 144.94 32.1 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.593 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 29.5 mmtp -75.68 -178.51 4.22 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -168.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -57.4 -41.85 92.89 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.91 12.79 2.82 Favored 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 121.588 1.526 . . . . 0.0 111.074 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 97' ' ' SER . 12.7 p -129.68 73.47 81.49 Favored Pre-proline 0 N--CA 1.435 -1.181 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 25.4 Cg_exo -64.77 0.63 2.32 Favored 'Trans proline' 0 N--CA 1.473 0.29 0 C-N-CA 123.412 2.741 . . . . 0.0 112.999 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.697 HD21 ' HB2' ' A' ' 3' ' ' ASP . 11.3 m-80 -145.86 -179.0 6.4 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.79 149.12 39.98 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.308 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.88 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -78.49 103.15 8.24 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 169.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB3' ' H ' ' A' ' 91' ' ' GLU . 0.1 OUTLIER 67.03 -130.49 0.15 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.539 -169.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.457 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.4 mt-10 -90.9 13.39 16.64 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -173.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.76 5.89 30.97 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 119.948 -1.12 . . . . 0.0 111.215 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 24.7 t -56.37 -30.49 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 121.902 0.858 . . . . 0.0 108.955 173.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.009 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.09 157.67 43.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.581 -1.19 . . . . 0.0 108.741 171.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 3.5 m -145.07 159.96 42.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.554 0.616 . . . . 0.0 110.401 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.549 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 35.2 t -109.04 120.94 44.04 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.619 ' HA ' HG22 ' A' ' 85' ' ' THR . 3.2 t -103.26 37.17 2.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.232 1.015 . . . . 0.0 108.864 175.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.5 t -134.99 44.26 2.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.337 176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.757 ' CB ' ' HA ' ' A' ' 3' ' ' ASP . 94.1 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.274 -176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 3' ' ' ASP . 2.0 p -169.34 -176.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -176.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.655 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 0.5 OUTLIER -46.14 110.25 1.16 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.425 0.631 . . . . 0.0 111.571 174.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.691 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.06 -9.21 0.03 OUTLIER 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.729 3.62 . . . . 0.0 118.148 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.38 14.46 0.96 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.467 1.485 . . . . 0.0 114.092 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.691 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 7.6 p-80 -76.64 19.4 0.27 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.7 m 43.92 -154.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.68 1.192 . . . . 0.0 114.053 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.09 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 38.3 t -152.97 151.35 30.21 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 114.314 1.228 . . . . 0.0 114.314 -170.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -144.63 98.41 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.742 158.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' HD11 ' A' ' 14' ' ' ILE . 8.9 t70 -131.13 156.26 45.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.365 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 13' ' ' ASP . 17.2 m 56.5 168.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 O-C-N 124.181 0.925 . . . . 0.0 113.022 168.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -90.27 -37.15 14.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.148 -0.97 . . . . 0.0 109.722 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' N ' HG22 ' A' ' 11' ' ' THR . 19.1 t70 -149.95 104.08 3.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.941 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.595 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.6 mp -76.34 141.91 70.68 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.774 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.595 ' HD2' HG23 ' A' ' 14' ' ' ILE . 83.1 Cg_exo -51.77 158.02 4.94 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.697 2.931 . . . . 0.0 114.389 -173.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HB2' HD22 ' A' ' 17' ' ' ASN . 1.0 OUTLIER -50.55 -67.58 0.24 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -176.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.705 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -85.57 34.36 0.58 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.35 164.21 23.15 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.594 -174.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.93 153.52 25.36 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.7 p -108.14 148.66 29.55 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.09 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 33.5 t80 -141.65 140.11 33.17 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.401 171.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 5.1 ttt180 -124.62 120.07 30.85 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.107 -175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.653 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.9 p30 -85.49 -177.26 6.39 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.054 -0.658 . . . . 0.0 112.553 -171.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HB2' HG12 ' A' ' 2' ' ' VAL . 22.4 t70 -70.67 -17.37 62.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.078 -174.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.73 11.08 30.35 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.032 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.35 85.16 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.877 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 11.3 m -75.85 123.64 26.0 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 122.552 0.341 . . . . 0.0 110.536 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 60.1 mt-10 -112.65 120.12 40.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.218 0.532 . . . . 0.0 110.783 179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -148.0 129.66 15.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.623 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.657 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 37.5 p-90 -103.09 157.29 17.09 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.448 169.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HD2' HG12 ' A' ' 93' ' ' VAL . 80.3 mtt180 -141.96 -179.37 6.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.11 -178.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.4 m -109.68 126.54 53.79 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -176.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 5.8 mt -56.56 160.5 3.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.476 -170.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.676 ' O ' ' HA ' ' A' ' 74' ' ' SER . 80.4 mt -61.04 132.84 55.13 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.101 -170.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 50' ' ' PRO . . . 89.13 0.5 80.52 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.076 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.705 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.6 m-30 -107.05 -173.99 2.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.726 -177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.4 pttt -149.94 173.87 13.32 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.143 -174.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.48 126.18 38.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.33 -111.43 3.58 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.785 -0.721 . . . . 0.0 114.348 -168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.448 ' H ' ' HG2' ' A' ' 40' ' ' GLU . 8.6 pt-20 -76.26 54.19 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.737 0.815 . . . . 0.0 111.43 -175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.05 -128.87 9.71 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.649 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 63.47 1.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.503 0.668 . . . . 0.0 110.275 176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.5 p -144.97 150.75 37.48 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.388 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 63.3 m -119.71 138.17 53.46 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.972 177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.06 151.66 17.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.015 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.7 mt-10 -60.24 111.62 1.61 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.916 177.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.646 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 t30 -73.67 -41.33 62.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.962 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.0 m120 70.35 -13.62 0.44 Allowed 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.08 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 47' ' ' ASN . 65.0 t30 -127.26 52.27 7.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-O 120.869 0.366 . . . . 0.0 110.021 167.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.661 ' HB2' HG12 ' A' ' 77' ' ' ILE . 18.1 Cg_endo -66.02 131.05 25.89 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.064 1.843 . . . . 0.0 113.229 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.9 t -121.49 149.05 43.63 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.762 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 14.1 t -86.62 128.34 34.99 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 173.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 17.3 t70 152.77 -55.18 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -162.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.436 ' C ' ' H ' ' A' ' 56' ' ' ASN . 70.5 mt -64.55 95.05 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 114.388 -1.278 . . . . 0.0 109.901 178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 66.4 t30 69.43 -56.48 0.55 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 122.189 0.995 . . . . 0.0 109.443 -173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 54' ' ' ILE . 34.8 p-10 167.89 43.75 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.139 -1.846 . . . . 0.0 108.026 -174.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.02 -9.4 66.34 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.881 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.12 22.75 7.36 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -173.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 28.8 m -106.26 -175.23 2.74 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.892 0.877 . . . . 0.0 108.89 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.064 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.5 t70 -100.02 143.81 27.19 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 174.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -55.85 -16.81 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.233 1.955 . . . . 0.0 111.93 -177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.426 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 44.3 p -92.28 -13.88 29.69 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.375 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -90.93 128.07 36.64 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.936 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.416 ' N ' ' HE2' ' A' ' 82' ' ' LYS . 0.4 OUTLIER -72.84 116.68 13.62 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.664 177.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 13.4 t -92.88 138.09 31.79 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.822 0.82 . . . . 0.0 111.856 -177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.477 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -129.37 140.09 51.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.094 174.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -100.19 141.76 32.59 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.782 0.801 . . . . 0.0 110.369 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.56 171.72 16.55 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.086 -1.416 . . . . 0.0 110.819 -171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -128.14 133.98 49.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.439 171.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.6 t -144.81 171.64 14.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.802 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.3 t -56.05 -33.98 65.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.1 0.476 . . . . 0.0 110.156 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.459 ' HB2' ' CG ' ' A' ' 75' ' ' LYS . 7.1 mt-10 -98.73 136.04 39.36 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.711 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 14.4 p30 -66.73 -26.0 66.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.58 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 29.3 t -81.49 -18.25 45.8 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.589 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' CG ' ' HB2' ' A' ' 72' ' ' GLU . 30.3 mmmt -99.19 15.02 27.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.488 -178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.711 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 58.9 mttt -89.07 -36.05 15.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.068 177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.661 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.7 mm -105.44 116.71 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -96.38 106.62 18.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.878 -177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.652 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -102.12 112.64 25.38 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.025 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 53.4 m -112.82 112.26 23.61 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.503 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 6.1 m -82.01 129.23 34.73 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 62' ' ' THR . 0.0 OUTLIER -75.47 -174.53 2.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.236 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 47.8 mt-10 -37.86 -57.12 1.71 Allowed Pre-proline 0 N--CA 1.469 0.498 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.9 Cg_endo -77.32 5.01 5.41 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.827 1.685 . . . . 0.0 111.759 -171.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 97' ' ' SER . 30.7 p -123.82 76.1 56.97 Favored Pre-proline 0 N--CA 1.436 -1.173 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.207 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.438 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 22.3 Cg_exo -66.01 -7.42 16.94 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.843 2.362 . . . . 0.0 111.779 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.629 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 9.8 m-80 -136.42 179.16 6.53 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.221 -172.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.81 150.47 40.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.145 0.498 . . . . 0.0 111.331 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.752 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.5 m-30 -82.97 103.81 12.71 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.693 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.35 -128.18 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.521 -173.221 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 5.5 mt-10 -85.11 0.27 52.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.87 2.91 16.34 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -171.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 31' ' ' ARG . 19.4 t -57.9 -30.57 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.765 -0.717 . . . . 0.0 110.144 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.064 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.96 159.04 44.04 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.028 171.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -149.51 156.08 41.39 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.663 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 7.9 t -106.26 121.26 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 122.301 -0.249 . . . . 0.0 110.481 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.722 ' HA ' HG22 ' A' ' 85' ' ' THR . 2.3 t -96.85 23.45 7.11 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.353 0.596 . . . . 0.0 111.837 -172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.0 m -121.5 45.62 2.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.726 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.655 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 26.6 t . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.449 -0.786 . . . . 0.0 109.687 174.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.086 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.682 HG22 ' H ' ' A' ' 3' ' ' ASP . 3.4 p -172.71 -171.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.682 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.7 OUTLIER -46.42 110.68 1.28 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 122.085 0.945 . . . . 0.0 110.907 171.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.791 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.1 Cg_endo -52.96 -1.91 0.09 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.352 3.368 . . . . 0.0 117.601 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 14.59 0.78 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 120.162 1.347 . . . . 0.0 113.941 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.2 p-80 -78.82 16.34 0.9 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m 42.4 -156.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.812 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -143.48 149.29 37.33 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.3 m -146.45 96.55 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 113.392 -1.731 . . . . 0.0 106.869 154.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.864 ' HB3' ' SG ' ' A' ' 20' ' ' CYS . 15.9 t70 -133.88 166.64 22.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.267 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.537 HG21 HG13 ' A' ' 14' ' ' ILE . 2.2 m 59.04 165.86 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 162.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 3.0 mpt_? -85.33 -45.29 12.06 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.919 -177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -153.66 100.09 2.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.005 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.553 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.5 mp -66.03 137.8 96.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' A' ' 14' ' ' ILE . 80.3 Cg_exo -50.48 156.39 4.22 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.632 2.888 . . . . 0.0 113.54 -173.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 18' ' ' ALA . 54.6 tttm -58.16 -56.66 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -171.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.723 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -87.72 30.09 0.85 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -176.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -126.7 164.29 21.62 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.41 -174.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -145.52 150.4 22.61 Favored Glycine 0 N--CA 1.428 -1.849 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.678 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 10' ' ' ASP . 1.5 t -108.78 149.1 29.54 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-O 121.307 0.575 . . . . 0.0 110.833 -175.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.812 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 44.3 t80 -142.33 139.07 31.68 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.411 171.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.9 ttt180 -113.57 112.3 23.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.085 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.763 ' OD2' ' HB ' ' A' ' 27' ' ' THR . 3.6 p30 -84.3 176.09 8.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.645 0.736 . . . . 0.0 111.589 -170.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' HB2' HG12 ' A' ' 2' ' ' VAL . 19.8 t70 -73.17 -19.49 61.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.384 -165.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.02 -3.39 41.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.54 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.81 -1.61 59.8 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.763 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 87.2 m -74.12 151.46 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.892 -0.654 . . . . 0.0 111.317 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.807 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 7.3 mt-10 -130.2 131.1 45.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.931 179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 6.1 tp10 -147.66 160.32 42.81 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.013 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -136.85 156.98 47.77 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 169.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -143.78 -178.7 6.04 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.257 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.655 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 65.5 m -109.74 126.76 54.07 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -174.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.88 160.02 5.0 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.581 -170.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' SER . 75.5 mt -59.72 135.24 57.62 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.212 -170.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 89.48 -3.65 83.75 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.05 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.752 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 7.6 m-30 -107.51 -174.13 2.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.87 0.367 . . . . 0.0 110.59 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 58.0 pttt -149.27 172.03 15.53 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.474 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 3.0 tppt? -88.04 132.27 34.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.54 -98.95 1.77 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.498 -0.858 . . . . 0.0 113.19 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.596 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.3 pt-20 -93.92 54.7 1.99 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.627 0.727 . . . . 0.0 111.557 -173.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.93 -71.3 1.97 Allowed Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.613 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -117.43 45.86 1.83 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.039 0.447 . . . . 0.0 111.358 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 23.6 p -137.17 155.98 48.89 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-O 121.092 0.472 . . . . 0.0 111.284 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.7 m -121.12 135.55 55.15 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.294 177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 17.0 m -140.48 152.93 21.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.644 -173.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.573 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 24.1 mt-10 -63.72 108.04 1.33 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.817 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.752 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 22.3 t30 -68.04 -42.51 80.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.282 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.8 m120 69.19 -13.44 0.36 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.479 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 47' ' ' ASN . 4.1 t-20 -128.39 53.66 11.61 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 168.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 18.2 Cg_endo -67.52 129.23 19.65 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.298 1.999 . . . . 0.0 112.946 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.546 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.4 t -120.85 150.72 40.6 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.31 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -86.33 129.27 34.91 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 174.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 30.2 t70 152.69 -58.14 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 124.212 0.945 . . . . 0.0 109.313 -165.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -56.82 -90.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.834 -171.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -108.82 53.36 0.69 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.38 35.18 12.41 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.65 -11.18 69.32 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.455 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 17.8 4.02 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -174.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 13.6 m -106.27 -176.04 2.96 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 124.488 1.115 . . . . 0.0 110.077 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.087 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.1 t70 -98.8 142.48 24.67 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.51 -15.51 15.78 Favored 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.441 2.094 . . . . 0.0 112.264 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.6 p -90.19 -19.87 23.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.577 0.703 . . . . 0.0 110.129 176.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -82.61 117.74 22.8 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.613 174.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.671 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 5.5 t -66.89 117.48 9.05 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.4 t -91.11 138.97 31.19 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.639 0.733 . . . . 0.0 112.178 -175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 3.7 mm-40 -126.2 137.74 53.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.326 174.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -97.35 139.5 33.2 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.99 -0.684 . . . . 0.0 110.323 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.24 166.0 34.91 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.417 -174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.8 93.72 3.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.778 0.799 . . . . 0.0 109.287 172.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 8.2 t -95.87 -173.28 2.8 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.415 -1.266 . . . . 0.0 109.991 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.6 t -72.88 -33.85 66.31 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.409 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 71.0 mm-40 -95.92 135.9 37.07 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.227 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 28.7 m-80 -66.31 -27.64 68.07 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.206 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 1.4 m -72.05 -23.75 61.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.865 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 11.2 mmpt? -99.09 11.44 39.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.066 -176.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 74.9 mttt -77.67 -32.79 53.41 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 121.028 0.442 . . . . 0.0 111.167 -176.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.7 mm -107.83 116.84 52.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.495 0.664 . . . . 0.0 109.454 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.545 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.5 mp -95.65 107.4 19.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.702 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 34' ' ' LEU . 12.9 m -101.47 112.1 24.53 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.296 0.569 . . . . 0.0 110.037 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -106.72 109.92 21.95 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.9 m -81.26 142.12 33.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.671 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.2 mmtp -70.44 -177.79 1.57 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -168.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -64.66 -34.02 9.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 73.0 Cg_endo -82.1 11.52 3.12 Favored 'Trans proline' 0 C--N 1.363 1.313 0 CA-C-N 121.342 1.515 . . . . 0.0 110.584 178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.693 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.6 p -128.51 75.8 79.08 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.381 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 17.3 Cg_exo -67.97 -7.65 20.36 Favored 'Trans proline' 0 CA--C 1.515 -0.469 0 C-N-CA 123.554 2.836 . . . . 0.0 111.498 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.791 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 31.8 m-80 -131.2 -177.75 4.53 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.938 -176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.68 151.29 34.67 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.6 m-30 -82.85 102.84 11.89 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 171.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.604 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 61.63 -134.25 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.376 -171.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.5 mt-10 -79.85 7.08 9.45 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -171.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 109.51 6.86 28.69 Favored Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 34' ' ' LEU . 41.2 t -59.53 -29.75 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.747 0.784 . . . . 0.0 109.56 176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.087 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.12 161.77 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.343 167.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.507 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -147.17 171.49 15.27 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.377 0.535 . . . . 0.0 109.976 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.688 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -131.03 131.81 44.54 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 122.454 -0.154 . . . . 0.0 110.875 -179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.693 ' HA ' HG22 ' A' ' 85' ' ' THR . 20.2 p -96.49 166.62 11.6 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.979 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 21.8 m 72.11 70.99 0.15 Allowed 'General case' 0 N--CA 1.463 0.214 0 O-C-N 123.816 0.697 . . . . 0.0 111.095 175.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 14.4 p . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.037 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.789 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 98' ' ' SER . 2.2 p 177.09 -178.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' H ' HG22 ' A' ' 2' ' ' VAL . 1.2 p-10 -46.91 105.16 0.45 Allowed Pre-proline 0 N--CA 1.465 0.319 0 CA-C-O 121.351 0.596 . . . . 0.0 110.88 175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.744 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 3.2 Cg_exo -43.16 -22.57 0.32 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.998 3.798 . . . . 0.0 118.01 -168.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.532 ' HG3' ' CG ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -75.78 15.52 0.5 Allowed 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 119.786 1.176 . . . . 0.0 114.159 -174.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 13.9 p-80 -74.05 24.63 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.468 ' H ' ' C ' ' A' ' 5' ' ' LYS . 16.5 m 48.57 -158.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.918 1.287 . . . . 0.0 114.014 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.79 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 3.9 t -158.45 158.25 33.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.661 0.743 . . . . 0.0 112.941 -172.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.507 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -149.19 100.33 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 161.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.6 t70 -128.91 158.84 37.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.646 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 14' ' ' ILE . 2.1 m 58.79 169.76 0.06 Allowed 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 166.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 4.5 mpt_? -89.4 -45.78 9.21 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.725 0.774 . . . . 0.0 109.235 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -144.15 97.04 2.98 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.571 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -74.53 140.73 75.66 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.807 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 73.3 Cg_exo -54.61 154.98 18.42 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.096 2.53 . . . . 0.0 112.709 -178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -66.99 -34.74 78.41 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.331 -168.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.796 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 8.0 m-80 -103.18 16.89 25.39 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.559 ' CB ' ' HB2' ' A' ' 15' ' ' PRO . . . -117.86 146.71 43.7 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.942 -174.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.639 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -121.4 155.95 16.42 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.452 175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.8 p -109.9 150.8 27.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.926 0.393 . . . . 0.0 109.994 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.79 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 49.1 t80 -130.45 139.99 50.55 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.387 0.613 . . . . 0.0 111.656 171.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -142.88 110.44 5.8 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 176.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.701 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 50.0 p30 -80.94 -172.05 3.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.725 -0.79 . . . . 0.0 112.354 -168.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.55 -4.2 47.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.387 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.01 -19.14 19.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.31 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.43 10.89 37.39 Favored Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 95.5 m -78.46 124.07 27.73 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.318 -0.441 . . . . 0.0 110.251 176.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.591 ' CG ' ' HG3' ' A' ' 22' ' ' ARG . 12.0 mt-10 -122.87 124.44 43.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.99 0.424 . . . . 0.0 111.855 -174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -150.17 134.43 17.18 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.536 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.9 p-90 -103.15 155.38 18.45 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.705 169.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.553 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -139.34 -179.52 5.93 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 1.073 ' SG ' ' HB2' ' A' ' 36' ' ' TYR . 5.0 t -110.03 134.69 51.87 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 6.0 mt -64.91 165.28 11.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.682 -166.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.826 HD22 ' SG ' ' A' ' 79' ' ' CYS . 53.0 mt -62.8 120.46 11.32 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.765 -1.107 . . . . 0.0 112.079 -169.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 102.84 -14.11 56.13 Favored Glycine 0 N--CA 1.435 -1.414 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.098 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 1.073 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 2.9 m-30 -97.58 -170.83 2.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.011 0.434 . . . . 0.0 111.043 -174.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.485 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 58.9 pttt -150.47 157.18 42.73 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.398 0.618 . . . . 0.0 110.762 -172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' THR . 1.3 tppp? -70.96 120.32 16.35 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.228 171.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.21 -75.67 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.273 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.564 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.8 pt-20 -99.86 -168.18 1.56 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 170.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -45.41 -34.17 4.66 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.729 0.643 . . . . 0.0 114.458 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HB2' ' HZ2' ' A' ' 30' ' ' TRP . 3.3 p-10 -149.06 58.09 1.03 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 117.64 0.72 . . . . 0.0 112.397 -177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.564 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 20.6 p -143.12 150.53 39.59 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.079 0.466 . . . . 0.0 111.28 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 10.7 t -110.51 141.78 43.19 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 170.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.569 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 16.8 m -140.85 147.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.593 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 12.3 mt-10 -62.1 103.85 0.41 Allowed 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.268 0.556 . . . . 0.0 111.438 -175.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.807 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 40.1 t30 -80.04 130.86 35.58 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 173.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.444 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 10.5 m120 -107.04 8.78 30.51 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.443 0.639 . . . . 0.0 109.502 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 57.6 t30 -135.92 51.45 5.35 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.796 171.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.641 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 15.7 Cg_endo -63.9 132.16 33.7 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.62 2.213 . . . . 0.0 112.252 176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.8 t -121.44 150.06 42.11 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.488 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.5 t -86.73 129.1 35.0 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 16.2 t70 153.99 -54.48 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 O-C-N 124.205 0.94 . . . . 0.0 109.145 -165.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 77.9 mt -63.26 -89.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.336 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -109.52 53.43 0.69 Allowed 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 62.96 31.66 16.03 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.566 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.01 -7.32 81.27 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.012 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.05 15.17 5.73 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.1 m -105.08 -177.62 3.42 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 124.179 0.991 . . . . 0.0 109.415 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.05 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 21.9 t70 -99.97 144.61 28.71 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.21 -12.87 11.08 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.135 1.89 . . . . 0.0 112.4 -175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 42.2 p -92.13 -18.84 22.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.531 0.682 . . . . 0.0 109.823 175.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.405 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.83 109.3 18.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.668 174.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.615 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 41.8 t -55.53 116.17 2.73 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 1.8 t -91.47 135.4 33.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.647 0.737 . . . . 0.0 111.374 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -123.51 116.64 23.51 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.011 174.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 52' ' ' CYS . 1.0 OUTLIER -86.5 128.87 35.01 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.872 0.844 . . . . 0.0 111.374 179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.69 162.91 31.85 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.735 -1.575 . . . . 0.0 109.101 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -121.26 79.8 1.57 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 123.017 1.389 . . . . 0.0 109.964 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.2 m -93.17 164.24 13.32 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 112.703 -2.044 . . . . 0.0 109.716 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 t -73.29 -32.81 64.86 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 6.1 mm-40 -69.47 111.84 5.59 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.851 168.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.86 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 15.3 m-80 -66.84 -31.7 72.49 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.4 m -76.89 -13.22 60.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.245 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 9.4 tppt? -115.98 16.61 16.1 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.315 0.579 . . . . 0.0 110.702 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.86 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 51.0 mttm -80.14 -38.07 32.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.418 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.46 HG12 ' HB2' ' A' ' 50' ' ' PRO . 50.9 mm -102.78 117.47 48.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.668 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.7 mp -96.15 104.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.002 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.826 ' SG ' HD22 ' A' ' 34' ' ' LEU . 38.6 m -97.49 116.32 29.47 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.926 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.9 m -114.86 112.78 23.28 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.079 -175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.432 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 12.5 m -81.94 148.63 28.62 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.615 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 33.7 mmtp -79.99 -175.89 5.2 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -167.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -49.34 -49.66 69.41 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' SER . 93.1 Cg_endo -81.96 12.11 2.91 Favored 'Trans proline' 0 C--N 1.36 1.136 0 C-N-CA 121.881 1.721 . . . . 0.0 111.43 -173.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 97' ' ' SER . 20.7 p -125.39 81.83 63.57 Favored Pre-proline 0 N--CA 1.433 -1.32 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.294 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.0 Cg_exo -68.6 -7.7 21.15 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 C-N-CA 122.778 2.319 . . . . 0.0 111.219 -177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.744 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 16.5 m-80 -139.91 -173.73 3.72 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.363 -170.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -150.64 148.27 28.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.941 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.8 m-30 -73.79 104.03 4.54 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 170.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 69.18 -121.05 0.14 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.914 -171.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.5 mt-10 -95.8 -6.55 39.3 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.9 0.57 6.53 Favored Glycine 0 CA--C 1.506 -0.488 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -170.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.546 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 16.0 t -55.55 -33.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-O 121.823 0.82 . . . . 0.0 109.454 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.05 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -148.72 157.51 43.5 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.711 171.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.9 OUTLIER -146.73 161.67 40.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 118.421 0.555 . . . . 0.0 110.689 179.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.725 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 2.5 t -115.98 128.87 56.08 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 -177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.708 ' HA ' HG22 ' A' ' 85' ' ' THR . 45.9 m -99.05 -10.66 22.32 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.596 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 16.1 m -94.12 50.9 1.44 Allowed 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.0 -0.438 . . . . 0.0 112.054 -175.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 80.1 p . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.458 -0.782 . . . . 0.0 109.926 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 112.136 -0.386 . . . . 0.0 112.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.636 ' C ' ' HA ' ' A' ' 99' ' ' SER . 4.0 p -157.61 168.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 8.6 p-10 -47.76 131.91 11.24 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-O 121.685 0.755 . . . . 0.0 110.848 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -44.92 -13.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 125.14 3.893 . . . . 0.0 117.735 -170.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' C ' ' H ' ' A' ' 7' ' ' VAL . 3.1 pptp? -76.25 13.85 0.84 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.418 1.008 . . . . 0.0 113.331 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.624 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 6.1 p-80 -70.97 18.91 0.06 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' H ' ' C ' ' A' ' 5' ' ' LYS . 17.6 m 47.97 -158.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.284 1.434 . . . . 0.0 113.77 168.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.76 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 11.1 t -159.58 151.63 20.71 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.838 0.828 . . . . 0.0 113.082 -173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.0 m -142.84 101.35 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 164.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 11.0 t70 -129.61 167.72 17.53 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.299 -171.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.572 HG22 HG13 ' A' ' 14' ' ' ILE . 3.1 m 30.62 132.74 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 158.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.523 ' H ' ' CD ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -59.42 -47.7 84.44 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 111.876 -2.42 . . . . 0.0 111.408 -170.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -131.47 81.18 1.97 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.386 176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.4 mt -67.29 134.74 93.31 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 81.4 Cg_exo -54.96 153.86 23.94 Favored 'Trans proline' 0 CA--C 1.515 -0.43 0 C-N-CA 123.349 2.699 . . . . 0.0 112.774 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -65.43 151.95 45.11 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 167.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.804 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.1 m-80 66.47 8.79 6.01 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.789 0.804 . . . . 0.0 109.521 -177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -119.78 147.67 44.36 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.968 178.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -128.54 152.57 19.27 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.103 176.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.759 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -108.67 150.98 26.79 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.119 0.485 . . . . 0.0 110.741 -173.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.703 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 50.1 t80 -129.88 140.1 51.04 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.14 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.76 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.7 ttt180 -128.67 117.95 22.05 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.041 174.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.44 -178.04 6.91 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.487 -171.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.63 -32.09 73.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.482 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 17.4 t70 -73.07 -28.49 62.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.177 0.513 . . . . 0.0 110.415 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.51 -0.99 14.12 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.645 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 17.0 m -62.54 128.69 37.17 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.093 0.557 . . . . 0.0 110.753 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 13.9 mt-10 -117.38 127.5 54.1 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.976 0.417 . . . . 0.0 111.18 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -147.4 130.78 16.64 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.97 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 47.8 p-90 -99.82 154.16 18.56 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.407 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 86.4 mtt180 -140.03 -178.82 5.63 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.75 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.5 m -109.7 126.68 53.95 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -175.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.2 mt -57.69 162.45 3.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.415 -169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD22 ' SG ' ' A' ' 79' ' ' CYS . 66.6 mt -66.98 130.19 42.34 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.235 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.725 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 83.91 20.36 59.63 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -174.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.804 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 7.8 m-30 -129.06 165.28 21.5 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.515 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 50.9 pttt -132.9 177.21 7.82 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.1 OUTLIER -92.76 127.1 38.14 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.86 -84.12 0.92 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.617 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -94.05 177.69 5.89 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 165.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -46.41 -38.09 8.89 Favored Glycine 0 CA--C 1.52 0.395 0 O-C-N 123.59 0.556 . . . . 0.0 113.973 -177.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' H ' ' HG3' ' A' ' 40' ' ' GLU . 18.3 m120 -122.47 51.12 1.41 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.617 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 6.8 p -147.61 139.88 24.43 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 120.922 0.392 . . . . 0.0 111.775 174.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 82.5 m -111.69 138.91 47.63 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.388 174.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.71 144.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.428 -172.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.607 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 30.6 mt-10 -61.92 109.22 1.19 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.859 176.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.537 HD21 ' HB3' ' A' ' 50' ' ' PRO . 10.4 p30 -74.29 -37.03 63.78 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -174.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.9 OUTLIER 71.07 -23.24 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.972 0.509 . . . . 0.0 111.49 179.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.471 ' H ' ' C ' ' A' ' 47' ' ' ASN . 1.4 p-10 -124.64 55.36 10.33 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 171.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.656 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 23.5 Cg_endo -70.11 136.59 32.45 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.385 2.723 . . . . 0.0 111.765 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.429 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.3 t -122.08 149.5 43.46 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.092 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 5.4 t -87.03 129.07 35.05 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 23.2 t70 152.42 -53.73 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -162.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.401 ' C ' ' H ' ' A' ' 56' ' ' ASN . 72.1 mt -68.1 90.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.831 176.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.4 t30 71.14 -54.72 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.949 0.88 . . . . 0.0 109.853 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 59' ' ' CYS . 33.8 p-10 166.95 41.63 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.246 -1.797 . . . . 0.0 108.691 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 88.41 -10.26 72.25 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.841 178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.01 22.39 7.26 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 14.4 m -105.7 -175.71 2.87 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 124.126 0.97 . . . . 0.0 108.794 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.073 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 14.1 t70 -100.02 143.75 27.08 Favored Pre-proline 0 C--N 1.302 -1.495 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.52 -18.82 16.07 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.275 1.983 . . . . 0.0 112.119 -176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.589 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 51.8 p -90.6 -13.29 34.71 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.338 177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -92.35 116.66 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.765 171.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.608 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 38.5 t -64.44 126.24 27.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 10.0 t -97.81 137.63 36.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.824 0.821 . . . . 0.0 112.001 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.572 ' HB2' HD13 ' A' ' 78' ' ' ILE . 5.3 mm-40 -128.68 138.39 52.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.211 -1.359 . . . . 0.0 108.097 172.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.505 0.669 . . . . 0.0 110.275 174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -162.82 171.98 15.88 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.043 -174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -138.48 115.66 11.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.8 0.809 . . . . 0.0 110.754 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 44.8 t -124.83 163.96 21.05 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.691 -1.141 . . . . 0.0 108.814 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 t -56.31 -27.36 55.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.313 0.577 . . . . 0.0 110.059 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 36.2 mt-10 -92.25 134.15 35.16 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.515 172.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.781 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.6 p30 -66.17 -34.07 77.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.059 173.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.671 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 18.6 p -65.39 -27.02 68.26 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.011 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 2.3 mmmm -93.79 13.61 21.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.664 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 18.1 mttm -92.63 -48.22 6.71 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.783 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.61 HG12 ' HB2' ' A' ' 50' ' ' PRO . 39.8 mm -98.67 116.93 42.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 121.433 0.635 . . . . 0.0 109.338 175.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 66' ' ' GLN . 3.8 mp -93.9 106.46 18.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.089 -177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.738 ' SG ' HD22 ' A' ' 34' ' ' LEU . 16.9 m -105.13 112.19 25.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.806 177.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 18.8 m -112.62 113.1 25.08 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.737 -178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 12.6 m -81.01 139.22 35.9 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.608 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -72.86 -176.83 2.15 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 35.4 mt-10 -58.2 -37.35 54.23 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 68.2 Cg_endo -75.28 -4.82 15.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.456 1.437 . . . . 0.0 111.969 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 96' ' ' SER . 44.6 p -113.26 85.76 8.85 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.685 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.744 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 31.7 Cg_exo -65.94 -12.84 37.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.695 2.263 . . . . 0.0 111.164 -176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.751 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 11.4 m-80 -136.33 -173.84 3.52 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.569 -176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.25 147.81 31.81 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.988 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.859 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 2.7 m-30 -73.06 102.72 3.6 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 171.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 65.95 -123.71 0.32 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.034 -170.335 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.2 mt-10 -94.29 4.1 54.33 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.42 3.27 20.94 Favored Glycine 0 CA--C 1.507 -0.446 0 C-N-CA 120.091 -1.052 . . . . 0.0 110.55 -172.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.588 ' HA ' HD21 ' A' ' 34' ' ' LEU . 22.0 t -56.41 -32.41 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 121.861 0.839 . . . . 0.0 109.295 173.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.073 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.4 155.14 39.98 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.282 -1.327 . . . . 0.0 108.279 171.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.1 m -143.89 160.28 41.08 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.897 0.771 . . . . 0.0 110.776 -178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.798 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 8.4 t -118.96 122.22 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.443 0.163 . . . . 0.0 111.035 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.513 ' HA ' HG22 ' A' ' 85' ' ' THR . 50.6 m -91.57 -12.76 33.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.411 0.624 . . . . 0.0 109.998 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 m -83.68 42.54 0.85 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.317 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 78.8 p . . . . . 0 C--O 1.256 1.396 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.278 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.799 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER 53.68 178.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.544 1.138 . . . . 0.0 112.432 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.905 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.1 OUTLIER -52.2 120.12 16.39 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.915 172.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.7 Cg_endo -50.38 -4.78 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.296 0 C-N-CA 123.785 2.99 . . . . 0.0 117.129 -175.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -78.4 13.02 1.69 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.728 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 13.4 p-80 -79.93 24.06 0.42 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -173.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m 45.59 -156.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.927 1.291 . . . . 0.0 114.293 168.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.003 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 44.8 t -158.45 154.1 26.28 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 m -149.32 101.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 113.141 -1.845 . . . . 0.0 106.564 158.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 7.3 t70 -129.2 165.42 21.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.385 -176.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.552 HG22 HG13 ' A' ' 14' ' ' ILE . 3.6 m 37.95 137.48 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 160.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.536 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 6.3 mpt_? -66.56 -46.06 77.29 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 112.746 -2.025 . . . . 0.0 110.785 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -128.22 89.92 2.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 20' ' ' CYS . 12.6 mt -84.12 136.53 40.84 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 175.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 87.0 Cg_exo -53.94 149.36 34.61 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.09 2.527 . . . . 0.0 112.73 -176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tttm -63.66 -38.37 90.85 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.987 -172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.721 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.7 OUTLIER -98.43 29.22 3.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.742 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -127.64 156.16 42.75 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.113 -175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -131.63 150.71 19.57 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 114.424 -1.262 . . . . 0.0 110.173 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.819 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.8 p -107.05 149.12 27.92 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.003 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 53.9 t80 -139.59 140.34 37.01 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.772 0.796 . . . . 0.0 111.469 173.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.605 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 44.7 ttt180 -121.09 126.91 51.01 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.394 -1.275 . . . . 0.0 109.77 -174.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 29.1 t70 -96.98 177.62 5.55 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.885 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.505 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 16.7 t70 -54.16 -42.25 69.38 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 124.045 0.938 . . . . 0.0 112.006 -174.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -64.27 -14.01 53.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.858 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.46 -0.02 58.19 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 23.6 m -57.58 127.17 30.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.604 -0.798 . . . . 0.0 110.754 177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 27.2 mt-10 -120.44 118.06 29.32 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.309 0.576 . . . . 0.0 110.901 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -144.02 133.82 23.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.588 -176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 51.2 p-90 -104.53 156.87 17.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 170.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 82.7 mtt180 -142.31 -179.18 6.11 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.762 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.1 m -109.09 128.65 55.17 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -175.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.7 mt -59.59 166.12 2.61 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.732 -168.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.739 HD22 ' SG ' ' A' ' 79' ' ' CYS . 69.9 mt -66.34 128.79 37.54 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 121.589 0.709 . . . . 0.0 111.764 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.6 ' HA2' ' HG3' ' A' ' 50' ' ' PRO . . . 90.03 0.93 76.92 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.958 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.753 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 5.3 m-30 -103.1 -174.18 2.49 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 56.3 pttt -151.21 172.26 16.12 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.036 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.0 128.67 36.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.092 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -94.7 -101.3 1.74 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.998 -176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.569 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.2 pt-20 -85.98 54.12 3.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.696 0.76 . . . . 0.0 111.552 -175.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.7 -66.29 2.89 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.764 178.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -122.6 45.43 2.38 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.116 0.484 . . . . 0.0 110.996 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.569 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 33.3 p -137.08 156.4 48.44 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.25 0.548 . . . . 0.0 110.458 176.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 65.4 m -120.83 133.73 55.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.34 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.0 m -138.93 150.89 23.37 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.448 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.524 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 44.2 mt-10 -61.92 104.04 0.42 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.531 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.753 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 29.2 t30 -64.06 -40.68 96.81 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.596 177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 1.5 t-20 69.56 -15.04 0.31 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 114.666 -1.152 . . . . 0.0 112.273 171.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.3 t30 -130.49 55.52 19.35 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 169.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.624 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 19.8 Cg_endo -64.08 138.19 60.82 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.191 2.594 . . . . 0.0 113.227 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.1 t -120.17 150.83 40.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.105 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 8.8 t -84.98 129.66 34.76 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 15.6 t70 148.64 -56.44 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 -164.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.7 mt -73.55 89.79 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.863 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.921 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.9 t30 54.07 45.54 27.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.553 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 1.2 m-20 68.31 26.35 6.85 Favored 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.079 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.99 4.71 74.58 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.349 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 113.18 11.81 13.09 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.552 -175.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 4.7 m -105.94 -178.8 3.76 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.654 0.74 . . . . 0.0 109.906 -175.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.031 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 15.2 t70 -100.4 145.7 30.73 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -57.86 -15.83 23.32 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.829 1.686 . . . . 0.0 111.902 -176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.596 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 43.3 p -90.36 -13.92 34.11 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.756 0.789 . . . . 0.0 109.852 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.58 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -91.77 105.98 18.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.711 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.61 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 22.0 t -54.66 124.71 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.51 137.74 35.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.823 0.821 . . . . 0.0 111.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -129.87 124.5 33.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.856 172.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -93.44 126.48 38.61 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.183 0.992 . . . . 0.0 111.069 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -141.08 176.18 9.03 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.311 -172.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.32 112.49 14.5 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.294 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.5 t -130.27 163.28 27.11 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.231 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.9 t -62.94 -22.22 66.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.454 ' OE2' ' HG3' ' A' ' 75' ' ' LYS . 16.5 mt-10 -101.36 132.48 46.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.918 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.3 OUTLIER -61.16 -32.19 71.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.625 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 19.6 p -75.97 -22.22 56.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.278 0.561 . . . . 0.0 110.933 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.454 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 2.8 mmmm -92.9 8.41 39.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.918 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 58.4 mttm -86.74 -50.07 7.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.276 0.56 . . . . 0.0 110.476 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.1 mm -94.74 117.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 78' ' ' ILE . 4.0 mp -93.11 111.68 25.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.827 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.739 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.6 m -107.19 112.34 25.18 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.604 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 93.1 m -112.02 112.04 23.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.826 -175.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 24.3 m -80.57 145.16 31.91 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 28.9 mmtp -73.07 -178.38 2.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -166.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -57.29 -43.2 99.02 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' O ' ' HD3' ' A' ' 86' ' ' PRO . 71.6 Cg_endo -79.88 2.8 8.12 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.378 1.385 . . . . 0.0 111.773 -177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.613 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.5 p -116.39 84.99 15.3 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 84' ' ' PRO . 17.1 Cg_exo -69.15 -1.26 7.65 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.258 2.638 . . . . 0.0 112.501 -174.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.79 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 28.8 m-80 -142.31 -176.59 4.89 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 -172.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -147.43 148.23 31.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.737 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 1.8 m-30 -77.04 104.89 7.79 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 173.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.578 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.35 -116.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.967 -172.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.511 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -96.08 -3.82 44.01 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 121.2 2.57 10.93 Favored Glycine 0 CA--C 1.508 -0.381 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -170.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.8 t -57.62 -32.0 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.57 -0.815 . . . . 0.0 110.09 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.031 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -146.94 160.05 42.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.524 171.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 m -144.75 162.55 36.46 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.38 0.536 . . . . 0.0 110.761 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.674 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 23.2 t -112.68 122.13 46.77 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.004 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.613 ' HA ' HG22 ' A' ' 85' ' ' THR . 23.4 m -106.98 66.67 0.68 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.737 0.779 . . . . 0.0 110.726 178.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.3 m -155.79 30.88 0.36 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.693 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.905 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.029 -175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.79 0 N-CA-C 112.214 -0.355 . . . . 0.0 112.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 99' ' ' SER . 9.5 p -60.53 134.96 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-O 121.6 0.714 . . . . 0.0 112.148 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.941 ' HA ' ' HB2' ' A' ' 99' ' ' SER . 21.6 p-10 -94.39 131.8 30.36 Favored Pre-proline 0 C--N 1.306 -1.289 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.881 177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.675 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 1.9 Cg_endo -45.19 -8.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.552 1.423 0 C-N-CA 124.787 3.658 . . . . 0.0 118.019 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.545 ' HE2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.43 10.7 1.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.73 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.2 p-80 -74.9 20.23 0.13 Allowed 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.67 0.272 . . . . 0.0 111.635 -177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.461 ' H ' ' C ' ' A' ' 5' ' ' LYS . 20.8 m 47.0 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.501 1.52 . . . . 0.0 113.868 170.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 26.2 p -157.57 150.49 23.21 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -171.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG2' ' HD2' ' A' ' 22' ' ' ARG . 3.1 m -151.69 103.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 165.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 28' ' ' GLU . 10.8 t70 -129.1 157.76 40.85 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.886 -174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.791 HG22 HG13 ' A' ' 14' ' ' ILE . 0.4 OUTLIER 58.04 -178.02 0.07 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 165.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.582 ' N ' HG23 ' A' ' 11' ' ' THR . 4.6 mpt_? -85.39 -43.19 13.86 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.086 0.946 . . . . 0.0 108.494 -175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.545 ' H ' HG23 ' A' ' 11' ' ' THR . 38.7 t70 -152.07 104.89 3.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.93 -1.487 . . . . 0.0 110.567 177.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.893 HD13 ' HB3' ' A' ' 20' ' ' CYS . 17.6 mt -75.8 134.7 71.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.533 -0.544 . . . . 0.0 109.533 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.599 ' HB2' ' HB2' ' A' ' 18' ' ' ALA . 85.4 Cg_exo -53.01 151.22 21.41 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 123.493 2.796 . . . . 0.0 113.362 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -58.56 -51.9 67.94 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.062 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.802 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 9.0 m120 -88.88 33.73 0.78 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.192 0.996 . . . . 0.0 108.782 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . . . -130.95 163.72 26.91 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.884 -177.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -138.77 163.61 25.83 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 114.597 -1.183 . . . . 0.0 110.839 175.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.893 ' HB3' HD13 ' A' ' 14' ' ' ILE . 14.7 p -116.53 154.52 30.27 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.382 0.61 . . . . 0.0 111.746 -169.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 23' ' ' ASP . 19.8 t80 -127.38 138.81 53.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.382 166.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' A' ' 27' ' ' THR . 5.1 ttt180 -137.42 117.13 13.05 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.55 167.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.73 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 50.9 p30 -84.2 -170.22 2.98 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 118.861 -1.136 . . . . 0.0 111.095 -173.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -74.55 -22.72 58.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.25 0.548 . . . . 0.0 110.79 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -76.33 -28.58 56.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.363 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.74 6.18 17.3 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.406 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.727 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 12.5 m -63.78 140.05 58.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.841 0.456 . . . . 0.0 110.089 176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 19.7 mt-10 -134.86 119.73 18.45 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.431 0.634 . . . . 0.0 111.248 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -147.43 128.23 14.35 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.106 -176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.489 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 28.3 p-90 -104.12 155.33 18.78 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.38 173.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.473 ' HG3' ' CE2' ' A' ' 94' ' ' PHE . 84.2 mtt180 -137.81 -179.06 5.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.856 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 60.3 m -110.53 131.16 55.29 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 -177.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 7.4 mt -59.89 168.22 1.89 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.539 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.781 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.6 mt -64.75 125.18 23.99 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.884 -174.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.748 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 78.25 26.87 58.89 Favored Glycine 0 N--CA 1.434 -1.441 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.358 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.802 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 5.1 m-30 -130.02 162.4 28.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 54.6 pttt -129.26 178.08 6.7 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.224 -174.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -95.9 130.43 42.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.247 177.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -101.33 -110.55 3.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.94 -175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -83.03 71.32 10.12 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.522 0.677 . . . . 0.0 111.305 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.32 -110.52 3.16 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.365 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -85.93 53.96 2.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.157 0.503 . . . . 0.0 111.116 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -140.59 145.4 36.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.582 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.563 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 72.7 m -121.9 140.09 52.85 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.762 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.499 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -144.44 148.76 17.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.731 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 29.5 mt-10 -58.68 111.64 1.34 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.445 175.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.589 ' HA ' ' HE2' ' A' ' 37' ' ' LYS . 11.0 p30 -76.38 -34.99 58.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.689 -176.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.604 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 16.0 m120 67.85 -13.2 0.27 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.854 0.721 . . . . 0.0 111.323 179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 47' ' ' ASN . 9.2 t30 -136.24 54.11 9.0 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 121.142 0.496 . . . . 0.0 110.427 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.64 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.7 Cg_endo -71.23 139.12 34.59 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 123.567 2.845 . . . . 0.0 113.028 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.584 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.2 t -121.53 148.79 44.02 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.924 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 7.1 t -87.47 129.72 34.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 172.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 152.44 -52.56 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.955 0.785 . . . . 0.0 108.897 -164.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.56 -90.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.219 -174.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.455 HD21 ' NH1' ' A' ' 31' ' ' ARG . 63.7 t30 -111.49 53.53 0.71 Allowed 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.5 OUTLIER 65.52 29.92 10.91 Favored 'General case' 0 C--O 1.213 -0.867 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -176.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.584 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 91.13 -8.15 79.92 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.931 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 93' ' ' VAL . . . 119.64 18.24 4.47 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -175.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 10.6 m -106.87 -176.59 3.12 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.159 0.983 . . . . 0.0 110.174 -175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.019 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.67 144.35 27.99 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.94 -16.74 21.49 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.115 1.877 . . . . 0.0 112.262 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 31.7 p -93.52 -15.72 25.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.527 0.68 . . . . 0.0 109.856 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -83.17 98.98 9.64 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.634 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.593 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 23.3 t -50.54 108.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.969 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.8 t -88.34 137.56 32.21 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.782 0.801 . . . . 0.0 111.717 -176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.479 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -127.03 132.15 50.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.075 173.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.78 132.2 36.59 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.806 0.813 . . . . 0.0 110.462 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -150.69 157.81 43.41 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.76 -171.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -116.37 108.8 16.52 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.748 0.785 . . . . 0.0 110.418 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.535 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 40.1 t -128.57 160.63 31.78 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.538 -177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.7 t -62.75 -27.71 69.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.22 0.533 . . . . 0.0 109.775 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 11.4 mm-40 -89.08 124.02 33.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.497 174.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.785 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 4.0 p30 -62.0 -35.73 79.38 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m -66.63 -26.72 67.21 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.139 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 75' ' ' LYS . 10.8 mmpt? -94.94 5.15 52.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.671 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 15.2 mttm -80.7 -40.28 25.65 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.417 0.627 . . . . 0.0 110.182 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 52.0 mm -105.83 116.87 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-O 121.546 0.688 . . . . 0.0 109.312 176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 3.5 mp -94.67 116.28 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.718 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.781 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -115.0 112.59 22.9 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.187 0.517 . . . . 0.0 110.032 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 90.4 m -112.5 108.3 17.36 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.44 -174.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.8 m -82.65 140.71 32.99 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' THR . 69.7 mmtt -78.37 -176.61 4.8 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -45.48 -49.69 33.44 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.3 7.31 3.04 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.812 1.675 . . . . 0.0 111.686 -173.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.677 HG22 ' HA ' ' A' ' 97' ' ' SER . 4.9 p -119.06 83.64 24.56 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 114.724 -1.126 . . . . 0.0 109.371 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 27.6 Cg_exo -67.52 -3.68 10.6 Favored 'Trans proline' 0 CA--C 1.522 -0.112 0 C-N-CA 122.276 1.984 . . . . 0.0 111.005 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.882 HD21 ' HB2' ' A' ' 3' ' ' ASP . 5.5 m-80 -145.13 -177.59 5.62 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.355 -174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.71 150.62 35.75 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.868 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.0 m-30 -76.62 103.35 6.56 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.714 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 65.21 -119.29 0.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.218 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 8.1 mt-10 -95.86 -2.94 46.38 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -171.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.62 4.7 11.64 Favored Glycine 0 CA--C 1.504 -0.597 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -170.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.45 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 20.8 t -58.02 -30.77 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 CA-C-O 122.035 0.922 . . . . 0.0 108.981 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.019 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -151.78 155.69 38.74 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.989 -1.46 . . . . 0.0 107.536 170.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.68 153.67 38.58 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.628 0.649 . . . . 0.0 110.817 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.631 ' HB2' ' CE1' ' A' ' 89' ' ' TYR . 12.9 t -103.65 120.74 41.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 122.269 -0.269 . . . . 0.0 110.322 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.677 ' HA ' HG22 ' A' ' 85' ' ' THR . 70.5 m -98.52 29.37 3.69 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.485 0.659 . . . . 0.0 110.734 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m -109.03 7.93 25.99 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.024 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.941 ' HB2' ' HA ' ' A' ' 3' ' ' ASP . 33.3 t . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.182 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.613 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.864 0 CA-C-O 120.109 -0.273 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 68.89 170.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.122 1.369 . . . . 0.0 111.991 -179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.756 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 12.1 p-10 -52.23 118.59 12.72 Favored Pre-proline 0 N--CA 1.457 -0.086 0 CA-C-O 121.403 0.621 . . . . 0.0 110.576 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.745 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -45.8 -13.88 0.1 OUTLIER 'Trans proline' 0 CA--C 1.551 1.354 0 C-N-CA 124.853 3.702 . . . . 0.0 118.055 -170.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -76.42 11.68 1.51 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 120.131 1.332 . . . . 0.0 114.032 -172.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 9.2 p-80 -74.24 16.22 0.26 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.593 0.235 . . . . 0.0 111.435 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 5' ' ' LYS . 23.9 m 43.82 -147.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.877 1.271 . . . . 0.0 113.668 173.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.845 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 5.2 t -158.29 155.79 29.49 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -144.48 100.34 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 162.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 14.9 t70 -129.87 170.37 14.0 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.284 -172.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.525 HG22 HG13 ' A' ' 14' ' ' ILE . 12.2 m 26.43 119.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 159.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 12' ' ' ARG . 5.4 mmt180 -60.94 -33.07 72.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.757 -1.111 . . . . 0.0 110.837 -173.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -128.78 83.23 2.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.115 177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.693 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.2 mt -82.15 139.02 45.5 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 54.5 Cg_exo -56.03 151.01 44.24 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.821 2.347 . . . . 0.0 112.025 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -64.84 -38.6 91.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.931 -172.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.697 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 5.2 m-80 -98.41 26.76 5.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.598 1.189 . . . . 0.0 108.104 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.576 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -128.27 153.51 46.89 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 113.548 -1.66 . . . . 0.0 110.484 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -129.16 152.07 19.34 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.154 175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.693 ' HB3' HD13 ' A' ' 14' ' ' ILE . 2.7 p -107.91 150.68 26.77 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.907 0.384 . . . . 0.0 110.148 -174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 41.8 t80 -130.16 139.24 50.9 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.545 172.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 27' ' ' THR . 0.0 OUTLIER -139.79 107.67 5.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 175.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.686 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 49.8 p30 -76.59 -175.26 3.28 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.791 -170.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.3 -20.92 62.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.343 0.592 . . . . 0.0 110.358 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -78.42 -27.86 46.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.681 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.05 8.32 20.22 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.729 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 20.2 m -73.19 118.79 16.57 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.605 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 29.1 mt-10 -115.28 124.08 50.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.06 0.457 . . . . 0.0 111.261 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -149.46 132.31 16.06 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.737 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 29.0 p-90 -104.29 151.7 23.11 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.245 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 88.3 mtt180 -136.62 -178.11 5.03 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.817 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.7 m -109.2 128.69 55.25 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.556 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 8.3 mt -58.7 165.47 2.25 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.797 -170.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.819 HD22 ' SG ' ' A' ' 79' ' ' CYS . 59.9 mt -66.97 128.84 37.85 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.835 -169.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.614 ' HA3' ' O ' ' A' ' 73' ' ' ASN . . . 88.26 4.51 77.43 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.749 -177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.778 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.6 m-30 -106.63 -174.35 2.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 59.9 pttt -150.14 172.57 15.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.257 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.46 130.18 40.93 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -104.21 -109.8 3.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.541 -172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.14 62.95 6.13 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 123.309 0.644 . . . . 0.0 111.182 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.91 -119.48 5.54 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.085 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -80.67 57.32 2.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.49 0.662 . . . . 0.0 110.85 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -141.78 141.83 33.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.564 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 59.9 m -117.58 141.26 48.57 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 174.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.2 156.39 21.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 O-C-N 123.783 0.677 . . . . 0.0 110.035 -176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.58 101.95 0.85 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.778 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 28.9 t30 -64.31 -45.7 86.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.27 -176.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.438 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER 69.52 -14.68 0.33 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.873 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 47' ' ' ASN . 63.7 t30 -123.63 50.02 3.05 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.078 170.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.557 ' HB2' HG12 ' A' ' 77' ' ' ILE . 32.1 Cg_endo -69.66 137.41 35.67 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.618 2.212 . . . . 0.0 113.231 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.457 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.1 t -121.28 148.91 43.67 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.559 178.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -86.51 129.43 34.86 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 24.0 t70 152.52 -50.12 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -162.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 56' ' ' ASN . 65.2 mt -72.64 90.08 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.385 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 65.7 t30 70.78 -53.95 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.199 0.937 . . . . 0.0 109.841 -174.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.649 ' O ' ' HB2' ' A' ' 65' ' ' CYS . 23.1 p30 169.31 32.56 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 113.334 -1.757 . . . . 0.0 109.451 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.29 -8.04 66.8 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.155 -1.022 . . . . 0.0 112.479 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.92 21.61 6.64 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.287 -176.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.433 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 9.8 m -106.28 -175.61 2.84 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 124.308 1.043 . . . . 0.0 108.196 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.078 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.8 t70 -100.65 143.96 27.56 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -55.23 -15.29 10.65 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.412 2.074 . . . . 0.0 112.424 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -93.22 -17.46 23.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.471 175.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -88.22 120.74 29.86 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.286 174.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.805 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 4.8 m -56.73 118.98 5.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.9 177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.84 144.59 25.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.439 0.637 . . . . 0.0 111.462 -178.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.645 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 6.3 mm-40 -143.51 140.64 30.39 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.978 176.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -100.38 139.52 35.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.301 0.572 . . . . 0.0 110.198 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.27 164.82 32.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.931 -175.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.69 93.27 3.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.03 0.919 . . . . 0.0 110.857 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.437 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 8.6 t -109.66 157.59 18.93 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.122 -1.399 . . . . 0.0 109.042 178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.2 t -61.66 -24.22 66.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.35 0.595 . . . . 0.0 110.055 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 11.6 mt-10 -92.85 125.98 37.71 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.894 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -60.57 -31.6 70.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.737 175.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.606 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.3 t -75.05 -18.88 60.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.36 0.6 . . . . 0.0 110.366 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 21.3 mmmt -98.86 7.48 45.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.147 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.894 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 49.4 mttm -84.94 -51.79 6.46 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.307 0.575 . . . . 0.0 110.044 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.557 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.1 mm -95.47 116.51 37.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 173.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.645 ' HB ' ' HG3' ' A' ' 66' ' ' GLN . 3.6 mp -94.51 108.85 21.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.468 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.819 ' SG ' HD22 ' A' ' 34' ' ' LEU . 23.4 m -103.81 112.05 24.84 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.804 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.805 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 53.1 m -112.06 111.47 22.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.84 -173.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.84 132.52 34.8 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HE2' ' OG ' ' A' ' 64' ' ' SER . 0.7 OUTLIER -74.37 -176.8 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -53.81 -44.11 97.49 Favored Pre-proline 0 CA--C 1.545 0.787 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.12 9.31 4.02 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.502 1.468 . . . . 0.0 110.893 -175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 97' ' ' SER . 27.7 p -131.65 67.96 80.37 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 23.2 Cg_exo -63.42 -4.76 7.19 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.958 3.106 . . . . 0.0 112.792 -167.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.745 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 17.8 m-80 -139.44 -173.53 3.63 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.096 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -146.61 150.91 36.4 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.932 0.396 . . . . 0.0 111.171 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.9 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.8 m-30 -78.36 103.46 8.32 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 168.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 68.79 -124.66 0.14 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.74 -171.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.47 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 3.8 mt-10 -91.96 -2.21 56.87 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -172.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.87 0.51 9.07 Favored Glycine 0 CA--C 1.506 -0.529 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -172.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.566 ' HA ' HD21 ' A' ' 34' ' ' LEU . 18.0 t -54.79 -32.11 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.85 0.834 . . . . 0.0 109.746 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.078 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.06 156.31 42.03 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.607 172.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.8 m -144.35 158.36 43.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.341 0.519 . . . . 0.0 110.37 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.745 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 8.9 t -105.22 125.08 50.59 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 120.432 0.158 . . . . 0.0 111.035 -176.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.3 m -107.29 73.11 0.91 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.245 0.545 . . . . 0.0 109.993 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 23.0 t -166.63 32.17 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.692 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.756 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 57.5 p . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.41 -0.805 . . . . 0.0 110.283 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.648 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.659 -0.577 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.648 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.6 OUTLIER 60.83 176.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.807 1.243 . . . . 0.0 112.343 -178.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.624 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -47.64 110.82 1.46 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-O 121.953 0.882 . . . . 0.0 111.672 173.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.74 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 4.3 Cg_exo -43.36 -21.28 0.26 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 125.046 3.831 . . . . 0.0 117.215 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.624 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -63.2 19.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -173.071 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.704 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 12.3 m80 -47.8 -35.7 10.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.749 0.82 . . . . 0.0 112.643 -179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 6' ' ' HIS . 2.0 m 72.14 152.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.284 1.834 . . . . 0.0 111.013 -168.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 17.6 t -119.23 145.61 45.91 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-O 122.161 0.981 . . . . 0.0 113.281 -169.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.7 m -146.41 100.88 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-N 112.937 -1.938 . . . . 0.0 106.32 165.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.581 ' OD1' ' HB3' ' A' ' 28' ' ' GLU . 8.3 t70 -129.15 159.35 36.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.492 -173.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.544 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.2 m 62.38 163.94 0.1 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 162.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -81.84 -39.62 23.7 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -152.3 100.27 2.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.718 176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.654 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.0 mt -72.07 139.75 82.56 Favored Pre-proline 0 CA--C 1.517 -0.315 0 CA-C-N 116.141 -0.482 . . . . 0.0 109.927 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.764 ' HB3' ' HA ' ' A' ' 43' ' ' THR . 73.2 Cg_exo -57.51 159.85 15.5 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 123.633 2.889 . . . . 0.0 113.727 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 153.03 43.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 165.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.741 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 3.5 m-80 58.52 14.95 3.28 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.57 0.7 . . . . 0.0 109.704 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -121.47 145.26 48.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.109 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.583 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -124.68 159.64 19.3 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.245 174.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 30' ' ' TRP . 1.6 p -117.53 150.25 39.27 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.94 0.37 . . . . 0.0 110.488 -173.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.692 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 4.2 t80 -136.01 132.19 35.97 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.495 0.664 . . . . 0.0 110.906 174.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.736 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 2.6 ttt180 -121.42 115.42 22.86 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -92.82 -167.04 1.65 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.174 -170.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.86 -47.6 85.64 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 123.511 0.725 . . . . 0.0 112.941 -167.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -70.79 -5.49 30.54 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 0.0 111.27 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.19 3.54 57.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 1.9 m -51.5 131.52 29.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.45 -0.875 . . . . 0.0 110.679 175.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.581 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 25.0 mt-10 -126.07 122.34 35.52 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.132 0.491 . . . . 0.0 110.953 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -148.25 129.1 14.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.456 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.3 p-90 -103.28 158.03 16.6 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 171.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.557 ' HD2' HG12 ' A' ' 93' ' ' VAL . 68.8 mtt-85 -146.6 -177.23 5.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.453 -178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.628 ' SG ' ' HD2' ' A' ' 38' ' ' LYS . 59.2 m -110.57 131.01 55.43 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 7.4 mt -59.13 166.1 2.26 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.77 -170.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.658 HD22 ' SG ' ' A' ' 79' ' ' CYS . 57.7 mt -65.05 132.81 50.21 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.365 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.736 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 77.35 22.71 69.86 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.031 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.741 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 4.8 m-30 -130.05 165.37 22.36 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 53.3 pttt -131.58 169.97 15.38 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.008 0.433 . . . . 0.0 110.645 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HE2' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -80.2 129.89 34.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.834 177.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.29 -107.49 2.66 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.783 -1.199 . . . . 0.0 111.315 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.645 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.9 pt-20 -90.87 -167.23 1.77 Allowed 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -37.34 -59.41 1.23 Allowed Glycine 0 CA--C 1.517 0.188 0 O-C-N 124.386 1.054 . . . . 0.0 113.551 -178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.39 75.69 1.67 Allowed 'General case' 0 C--N 1.32 -0.688 0 O-C-N 122.256 -0.555 . . . . 0.0 111.371 174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 9.2 p -147.85 134.95 20.37 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.037 168.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.655 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 74.2 m -114.27 139.79 49.13 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 170.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -141.8 144.08 26.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 120.89 0.376 . . . . 0.0 110.784 -170.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.614 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -57.13 110.64 0.87 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.878 176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.543 HD21 ' HB3' ' A' ' 50' ' ' PRO . 9.9 p30 -75.68 -33.38 60.38 Favored 'General case' 0 N--CA 1.435 -1.184 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.304 -175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.575 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.3 m120 68.86 -18.26 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.907 0.755 . . . . 0.0 111.666 176.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 47' ' ' ASN . 8.5 t30 -132.73 59.95 46.7 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.602 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 34.4 Cg_endo -72.7 138.34 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.272 2.648 . . . . 0.0 112.201 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 9.0 t -120.58 149.68 42.07 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.771 177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 32.6 t -86.13 127.2 34.66 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 174.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 14.5 t70 148.02 -56.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.371 1.045 . . . . 0.0 108.333 -160.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.05 98.69 3.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.583 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.738 -176.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.5 t30 55.71 42.51 29.21 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 60.31 39.5 18.8 Favored 'General case' 0 C--O 1.211 -0.942 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.264 -179.014 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 79.53 -0.14 82.12 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.876 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.13 14.1 10.25 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.7 -175.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 7.5 m -104.94 -176.21 3.01 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.564 -175.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 12.7 t70 -98.06 142.58 24.81 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -56.77 -13.59 11.56 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.297 1.998 . . . . 0.0 112.411 -174.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.492 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 37.2 p -93.67 -20.89 19.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.15 176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -79.61 118.03 21.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.3 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.508 ' OG ' ' HE2' ' A' ' 82' ' ' LYS . 0.7 OUTLIER -60.11 119.71 8.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 173.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 6.3 t -101.79 139.02 38.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.514 0.673 . . . . 0.0 111.833 -177.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.545 ' HB2' HD13 ' A' ' 78' ' ' ILE . 1.4 mm100 -129.13 131.57 47.23 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.595 174.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -92.47 128.17 38.22 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 172.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.77 169.37 17.77 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.684 -174.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -123.54 132.85 54.01 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.723 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -160.57 170.6 20.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -68.89 -30.31 68.78 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 173.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.6 mm-40 -80.4 121.55 25.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.912 177.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.765 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 6.2 p30 -67.67 -38.96 84.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 39.8 t -71.81 -20.82 61.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.497 0.665 . . . . 0.0 110.279 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -91.96 2.4 56.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.124 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 34.0 mttm -82.49 -52.27 7.02 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.378 0.608 . . . . 0.0 110.311 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.99 117.21 37.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.988 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.3 mp -93.43 115.42 32.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.989 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.658 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.5 m -112.68 112.93 24.79 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.192 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.4 m -117.22 114.25 23.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.552 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 88' ' ' ALA . 8.9 m -82.13 148.11 28.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.628 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 26.8 mmtp -77.86 -178.6 5.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.326 -169.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -57.76 -40.59 84.94 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.628 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 98.2 Cg_endo -79.83 6.79 4.99 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 121.45 1.433 . . . . 0.0 110.858 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.719 HG22 ' HA ' ' A' ' 97' ' ' SER . 31.7 p -128.25 74.63 79.44 Favored Pre-proline 0 N--CA 1.44 -0.958 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.243 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 18.5 Cg_exo -68.67 -8.11 22.37 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.822 2.348 . . . . 0.0 111.846 -173.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.74 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 29.8 m-80 -127.6 141.31 51.66 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.082 -174.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.587 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -118.11 148.76 41.99 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.631 ' HB2' ' HB2' ' A' ' 94' ' ' PHE . 3.7 m-85 -100.61 118.0 35.88 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.427 1.108 . . . . 0.0 111.859 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.4 OUTLIER 64.48 -137.78 0.27 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 112.317 -2.22 . . . . 0.0 109.693 -163.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.415 ' HB2' HD12 ' A' ' 34' ' ' LEU . 8.5 mt-10 -80.18 6.09 12.71 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.336 -0.545 . . . . 0.0 111.959 -171.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 123.24 17.23 3.33 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -173.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HD2' ' A' ' 31' ' ' ARG . 17.6 t -74.11 -31.03 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 CA-C-N 115.084 -0.558 . . . . 0.0 110.71 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.729 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -130.7 157.97 41.35 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 169.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.2 m -150.39 141.31 22.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 168.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.509 ' O ' HG22 ' A' ' 85' ' ' THR . 3.2 t -108.36 132.41 53.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -177.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.719 ' HA ' HG22 ' A' ' 85' ' ' THR . 15.1 m -97.01 158.23 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.581 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 16.4 t 70.63 71.49 0.2 Allowed 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.94 177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 43.8 p . . . . . 0 C--O 1.248 1.022 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.674 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 3' ' ' ASP . 4.1 p -169.2 175.05 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -175.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.669 ' OD2' ' HE2' ' A' ' 5' ' ' LYS . 8.2 p-10 -61.21 110.71 3.28 Favored Pre-proline 0 N--CA 1.453 -0.305 0 CA-C-O 121.975 0.893 . . . . 0.0 110.735 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.767 ' HG2' ' HB2' ' A' ' 87' ' ' ASN . 1.1 Cg_endo -51.59 -1.46 0.06 OUTLIER 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 125.2 3.934 . . . . 0.0 117.806 -172.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.669 ' HE2' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -68.23 11.22 0.17 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -174.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.621 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 4.5 p-80 -82.72 12.4 4.78 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -169.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 m 46.9 -159.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.634 1.174 . . . . 0.0 114.121 168.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.105 ' HB3' ' HA ' ' A' ' 21' ' ' PHE . 26.1 p -148.78 152.05 35.88 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.202 0.525 . . . . 0.0 112.41 -174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' VAL . 2.4 m -148.71 97.42 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 164.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.667 ' HB2' ' CD ' ' A' ' 28' ' ' GLU . 25.9 t70 -131.31 170.67 14.3 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.521 -168.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.517 ' CG2' HG13 ' A' ' 14' ' ' ILE . 3.0 m 35.78 125.36 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 155.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 12' ' ' ARG . 3.4 mmt180 -48.78 -37.91 20.41 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 113.671 -1.604 . . . . 0.0 111.418 -174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.45 90.25 1.85 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.411 176.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 11' ' ' THR . 3.7 mt -68.73 131.32 91.29 Favored Pre-proline 0 CA--C 1.51 -0.588 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 78.0 Cg_exo -51.18 149.6 15.8 Favored 'Trans proline' 0 C--N 1.331 -0.374 0 C-N-CA 123.696 2.931 . . . . 0.0 113.342 -169.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.457 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 58.3 tptt -62.51 143.45 57.16 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 168.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.612 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 12.0 m-80 70.17 8.27 6.58 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.485 0.66 . . . . 0.0 109.722 -176.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.714 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -120.59 157.68 28.99 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.347 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.606 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -137.58 159.79 24.99 Favored Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.276 176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB3' HD13 ' A' ' 14' ' ' ILE . 20.5 p -107.84 152.14 24.8 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -175.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.105 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 45.2 t80 -145.24 136.6 25.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 118.776 -1.169 . . . . 0.0 113.303 167.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.71 ' HB2' ' OE2' ' A' ' 28' ' ' GLU . 1.3 ttt180 -113.74 119.24 36.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.487 -175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -89.92 176.75 6.69 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.447 -169.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.95 -30.0 70.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.437 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.32 -16.45 61.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 110.346 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.37 10.83 37.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.536 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 m -81.34 149.68 28.8 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.6 -0.3 . . . . 0.0 110.28 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.71 ' OE2' ' HB2' ' A' ' 22' ' ' ARG . 1.2 mm-40 -132.81 137.0 46.62 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-O 122.24 1.019 . . . . 0.0 112.935 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' TRP . 5.1 tp10 -149.76 156.35 41.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 113.149 -1.841 . . . . 0.0 108.748 -171.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.49 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 33.7 p-90 -130.25 152.99 49.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 168.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 89.5 mtt180 -139.44 179.58 6.46 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.663 -176.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.517 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 57.2 m -110.85 126.56 54.8 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 17' ' ' ASN . 3.7 mt -55.41 157.54 3.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.498 -170.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.87 HD22 ' SG ' ' A' ' 79' ' ' CYS . 64.8 mt -58.3 128.17 35.78 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.675 -167.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.599 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 98.73 -17.16 58.72 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.823 -179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.762 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 9.4 m-30 -90.78 -174.75 4.16 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.062 0.458 . . . . 0.0 110.838 -174.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' CG ' ' HB2' ' A' ' 47' ' ' ASN . 59.2 pttt -144.95 169.3 18.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.396 -176.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.517 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -91.42 129.04 37.46 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.579 177.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 -93.82 1.37 Allowed Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.716 -176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.593 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.5 pt-20 -95.37 49.29 1.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.558 0.695 . . . . 0.0 111.615 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.27 -63.79 3.35 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.802 177.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -117.23 41.78 2.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.136 0.493 . . . . 0.0 111.269 -177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 19.7 p -137.87 151.6 48.21 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.21 176.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 67.3 m -117.58 137.98 52.24 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.657 176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 36' ' ' TYR . 20.9 m -142.02 150.76 18.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.593 -174.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -63.24 109.43 1.55 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.766 -177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.762 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 36.9 t30 -90.66 121.58 32.69 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.512 HD21 HD22 ' A' ' 73' ' ' ASN . 1.0 OUTLIER -101.2 11.31 39.64 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.377 0.608 . . . . 0.0 109.91 -176.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.444 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 9.6 t30 -140.13 54.42 5.28 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.221 169.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.632 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.1 Cg_endo -59.06 134.9 62.73 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.87 2.38 . . . . 0.0 112.266 176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.4 t -121.21 151.16 40.3 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.201 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.8 t -84.85 128.54 34.66 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 12.4 t70 148.9 -59.43 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -163.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -71.6 94.94 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.914 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.4 t30 50.61 45.57 26.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.2 OUTLIER 63.27 33.27 14.26 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.61 -0.32 77.03 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.507 178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.32 12.01 12.58 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.3 m -104.85 -178.44 3.66 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.808 0.843 . . . . 0.0 109.516 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.044 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 24.1 t70 -100.79 146.21 31.71 Favored Pre-proline 0 C--N 1.301 -1.513 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -57.07 -12.66 10.19 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.059 1.839 . . . . 0.0 112.254 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.9 p -92.18 -18.4 23.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.601 0.715 . . . . 0.0 109.867 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 80' ' ' THR . . . -89.07 117.37 28.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.723 174.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.506 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 11.5 t -64.63 128.35 35.39 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 2.9 t -97.98 139.94 33.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.653 0.739 . . . . 0.0 112.211 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 4.5 mm-40 -134.98 125.21 26.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.453 172.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' HA ' HD13 ' A' ' 77' ' ' ILE . 5.2 p-10 -93.82 129.7 40.12 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.878 0.847 . . . . 0.0 110.566 174.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.81 44.55 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.02 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -109.97 108.61 18.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.499 0.666 . . . . 0.0 110.358 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.432 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 21.7 t -126.64 160.26 31.23 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.296 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -59.51 -30.22 68.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.729 0.776 . . . . 0.0 109.102 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 31.2 mm-40 -84.5 116.87 23.34 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.891 178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.87 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 14.9 p30 -67.68 -29.52 68.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.743 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 36.9 t -79.82 -11.36 59.83 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.423 0.63 . . . . 0.0 110.071 176.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.595 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 6.6 tppt? -111.4 11.87 21.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.584 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.4 mttm -81.84 -51.25 8.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.379 178.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG12 ' HB2' ' A' ' 50' ' ' PRO . 44.3 mm -92.09 119.84 40.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.338 0.59 . . . . 0.0 109.79 177.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 4.1 mp -92.51 108.3 20.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.794 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.87 ' SG ' HD22 ' A' ' 34' ' ' LEU . 50.4 m -104.55 113.27 26.73 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.792 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 85.9 m -112.85 112.86 24.64 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.274 -174.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 16.7 m -81.83 149.22 28.44 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 31.1 mmtp -80.72 -177.64 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 -166.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -47.37 -48.69 56.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.81 ' HB2' ' H ' ' A' ' 98' ' ' SER . 92.5 Cg_endo -83.24 16.69 1.81 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.306 2.004 . . . . 0.0 111.678 -173.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.643 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.9 p -124.37 83.52 57.17 Favored Pre-proline 0 N--CA 1.441 -0.901 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.776 179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.451 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 16.3 Cg_exo -72.1 -7.74 21.58 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.234 2.622 . . . . 0.0 111.342 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.767 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 17.0 m-80 -132.6 177.74 7.38 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.72 -176.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.0 144.93 27.06 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.751 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.9 OUTLIER -73.62 103.85 4.36 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 173.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.606 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 62.65 -118.22 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.54 -169.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.534 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.9 mt-10 -95.65 -0.15 52.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -172.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 117.71 2.56 16.89 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -169.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' HA ' HD21 ' A' ' 34' ' ' LEU . 21.1 t -56.42 -31.33 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 114.45 -0.875 . . . . 0.0 109.325 173.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.044 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.11 160.75 43.07 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.516 168.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -149.06 167.18 26.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.478 0.581 . . . . 0.0 110.496 176.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.692 ' HB2' ' HE1' ' A' ' 89' ' ' TYR . 1.6 t -124.25 128.34 49.03 Favored 'General case' 0 CA--C 1.515 -0.373 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.643 ' HA ' HG22 ' A' ' 85' ' ' THR . 8.6 p -101.53 170.79 7.97 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.545 -177.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.81 ' H ' ' HB2' ' A' ' 84' ' ' PRO . 27.9 m 66.62 56.01 0.76 Allowed 'General case' 0 C--O 1.234 0.247 0 O-C-N 124.001 0.813 . . . . 0.0 111.316 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 48.6 p . . . . . 0 C--O 1.252 1.228 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.821 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.901 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 3' ' ' ASP . 3.0 p -153.11 -176.76 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 0.9 OUTLIER -46.79 115.82 3.53 Favored Pre-proline 0 C--O 1.224 -0.25 0 CA-C-O 121.684 0.754 . . . . 0.0 110.898 173.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.811 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.4 Cg_endo -46.19 -12.45 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 125.254 3.969 . . . . 0.0 117.942 -169.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -76.83 13.01 1.12 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -175.205 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.701 ' CD2' ' HA ' ' A' ' 23' ' ' ASP . 8.9 p-80 -77.82 18.71 0.45 Allowed 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.193 -0.317 . . . . 0.0 111.683 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m 44.88 -145.85 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.493 1.117 . . . . 0.0 113.474 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.85 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 6.8 t -161.76 156.34 22.71 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.3 m -146.35 100.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 160.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.0 t70 -130.69 168.9 16.39 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 119.002 -0.523 . . . . 0.0 110.628 -175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.561 ' CG2' HG13 ' A' ' 14' ' ' ILE . 14.5 m 35.98 123.88 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 159.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -63.92 -37.78 88.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.982 -173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -129.65 78.02 1.82 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.639 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.712 HD13 ' HB3' ' A' ' 20' ' ' CYS . 7.8 mt -70.0 137.01 87.2 Favored Pre-proline 0 CA--C 1.516 -0.352 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 14' ' ' ILE . 88.9 Cg_exo -56.24 152.27 39.35 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.206 2.604 . . . . 0.0 113.454 -175.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . 23.3 tptm -61.44 147.55 44.71 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.651 -1.241 . . . . 0.0 107.651 167.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.779 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 6.0 m-80 67.21 9.29 6.84 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.48 0.657 . . . . 0.0 110.391 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.681 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -117.65 146.13 43.89 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.507 0.67 . . . . 0.0 110.997 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -122.27 153.51 16.84 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.752 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.712 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.45 150.41 27.45 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.951 0.405 . . . . 0.0 110.094 -174.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.85 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 34.7 t80 -130.0 140.21 50.92 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.267 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.72 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 43.9 ttt180 -134.71 113.62 11.86 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.694 173.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.734 ' HB2' ' CE2' ' A' ' 21' ' ' PHE . 31.4 t70 -85.25 178.43 7.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.311 0.577 . . . . 0.0 111.56 -174.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 4.2 t70 -57.71 -38.59 75.5 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.189 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.35 5.76 3.42 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.978 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.61 -7.59 75.95 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.117 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 24.2 m -55.09 119.95 6.24 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.09 0.556 . . . . 0.0 111.34 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' OD1' ' A' ' 10' ' ' ASP . 17.7 mt-10 -115.81 119.64 36.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -146.76 129.45 16.1 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.235 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 41.8 p-90 -100.22 154.77 18.19 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.528 171.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HD2' HG12 ' A' ' 93' ' ' VAL . 67.6 mtt180 -140.1 -178.52 5.5 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.603 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 59.9 m -109.37 126.78 53.78 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 3.5 mt -55.83 161.77 2.07 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.283 -169.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 ' SG ' ' A' ' 79' ' ' CYS . 65.1 mt -61.59 140.08 58.18 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.12 -177.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.712 ' O ' ' HD1' ' A' ' 36' ' ' TYR . . . 71.12 22.18 78.47 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.234 -175.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.779 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 3.5 m-30 -130.69 167.21 19.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.452 ' CG ' ' HB3' ' A' ' 47' ' ' ASN . 58.6 pttt -136.74 174.2 10.87 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.822 0.344 . . . . 0.0 110.302 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.593 ' HE3' ' CZ3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -92.43 129.53 38.34 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.437 177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.08 -108.94 2.62 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.902 -176.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.493 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 11.8 pt-20 -81.37 57.95 3.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.728 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.62 -81.11 1.57 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.883 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -109.31 50.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.359 0.6 . . . . 0.0 110.76 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 2.8 p -140.28 142.88 35.68 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.14 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 75.1 m -113.49 139.22 49.13 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.953 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.0 m -140.25 146.22 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.527 -175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.545 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 28.4 mt-10 -64.75 102.89 0.63 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.73 175.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.558 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 16.4 p30 -65.44 -38.24 89.3 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 121.09 0.471 . . . . 0.0 110.794 -176.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HB3' ' A' ' 73' ' ' ASN . 0.6 OUTLIER 64.65 -4.0 0.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.439 174.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.0 t30 -139.54 52.5 3.95 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 0.0 109.702 166.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' HB3' HD21 ' A' ' 47' ' ' ASN . 18.4 Cg_endo -63.98 136.96 55.11 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.182 2.588 . . . . 0.0 112.568 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.7 t -119.23 148.75 42.77 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.081 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 31.1 t -86.9 127.73 35.05 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.9 t70 149.98 -56.28 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.425 1.078 . . . . 0.0 108.497 -164.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.1 mt -72.58 92.68 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.9 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 60.3 t30 54.58 45.77 26.21 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 59' ' ' CYS . 0.6 OUTLIER 64.49 34.14 10.42 Favored 'General case' 0 C--O 1.21 -1.006 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.075 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.03 4.45 90.26 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.824 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.43 13.44 10.62 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.807 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 5.7 m -105.72 -176.58 3.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.031 0.919 . . . . 0.0 110.472 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.034 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 13.9 t70 -99.26 143.6 26.71 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 175.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -57.42 -15.55 19.88 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.087 1.858 . . . . 0.0 112.428 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 44.0 p -87.85 -20.11 26.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.684 0.754 . . . . 0.0 109.605 174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.531 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -85.56 98.93 10.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.747 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB3' ' HB ' ' A' ' 80' ' ' THR . 10.9 t -57.47 119.52 6.66 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 4.1 t -94.74 144.32 25.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.72 0.772 . . . . 0.0 112.656 -173.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.508 ' HB2' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -134.85 135.89 42.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.084 171.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.42 134.63 40.42 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.266 175.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.04 164.9 28.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.299 -174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.04 90.62 3.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 121.979 0.895 . . . . 0.0 108.618 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.624 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 3.7 t -99.4 166.44 11.18 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.696 -171.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 m -64.92 -37.22 86.91 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.653 0.74 . . . . 0.0 109.099 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB2' ' HG2' ' A' ' 75' ' ' LYS . 12.9 mm-40 -96.71 131.65 43.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.514 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.717 ' HA ' ' CE ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -56.31 -37.76 70.37 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 174.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 26.8 t -70.68 -28.6 64.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.514 -176.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.494 ' HG2' ' HB2' ' A' ' 72' ' ' GLU . 11.1 mmpt? -91.61 5.32 50.08 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.28 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' CE ' ' HA ' ' A' ' 73' ' ' ASN . 21.5 mttt -73.77 -43.38 59.13 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.226 0.536 . . . . 0.0 109.951 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.419 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 47.9 mm -95.62 116.54 37.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 121.713 0.768 . . . . 0.0 109.408 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 65' ' ' CYS . 4.2 mp -91.32 108.64 20.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 114.799 -1.091 . . . . 0.0 109.987 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.683 ' SG ' HD22 ' A' ' 34' ' ' LEU . 18.2 m -101.19 119.03 38.14 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.538 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 31.5 m -114.62 104.71 12.27 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.913 -175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 11.5 m -81.87 145.33 30.43 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -177.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 62' ' ' THR . 30.2 mmtp -76.25 -176.58 3.65 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -167.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -55.99 -44.16 99.57 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 87.1 Cg_endo -80.25 8.8 3.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.617 1.545 . . . . 0.0 111.288 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 97' ' ' SER . 8.0 p -126.05 75.82 71.93 Favored Pre-proline 0 N--CA 1.438 -1.041 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.829 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.3 Cg_exo -65.0 -10.6 26.11 Favored 'Trans proline' 0 N--CA 1.472 0.243 0 C-N-CA 123.058 2.506 . . . . 0.0 111.909 -175.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 21.1 m-80 -134.15 -174.4 3.54 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.524 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.16 27.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.589 178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.4 m-30 -71.72 104.06 3.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 66.99 -122.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.778 -170.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.46 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 10.2 mt-10 -93.61 -0.19 56.28 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -171.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.16 2.64 12.24 Favored Glycine 0 CA--C 1.508 -0.383 0 N-CA-C 110.299 -1.121 . . . . 0.0 110.299 -171.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.7 t -56.19 -32.37 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 121.856 0.836 . . . . 0.0 109.637 175.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.034 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -149.82 155.67 40.49 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.184 172.193 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.531 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.4 m -145.3 157.96 43.93 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.898 0.772 . . . . 0.0 110.406 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.811 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 22.9 t -108.45 122.14 46.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 122.148 0.179 . . . . 0.0 111.324 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.588 ' HA ' HG22 ' A' ' 85' ' ' THR . 0.8 OUTLIER -106.89 76.21 1.09 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.523 0.677 . . . . 0.0 111.569 178.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 26.6 t 178.45 54.91 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.012 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 35.7 p . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.999 -177.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.716 -0.554 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 99' ' ' SER . 6.5 p -106.4 151.22 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-O 120.357 0.122 . . . . 0.0 110.911 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.813 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 10.4 p-10 -129.06 142.06 43.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 160.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 86' ' ' PRO . 3.3 Cg_exo -47.39 -2.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.517 0 C-N-CA 124.59 3.527 . . . . 0.0 118.282 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.36 8.28 1.43 Allowed 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.692 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 5.1 p-80 -78.89 18.37 0.62 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.1 m 40.08 -145.74 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 124.696 1.198 . . . . 0.0 113.729 170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 42.8 t -159.67 154.53 24.6 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.69 100.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 113.088 -1.869 . . . . 0.0 106.022 161.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.3 t70 -130.03 168.4 16.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.164 -173.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 13' ' ' ASP . 17.8 m 25.51 113.68 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 160.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' N ' ' HD2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -36.25 -37.13 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.997 -1.456 . . . . 0.0 113.594 171.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' H ' HG22 ' A' ' 11' ' ' THR . 25.2 t70 -142.46 86.1 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.518 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.671 HD13 ' HB3' ' A' ' 20' ' ' CYS . 3.2 mt -82.77 138.57 43.55 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 87.5 Cg_exo -53.37 150.03 27.71 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.51 2.807 . . . . 0.0 113.389 -174.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -60.82 -41.11 95.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.887 -1.051 . . . . 0.0 112.555 -175.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.7 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -97.11 36.31 1.46 Allowed 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.669 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -140.24 171.57 13.98 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.888 -174.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -150.65 158.32 27.62 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 175.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -110.47 148.1 32.75 Favored 'General case' 0 CA--C 1.486 -1.5 0 C-N-CA 120.074 -0.651 . . . . 0.0 109.438 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.999 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 38.3 t80 -141.91 138.71 32.23 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.476 170.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.677 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 29.7 ttt180 -121.07 121.09 37.15 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.958 -176.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 2.8 p30 -79.36 174.56 11.44 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.706 -175.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -74.81 -6.44 49.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.658 -164.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.87 -17.98 32.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.036 0.446 . . . . 0.0 109.962 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.55 0.7 26.18 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.534 -178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.59 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 21.5 m -68.61 137.99 54.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.727 -0.736 . . . . 0.0 110.744 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 52.4 mt-10 -127.87 119.82 26.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.474 0.655 . . . . 0.0 111.132 -177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -140.43 138.14 34.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.317 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 50.6 p-90 -109.42 157.68 18.69 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.863 168.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HD2' HG12 ' A' ' 93' ' ' VAL . 88.4 mtt180 -142.14 -178.92 5.94 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.884 -1.053 . . . . 0.0 108.403 -178.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 61.7 m -110.27 126.28 54.01 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -175.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 6.9 mt -51.54 151.61 3.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.793 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.849 HD22 ' SG ' ' A' ' 79' ' ' CYS . 55.8 mt -55.8 132.85 50.43 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.921 -175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 88.59 -1.17 83.66 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.958 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.793 ' HA ' ' H ' ' A' ' 47' ' ' ASN . 4.5 m-30 -106.14 -173.88 2.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.901 0.381 . . . . 0.0 110.134 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.441 ' HE2' ' HA ' ' A' ' 47' ' ' ASN . 60.0 pttt -149.21 168.96 21.83 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.507 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.405 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.62 127.05 39.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.434 178.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -100.05 -116.01 3.84 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.332 -173.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.2 59.44 0.99 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 123.317 0.647 . . . . 0.0 111.906 -177.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.01 -113.94 4.47 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.4 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.49 55.64 3.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.591 0.71 . . . . 0.0 110.869 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 p -141.33 142.57 33.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.488 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 66.3 m -118.52 137.38 53.25 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.587 176.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.74 156.09 20.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.692 -176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.577 ' HB3' ' ND2' ' A' ' 48' ' ' ASN . 28.6 mt-10 -64.96 107.0 1.36 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.748 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.793 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 48.9 t-20 -59.16 -45.98 89.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.34 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.577 ' ND2' ' HB3' ' A' ' 46' ' ' GLU . 0.9 OUTLIER 72.91 -18.48 0.35 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.63 -0.713 . . . . 0.0 112.53 175.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 47' ' ' ASN . 64.8 t30 -133.6 55.67 17.1 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 121.309 0.576 . . . . 0.0 109.696 168.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.651 ' HB2' HG12 ' A' ' 77' ' ' ILE . 10.0 Cg_endo -62.67 136.65 59.32 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.824 2.349 . . . . 0.0 112.838 -176.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.482 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 14.1 t -118.73 149.33 41.63 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.985 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 12.7 t -87.22 128.26 35.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 20.0 t70 151.41 -62.04 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -165.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.4 mt -66.85 96.28 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.828 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 63.0 t30 53.21 45.87 27.68 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 59' ' ' CYS . 0.1 OUTLIER 57.64 42.68 23.56 Favored 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.564 -178.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 84.75 -0.0 89.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.63 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 93' ' ' VAL . . . 111.71 11.69 16.37 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.072 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 56' ' ' ASN . 4.3 m -104.97 -177.57 3.4 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 109.296 -176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.018 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 19.2 t70 -100.41 145.15 29.79 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -57.32 -14.08 14.74 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.086 1.858 . . . . 0.0 112.145 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.513 ' O ' ' HE3' ' A' ' 82' ' ' LYS . 30.1 p -91.55 -16.87 26.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.639 0.733 . . . . 0.0 109.921 175.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.622 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -89.97 121.72 32.32 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.706 172.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 80' ' ' THR . 2.3 m -64.18 133.78 53.53 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.8 t -112.47 128.68 56.4 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 123.422 1.582 . . . . 0.0 113.689 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.734 ' HB2' ' HB ' ' A' ' 78' ' ' ILE . 1.0 OUTLIER -106.73 141.23 38.31 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 110.92 -2.855 . . . . 0.0 108.948 176.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -111.42 129.42 56.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.954 0.883 . . . . 0.0 110.453 168.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -148.42 172.15 14.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.713 -171.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -128.93 142.79 50.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.003 0.43 . . . . 0.0 110.701 174.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.1 t -163.11 163.64 25.68 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.181 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -58.18 -30.53 66.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.351 0.596 . . . . 0.0 109.414 173.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 75' ' ' LYS . 38.1 mt-10 -86.8 114.63 23.63 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.027 175.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.824 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 25.1 m-80 -67.38 -30.95 70.87 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.117 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.613 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 12.8 p -74.18 -25.0 59.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.948 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 3.4 tppt? -84.06 -7.17 59.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.218 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.824 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 65.1 mttt -73.36 -45.79 52.93 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.482 -174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG12 ' HB2' ' A' ' 50' ' ' PRO . 48.5 mm -93.73 117.35 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.734 ' HB ' ' HB2' ' A' ' 66' ' ' GLN . 2.3 mp -94.87 127.26 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.849 ' SG ' HD22 ' A' ' 34' ' ' LEU . 36.7 m -116.46 117.23 29.35 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.486 0.66 . . . . 0.0 109.695 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 58.7 m -113.27 111.26 21.75 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.992 -174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 17.4 m -82.06 148.29 28.67 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.649 ' HB2' ' HD2' ' A' ' 84' ' ' PRO . 28.3 mmtp -80.14 -177.7 6.19 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -167.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.79 -42.28 95.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.649 ' HD2' ' HB2' ' A' ' 82' ' ' LYS . 84.1 Cg_endo -84.98 22.39 0.96 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 121.921 1.747 . . . . 0.0 110.658 -178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.659 HG22 ' HA ' ' A' ' 97' ' ' SER . 16.4 p -131.81 79.02 68.99 Favored Pre-proline 0 C--N 1.312 -1.047 0 CA-C-N 114.834 -1.075 . . . . 0.0 108.33 176.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.76 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 26.2 Cg_exo -65.09 -0.85 3.68 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.382 2.721 . . . . 0.0 112.817 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.698 ' HB2' ' HB2' ' A' ' 4' ' ' PRO . 15.6 m-80 -146.43 -179.54 6.83 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.279 -172.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -142.8 149.52 38.76 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.782 0.325 . . . . 0.0 110.388 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.71 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 3.2 m-30 -82.74 104.04 12.68 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 173.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.662 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 63.55 -129.88 0.46 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.588 -170.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.561 ' OE2' ' HB3' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -85.74 -0.64 55.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -172.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.83 3.55 6.38 Favored Glycine 0 CA--C 1.509 -0.33 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.6 t -59.44 -31.01 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 121.565 0.697 . . . . 0.0 110.367 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.018 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -145.48 162.6 36.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.835 173.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 2.4 m -147.3 166.78 26.07 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.558 ' HB2' ' OH ' ' A' ' 89' ' ' TYR . 42.8 t -114.84 122.51 46.55 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.659 ' HA ' HG22 ' A' ' 85' ' ' THR . 12.1 p -89.43 170.05 10.86 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 123.423 0.452 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 t 69.09 35.45 2.74 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.947 0.779 . . . . 0.0 110.942 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.813 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.34 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.709 -0.156 . . . . 0.0 112.709 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 63.97 170.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.372 1.469 . . . . 0.0 112.702 176.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.729 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 10.0 p-10 -59.2 127.58 84.24 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-O 121.77 0.795 . . . . 0.0 110.207 177.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.736 ' HD3' ' HB3' ' A' ' 96' ' ' SER . 1.5 Cg_endo -47.51 -10.8 0.08 OUTLIER 'Trans proline' 0 CA--C 1.551 1.361 1 C-N-CA 125.35 4.033 . . . . 0.0 118.541 -168.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HD2' ' C ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -76.18 12.0 1.32 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.109 1.322 . . . . 0.0 113.547 -173.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.679 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 10.6 p-80 -76.0 18.66 0.26 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 122.4 -0.188 . . . . 0.0 111.4 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 5' ' ' LYS . 21.1 m 45.06 -154.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.138 1.375 . . . . 0.0 113.631 172.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.705 ' HA ' ' HB3' ' A' ' 22' ' ' ARG . 5.1 t -158.24 160.08 36.72 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -173.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.496 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 1.1 m -151.11 100.5 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.552 ' O ' HD11 ' A' ' 14' ' ' ILE . 16.4 t70 -130.69 159.29 37.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.344 -176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.599 ' CG2' HG13 ' A' ' 14' ' ' ILE . 1.8 m 60.57 162.18 0.06 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 162.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -87.06 -45.65 10.54 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.624 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -134.04 90.59 2.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.251 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.685 HD13 ' HB3' ' A' ' 20' ' ' CYS . 6.9 mt -73.15 133.19 81.56 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HB2' ' CB ' ' A' ' 18' ' ' ALA . 75.7 Cg_exo -53.46 150.64 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 123.064 2.509 . . . . 0.0 113.023 -174.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -59.58 -39.51 84.35 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.472 -1.24 . . . . 0.0 112.672 -172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.805 ' HB3' ' CD2' ' A' ' 36' ' ' TYR . 10.3 m120 -101.9 36.24 2.14 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.02 0.914 . . . . 0.0 108.758 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -135.79 152.2 50.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.563 -174.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 90' ' ' TYR . . . -128.04 154.91 20.03 Favored Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 175.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' HB3' HD13 ' A' ' 14' ' ' ILE . 1.7 p -108.2 149.41 28.61 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 117.226 0.513 . . . . 0.0 110.151 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.694 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 39.1 t80 -128.37 138.91 52.58 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.633 171.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.705 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 41.4 ttt180 -136.62 117.52 14.19 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.906 173.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.675 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -84.34 179.82 7.36 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.636 -171.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -61.69 -30.04 70.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.293 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -68.9 -22.58 64.16 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.088 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.53 -1.24 29.25 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.001 -0.619 . . . . 0.0 111.934 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 22' ' ' ARG . 10.4 m -63.35 141.63 58.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.836 0.454 . . . . 0.0 110.504 178.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' HG2' ' HB2' ' A' ' 22' ' ' ARG . 74.4 mt-10 -133.75 120.79 20.99 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.049 0.452 . . . . 0.0 111.159 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -147.63 132.0 17.57 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.215 -175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 31.6 p-90 -106.38 154.81 20.26 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.309 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 94' ' ' PHE . 83.4 mtt180 -136.77 -179.26 5.59 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.236 -178.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.557 ' SG ' ' HD3' ' A' ' 38' ' ' LYS . 79.9 m -109.51 127.96 54.83 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' HB2' ' CD2' ' A' ' 36' ' ' TYR . 10.0 mt -58.84 165.05 2.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.148 -168.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.809 HD22 ' SG ' ' A' ' 79' ' ' CYS . 51.4 mt -59.81 132.68 54.69 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.505 -171.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.604 ' O ' ' HB3' ' A' ' 47' ' ' ASN . . . 89.94 -13.3 64.96 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.117 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.805 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.4 m-30 -93.94 -174.9 3.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.27 0.557 . . . . 0.0 111.479 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.434 ' HD3' ' HB2' ' A' ' 47' ' ' ASN . 57.8 pttt -149.05 169.92 19.55 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.926 -175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' HD3' ' SG ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -93.35 131.94 38.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.986 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -98.48 -105.47 2.52 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.954 -176.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.578 ' HG2' ' OG1' ' A' ' 43' ' ' THR . 12.0 pt-20 -83.95 51.31 2.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.405 0.621 . . . . 0.0 111.668 -173.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.75 -73.85 2.14 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.223 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -111.39 48.61 0.93 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.11 0.481 . . . . 0.0 111.399 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HG2' ' A' ' 40' ' ' GLU . 32.3 p -140.58 154.24 46.42 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.594 0.712 . . . . 0.0 110.799 175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 81.6 m -121.03 136.14 55.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.953 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' HA ' ' OD1' ' A' ' 17' ' ' ASN . 16.6 m -138.81 153.69 25.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.996 -173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' HG2' ' CE1' ' A' ' 36' ' ' TYR . 26.5 mt-10 -69.63 115.79 9.28 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.171 -175.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.61 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 27.6 t30 -96.25 125.2 40.6 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 172.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.65 4.06 53.39 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.079 0.466 . . . . 0.0 110.976 -176.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 4.8 t30 -136.58 55.86 12.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.7 172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 11.0 Cg_endo -62.76 133.2 40.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.198 1.932 . . . . 0.0 112.28 173.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 13.6 t -121.08 151.31 39.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.358 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 6.0 t -84.93 128.37 34.59 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 35.0 t70 151.1 -59.72 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.417 0 O-C-N 124.182 0.926 . . . . 0.0 108.962 -165.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 86.1 mt -54.06 -82.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.76 -171.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -120.14 51.57 1.19 Allowed 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 66.22 29.0 9.88 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.616 -1.174 . . . . 0.0 107.926 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 51' ' ' THR . . . 96.33 -11.14 67.28 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.931 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.38 12.59 4.18 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 -176.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 63' ' ' ALA . 3.8 m -105.07 -176.9 3.21 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.612 1.165 . . . . 0.0 110.126 -174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 1.07 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 18.3 t70 -99.96 146.41 31.85 Favored Pre-proline 0 C--N 1.302 -1.471 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 173.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.74 -16.9 21.1 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.202 1.935 . . . . 0.0 112.49 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.64 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 34.2 p -89.45 -16.49 30.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.701 0.762 . . . . 0.0 109.772 176.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' SG ' ' A' ' 95' ' ' CYS . . . -87.37 108.62 19.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.543 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.66 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 35.9 t -55.29 119.84 6.17 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 2.6 t -91.97 132.68 36.34 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.903 0.858 . . . . 0.0 111.539 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.47 ' CG ' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -126.07 126.78 44.78 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.793 174.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -92.6 135.59 33.95 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.69 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -154.62 167.22 30.87 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.862 -173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.53 125.77 50.56 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.546 0.688 . . . . 0.0 110.1 175.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' H ' ' HG2' ' A' ' 76' ' ' LYS . 34.0 t -140.1 159.41 42.26 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.668 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -63.34 -22.75 67.07 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.596 ' HB2' ' HB2' ' A' ' 75' ' ' LYS . 8.1 mm-40 -94.71 130.86 41.06 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.126 173.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.868 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 1.2 p30 -64.78 -38.02 89.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.816 174.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 44.5 t -72.52 -18.37 61.65 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.486 . . . . 0.0 110.581 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.596 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 29.4 mmmt -97.73 2.55 49.74 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE2' ' HA ' ' A' ' 73' ' ' ASN . 52.1 mttm -80.16 -46.14 16.9 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.389 0.614 . . . . 0.0 109.709 176.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 50' ' ' PRO . 49.1 mm -98.86 117.56 44.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.762 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.6 mp -93.9 105.18 16.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.801 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.809 ' SG ' HD22 ' A' ' 34' ' ' LEU . 21.1 m -100.6 115.19 29.6 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.07 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 53.8 m -119.91 113.78 21.08 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.002 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.462 ' HB3' ' OG1' ' A' ' 85' ' ' THR . 13.9 m -80.39 149.5 30.17 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.66 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 27.7 mmtp -80.81 -176.44 5.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -167.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HB2' ' HD3' ' A' ' 84' ' ' PRO . 12.4 mt-10 -48.86 -51.33 55.55 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.67 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 83' ' ' GLU . 73.5 Cg_endo -77.21 1.48 8.67 Favored 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 121.695 1.597 . . . . 0.0 111.705 -175.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 97' ' ' SER . 18.2 p -121.66 76.12 36.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.021 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.536 ' HD2' ' HD2' ' A' ' 4' ' ' PRO . 24.7 Cg_exo -65.62 -10.03 24.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 123.048 2.498 . . . . 0.0 112.127 -174.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.729 ' ND2' ' HB2' ' A' ' 3' ' ' ASP . 23.0 m-80 -134.04 -177.07 4.4 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.224 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB1' ' HA2' ' A' ' 92' ' ' GLY . . . -142.65 146.6 34.64 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.729 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.862 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 4.2 m-30 -75.88 103.15 5.82 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 170.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.602 ' CD2' ' HA3' ' A' ' 19' ' ' GLY . 0.1 OUTLIER 66.8 -124.12 0.25 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.542 -172.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.452 ' H ' ' HB3' ' A' ' 90' ' ' TYR . 4.3 mt-10 -87.93 -0.76 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -171.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.415 ' HA2' ' HB1' ' A' ' 88' ' ' ALA . . . 114.85 6.16 19.4 Favored Glycine 0 CA--C 1.505 -0.574 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -171.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 94' ' ' PHE . 21.4 t -58.13 -30.56 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.382 -0.909 . . . . 0.0 109.763 175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 1.07 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -150.88 156.15 40.63 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.439 -1.255 . . . . 0.0 108.468 173.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 63' ' ' ALA . 1.7 m -144.84 161.06 40.23 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.52 0.6 . . . . 0.0 110.46 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.736 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 30.0 t -108.25 121.53 45.07 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.602 ' HA ' HG22 ' A' ' 85' ' ' THR . 1.8 p -107.32 75.97 1.05 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.313 0.578 . . . . 0.0 112.054 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' SER . 5.5 t 172.26 71.82 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.323 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HB3' ' HA ' ' A' ' 3' ' ' ASP . 23.7 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.479 -0.772 . . . . 0.0 111.142 -174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 3' ' ' ASP . 1.0 OUTLIER -172.21 -178.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.765 0.317 . . . . 0.0 110.979 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.675 ' H ' HG22 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -51.37 107.94 0.94 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 178.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.625 ' HA ' ' CE1' ' A' ' 6' ' ' HIS . 2.7 Cg_endo -44.1 -7.54 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.968 3.112 . . . . 0.0 116.043 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -77.16 13.05 1.21 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 4' ' ' PRO . 1.8 p-80 -69.47 16.73 0.05 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.74 0.7 . . . . 0.0 112.398 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.483 ' H ' ' C ' ' A' ' 5' ' ' LYS . 13.8 m 42.18 -157.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.787 ' HB2' ' HA ' ' A' ' 21' ' ' PHE . 10.5 t -158.49 168.28 27.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.655 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.9 OUTLIER -160.26 101.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 112.014 -2.357 . . . . 0.0 105.528 175.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 16.9 t70 -129.56 160.77 32.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -177.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.718 HG23 ' N ' ' A' ' 13' ' ' ASP . 0.6 OUTLIER 38.84 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.371 176.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.631 ' N ' HG23 ' A' ' 11' ' ' THR . 5.7 mmm180 -100.12 -30.15 12.1 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.639 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.718 ' N ' HG23 ' A' ' 11' ' ' THR . 24.6 t70 -157.9 82.68 0.87 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.799 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.653 HG23 ' HD2' ' A' ' 15' ' ' PRO . 2.1 mp -54.22 145.46 35.65 Favored Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.653 ' HD2' HG23 ' A' ' 14' ' ' ILE . 71.1 Cg_exo -50.44 150.52 11.32 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.062 1.841 . . . . 0.0 112.563 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -47.33 -70.81 0.08 Allowed 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.715 HD22 ' N ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -77.13 26.78 0.15 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.461 0.648 . . . . 0.0 109.541 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.758 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . . . -122.79 148.8 44.94 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.188 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' CE2' ' A' ' 90' ' ' TYR . . . -118.53 165.1 12.87 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 177.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -120.83 147.25 45.62 Favored 'General case' 0 CA--C 1.487 -1.463 0 CA-C-O 121.668 0.747 . . . . 0.0 111.629 -178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.787 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 37.5 t80 -138.74 135.35 34.62 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.683 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' A' ' 8' ' ' CYS . 3.4 ttt180 -126.56 114.56 18.26 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.556 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' HA ' ' CD2' ' A' ' 6' ' ' HIS . 8.8 p30 -71.89 169.97 14.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.844 0.354 . . . . 0.0 111.803 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -56.87 -30.16 63.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.887 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -69.2 7.08 0.81 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.805 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.96 -15.09 28.72 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.455 ' HB ' ' OD2' ' A' ' 23' ' ' ASP . 18.8 m -56.28 145.18 27.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.668 -0.266 . . . . 0.0 110.634 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' HG3' ' HG3' ' A' ' 22' ' ' ARG . 37.8 mt-10 -131.03 128.71 40.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.224 0.535 . . . . 0.0 111.692 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -148.57 132.91 17.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.864 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -106.89 156.57 18.55 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.854 178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HD2' HG12 ' A' ' 93' ' ' VAL . 49.3 mtt180 -138.46 -177.32 4.8 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.647 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 59.2 m -109.77 124.62 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.686 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -46.85 149.49 0.86 Allowed 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.843 -177.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.759 HD22 ' SG ' ' A' ' 79' ' ' CYS . 52.1 mt -51.83 126.61 18.52 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.567 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.45 ' HA3' ' ND2' ' A' ' 73' ' ' ASN . . . 95.16 -4.4 67.49 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.103 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 17' ' ' ASN . 8.7 m-30 -100.69 -173.26 2.35 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.155 0.502 . . . . 0.0 111.35 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' ASN . 54.6 pttt -146.83 178.86 8.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.098 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.57 129.18 45.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.839 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -97.59 -114.77 3.29 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.824 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 10.3 pt-20 -72.23 68.46 0.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.133 0.492 . . . . 0.0 112.125 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.73 -101.57 1.55 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.934 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -90.03 60.73 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.916 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.455 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 4.8 p -146.71 151.05 36.56 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.765 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.758 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 85.8 m -121.01 139.07 53.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.946 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.2 m -144.84 156.55 14.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.502 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -65.72 111.41 3.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.704 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.497 ' H ' ' HA ' ' A' ' 36' ' ' TYR . 9.7 t30 -76.67 -39.48 52.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.214 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.12 7.91 0.95 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 111.509 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.62 ' N ' ' CD ' ' A' ' 50' ' ' PRO . 61.0 t30 -145.15 40.51 0.28 Allowed Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.754 178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 49' ' ' ASN . 31.9 Cg_endo -65.92 132.74 31.22 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.859 2.372 . . . . 0.0 113.863 -178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.2 t -121.4 149.29 43.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.957 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.677 ' O ' ' HB2' ' A' ' 53' ' ' ASP . 16.2 t -87.09 129.15 35.04 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' HB2' ' O ' ' A' ' 52' ' ' CYS . 0.4 OUTLIER 150.2 -43.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -177.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 56' ' ' ASN . 80.8 mt -64.96 86.66 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.685 178.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.453 ' HB3' ' O ' ' A' ' 54' ' ' ILE . 66.4 t30 76.31 -44.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.59 0.709 . . . . 0.0 109.305 -177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.53 ' H ' ' C ' ' A' ' 54' ' ' ILE . 16.4 p30 152.71 50.54 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.413 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 77' ' ' ILE . . . 72.99 3.89 61.37 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.716 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 18.54 15.93 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.539 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 2.8 m -106.86 -175.58 2.83 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.941 0.896 . . . . 0.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.881 ' HB2' ' HA ' ' A' ' 94' ' ' PHE . 3.8 t70 -101.56 147.96 34.56 Favored Pre-proline 0 C--N 1.316 -0.872 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 60' ' ' ASP . 53.3 Cg_exo -47.81 -23.85 4.41 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.179 1.919 . . . . 0.0 112.038 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 82' ' ' LYS . 24.2 p -84.94 -31.7 23.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.544 ' HB3' ' H ' ' A' ' 60' ' ' ASP . . . -78.1 97.48 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.589 ' HB2' ' HE2' ' A' ' 82' ' ' LYS . 19.2 t -48.45 114.79 1.03 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.837 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 56' ' ' ASN . 15.3 t -90.3 145.31 25.07 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.304 0.574 . . . . 0.0 112.048 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HG3' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -146.82 130.79 17.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.571 178.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.534 HD22 ' HB3' ' A' ' 52' ' ' CYS . 0.3 OUTLIER -83.11 142.62 31.12 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 121.399 0.618 . . . . 0.0 111.212 179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 76' ' ' LYS . . . -163.33 160.65 23.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.924 -1.035 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -120.17 122.83 41.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.352 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.4 t -142.9 169.4 17.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.046 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.437 HG23 ' HG3' ' A' ' 72' ' ' GLU . 1.8 t -57.44 -26.73 61.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.611 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' HG3' HG23 ' A' ' 71' ' ' THR . 13.6 mt-10 -106.66 138.6 42.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.967 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.783 ' HA ' ' HE3' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.68 -32.82 73.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.671 179.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 43.2 t -78.17 -26.88 47.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.709 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -79.68 6.51 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.934 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.783 ' HE3' ' HA ' ' A' ' 73' ' ' ASN . 52.6 mttt -87.41 -54.07 4.48 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.522 HG12 ' HB2' ' A' ' 50' ' ' PRO . 40.2 mm -93.21 118.14 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.511 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.092 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 78' ' ' ILE . 3.3 mp -92.87 104.07 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.158 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.759 ' SG ' HD22 ' A' ' 34' ' ' LEU . 33.9 m -102.93 118.17 36.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.562 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 63' ' ' ALA . 2.9 m -128.51 118.56 23.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.236 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 3.3 m -83.04 144.09 30.17 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.589 ' HE2' ' HB2' ' A' ' 64' ' ' SER . 1.9 mptp? -69.79 -176.87 1.14 Allowed 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 35.4 mt-10 -56.97 -40.5 85.57 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 83' ' ' GLU . 61.7 Cg_endo -74.08 5.83 3.32 Favored 'Trans proline' 0 CA--C 1.511 -0.652 0 C-N-CA 121.394 1.396 . . . . 0.0 111.453 -178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 97' ' ' SER . 3.9 p -121.1 74.57 28.57 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.451 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.76 -11.98 10.67 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.615 2.21 . . . . 0.0 111.625 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.536 ' H ' ' HG2' ' A' ' 4' ' ' PRO . 8.5 m-80 -131.83 -164.88 1.51 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.236 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -165.07 132.08 2.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.66 ' CD2' ' HB2' ' A' ' 94' ' ' PHE . 0.7 OUTLIER -62.59 102.63 0.34 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CE2' ' HA3' ' A' ' 19' ' ' GLY . 0.2 OUTLIER 70.79 -131.62 0.05 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.972 -177.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HG2' ' HD1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -85.95 7.71 23.25 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.979 0.362 . . . . 0.0 111.979 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 119.52 -6.5 12.67 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.502 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.696 ' HA ' HD21 ' A' ' 34' ' ' LEU . 23.4 t -45.76 -32.38 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.629 0.728 . . . . 0.0 109.25 178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.881 ' HA ' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -152.08 154.55 36.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.349 176.881 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.59 163.0 38.55 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.3 t -110.03 125.36 52.84 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.09 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.546 ' HA ' HG22 ' A' ' 85' ' ' THR . 25.9 t -109.04 109.36 20.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.202 0.525 . . . . 0.0 110.746 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 177.33 -47.03 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.798 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.197 -179.68 . . . . . . . . 1 1 . 1 stop_ save_